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Abstract
Abstract
Pregnancy-Specific Glycoproteins (PSG) are the most abundant fetally expressed
proteins in the maternal bloodstream at term. This multigene family are
immunoglobulin superfamily members and are predominantly expressed in the
syncytiotrophoblast of human placenta and in giant cells and spongiotrophoblast of
rodent placenta. PSGs are encoded by seventeen genes in the mouse and ten genes in
the human. Little is known about the function of this gene family, although they have
been implicated in immune modulation and angiogenesis through the induction of
cytokines such as IL-10 and TGFβ1 in monocytes, and more recently, have been shown
to inhibit the platelet-fibrinogen interaction. I provide new information concerning
the evolution of the murine Psg genomic locus structure and organisation, through
the discovery of a recent gene inversion event of Psg22 within the major murine
Psg cluster. In addition to this, I have performed an examination of the expression
patterns of individual Psg genes in placental and non-placental tissues. This study
centres on Psg22, which is the most abundant murine Psg transcript detected in the
first half of pregnancy. A novel alternative splice variant transcript of Psg22 lacking
the protein N1-domain was discovered, and similar to the full length isoform induces
TGFβ1 in macrophage and monocytic cell lines. The identification of a bidirectional
antisense long non-coding RNA transcript directly adjacent to Psg22 and its associated
active local chromatin conformation, suggests an interesting epigenetic gene-specific
regulatory mechanism that may be responsible for the high level of Psg22 expression
relative to the other Psg family members upon trophoblast giant cell differentiation.
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Chapter 1
Introduction
The placenta of eutherian mammals is a remarkable biological structure which
originated more than 100 million years ago (mya) [1] and therefore is relatively recent
in terms of vertebrate evolution [2]. It is composed of both embryonic and maternally
derived cells, and facilitates the complex interactions between the mother and the
fetus that are necessary for fetal growth and survival [3]. The mouse (Mus musculus),
serves as a useful model for studying the development of the haemochorial placenta,
as corresponding placental tissues from the human at many stages of gestation are
not generally accessible due to legal and ethical constraints. Mouse and human
placentas share a discoid shape, hemochorial exchange, analogous cell types and
cell layers, and molecular features [4, 5]. There are exceptions to this placental
similarity, with idiosyncracies in our fetal membrane development including primary
interstitial implantation in a simplex uterus, the lack of yolk sac placentation, and the
development of an allantoic stalk rather than an allantoic sac [6]. Murine implantation
and trophoblast invasion is shallower and more restricted than in humans [6].
Despite these differences, the mouse is a useful model to investigate the
genetic basis of trophoblast development. In addition to anatomical similarities
in trophoblast development, these two species demonstrate a large amount
of chromosomal synteny and gene orthology, in the developmental regulatory
mechanisms of the trophoblast, which is useful for comparative genetic analysis.
A major benefit of mice compared to other rodent models lies in the availability
1. INTRODUCTION
of embryonic stem cells and technologies to produce genetic knockout (-/-) and
transgenic mice [6]. Null phenotype data generated in the mouse has helped us
gain valuable insights into the complexity of the differentiation and regulation of
the trophoblast. Gene expression patterns that are conserved in humans should
enable the interpretation of the molecular basis of human placental dysfunction [5].
Placental dysfunction and disease can have detrimental effects which contribute to
morbidity and mortality in mother and fetus. Preeclampsia, Hydatidaform mole,
and spontaneous abortion are a number of pregnancy complications that occur in the
human. An understanding of the embryological development of the placenta in a
variety of eutherian mammals will facilitate in the treatment and prevention of these
common disorders.
The fully developed placenta in humans and rodents is composed of three
distinct layers: the outer maternal layer (decidua basilis), which includes decidual
cells of the uterus as well as the maternal vasculature that brings blood to/from
the implantation site; a middle spongiotrophoblast (SpT) “junctional” region, which
attaches the fetal placenta to the uterus and contains fetoplacental (trophoblast) cells
that invade the uterine wall and maternal vessels; and an inner labyrinth layer,
composed of highly branched villi that is bathed in maternal blood and facilitates
efficient nutrient exchange [7]. Each of these layers possess specialised endocrine,
paracrine, vascular, immunological or transport functions during gestation [8]. The
maternal blood supply passes through this junctional zone via large central ‘arterial’
sinuses in which the maternal endothelial cells are eroded away and replaced by
trophoblast cells. The maternal blood eventually enters into the intricate spaces of
the labyrinth where the fetal trophoblastic villi are bathed by maternal blood enabling
material exchange between the two blood systems [9]. The fetal trophoblastic villi
are composed of outer epithelial layers that are derived from the trophoblast cell
lineage and an inner core of stromal cells and blood vessels [7]. It is this invasive
form of implantation and direct foetal contact with maternal perfusing blood that is
characteristic of haemochorial placentation (Fig:1.1.).
Functionally the placenta is an endocrine organ that produces various
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placental hormones and secreted factors that are found in abundance in the
maternal bloodstream during pregnancy and are essential for maintaining a suitable
environment for pregnancy and fetal development [10]. The fetus is considered to be
semi-allotypic in the maternal body; nevertheless, in most cases, immune rejection
of the fetus does not occur [11]. At the interface of fetal and maternal tissues,
the cells of the innate and adaptive immune systems have been found to produce
both Th1- and Th2-type cytokine subclasses. Changes in the cytokine profile is
dependent on gestational-age, and in some pregnancy complications, many cytokines
have been shown to exert both pro- and anti-inflammatory functions, depending
on their binding with their receptors, or intensity, and duration of the stimulation
[12, 13]. A multitude of data suggests that maternal immunity is skewed toward the
anti-inflammatory Th2 condition during pregnancy, which protects the developing
fetus from immune rejection [14]. Initial data demonstrating an immunoregulatory
function for the placenta was the discovery of high expression of HLA-G in human
trophoblasts [15]. It is these trophoblast cells that secrete placenta-specific hormones
that are responsible for the immunomodulatation of the maternal physiology and also
fulfill a variety of structural and functional roles in the haemochorial placenta. The
cells of the trophoblast lineage constitute the epithelial compartment of the placenta,
and the establishment and maintenance of pregnancy is dependent on the precise
development of these cells [16].
1.1 The Trophoblast
1.1.1 Development of the trophoblast
Once the embryo is anchored within the uterine wall, the next major event is
the formation of the extraembryonic lineages, a necessary prelude to assembly of
the maternal-fetal interface [17]. Only recently, considerable insights have been
gained into how the trophoblast lineage differentiates at the blastocyst stage due
to the generation over 100 mutant mouse lines that manifest defects in placental
development. In addition, the derivation of murine trophoblast stem cells (TSC)
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has provided a powerful resource for understanding the molecular mechanisms
governing TSC maintenance and differentiation [16]. In all mammals, the trophoblast
cell lineage is specified before implantation. Implantation involves a succession of
genetic and cellular signals [18], that implement a reciprocal interaction mediating
apposition and adhesion between trophectoderm (TE) in the blastocyst and uterine
epithelium, followed by trophoblast invasion [19]. In mice at embryonic day (E) 3.5,
placental development begins when this lineage appears in the blastocyst as the TE, a
sphere of epithelial cells surrounding the inner cell mass (ICM) and the blastocoel at
around the 32-cell stage of development [20, 21, 22]. The appearance of a progenitor
population of TSC represents the initial differentiation event of embryogenesis [23].
At this stage they have not fully committed to a definite cell fate, as evidence has been
found that the outside cells of the late morula can produce ICM derivatives [24], and
inside cells can make trophoblast tissue [25]. It is not until blastocyst formation that
the TE and ICM lineages are irreversibly determined [26].
The TE layer of the preimplantation embryo is the precursor to all trophoblast
cell subtypes (Fig:1.1. and Fig:1.2.). However, the entirety of the TE layer does not
contribute equally to the various trophoblast subtypes. Upon implantation, the TE of
the blastocyst not in contact with the ICM, designated the mural TE, differentiates
to form post-mitotic primary trophoblast giant cells (TGC) that migrate into the
antimesometrial portion of the implantation chamber and surround the future parietal
yolk sac. In contrast, the TE directly overlying the ICM, known as the polar TE, retains
its capacity to proliferate and expands to form the extraembryonic ectoderm (ExE) and
ectoplacental cone (EPC) [27]. The chorion, which is a tightly packed layer of TSC,
is in contact with the base of the EPC. TSC are defined as pluripotent cells whose
differentiated derivatives are restricted to the trophoblast lineages. The restricted
potential of TSC to exclusively contribute to trophoblast-derived cell types has been
demonstrated in chimeras in vivo where they can they can give rise to all trophoblast
elements of the mouse placenta, but they are unable to contribute to the embryonic
germ layers giving rise to the tissues of the fetus [21]. Stem cell potential is maintained
in trophoblast cells of the ExE post-implantation. This is reflected by the ability to
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derive morphologically and functionally indistinguishable TSC lines from blastocyst
stage embryos as well as from the ExE and its derivatives in the chorion until E8.5 [21].
The TSC of the chorion layer develops from the ExE, and later some of these
TSC will differentiate towards a labyrinth fate. During this development, the labyrinth
is structurally supported by the SpT which is derived from the EPC. The vasculature
of the placenta is derived from the extraembryonic mesoderm of the allantois that
extends from the posterior end of the embryo at E8.0. The junction of the allantois
and the chorion joins together at E8.5, in a process called chorioallantoic fusion, even
though no physical cell fusion occurs [9]. After chorioallantoic fusion takes place,
folds begin to form in the chorion which develop into the villi, creating a space into
which the fetal blood vessels grow from the allantois and this becomes the fetal
component of the placental vasculature [31]. The labyrinthine villi become larger
and more extensively branched until birth (E18.5–19.5). Around E11.5, the labyrinth
and junctional zones are indistinguishable and consists of strands of SpT and TGC,
separated by maternal blood sinuses. Glycogen trophoblast cells (GlyT) appear at
E12.5 and at this stage the labyrinth and junctional zones are distinguishable [32].
These GlyT differentiate within the SpT layer, and form a dense layer of non-syncytial
cells between the labyrinth and the outer giant cells, which consequently diffusely
invade the uterine wall and corresponds to the column cytotrophoblast (CTB) of the
human placenta [33, 9]. Differentiating trophoblast cells acquire specialized functions
that are essential for the establishment and maintenance of pregnancy including:
invasion, nutrient and waste transport, metabolism, protection from the maternal
immune system, and production of hormones and cytokines that likely contribute
to all of these functions. Progression along the trophoblast lineage is dictated by
the activation of sets of genes characteristic of the specific differentiated trophoblast
phenotype [34].
1.1.2 Trophoblast Giant cells
In rodents, the most invasive of the placental cells are the TGC, so named because
of their unusually large size which is related to the fact that they are extensively
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
6 John Michael Williams
1. INTRODUCTION 1.1 The Trophoblast
Morula
Blastocyst
Inner Cell Mass Trophectoderm
       Polar
Trophectoderm
      Mural
TrophectodermYolk sac Mesoderm
Trophoblast Stem Cells
Extraembryonic 
    Ectoderm
Chorionic 
Ectoderm
Ectoplacental 
       Cone
      Labyrinth 
Syncytiotrophblast Spongiotrophoblast
 Secondary 
Trophoblast
 Giant cells
   Primary 
   Parietal 
Trophoblast
 Giant cells
Glycogen 
   TGC
Spiral
Artery
 TGC
Canal
 TGC
Sinusoidal 
   TGC
  Invasive Giant cells
Figure 1.2: Trophoblast lineage and origins of TGC subtypes. (modified from [16, 28, 29,
30]).
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polyploid and terminally differentiated cell types. In rodents, TGC are the first
terminally differentiated subtype of cells to be derived from the trophoblast cell
lineage [35]. Proliferative trophoblasts differentiate into TGC as they exit the cell cycle
and enter a process of endoreduplication, an unusual cell cycle with successive rounds
of deoxyribonucleic acid (DNA) synthesis in the absence of intervening mitoses
[36, 37]. TGC in the rodent placenta form the outermost layer of the extraembryonic
compartment. This layer is responsible for establishing direct contact with maternal
cells facilitating in embryo implantation, conceptus invasion, and provides a number
of pregnancy-specific cytokine hormones [8, 38].
The mural trophectoderm, trophectoderm cells which are not in contact with
the ICM at the time of implantation (E4.5), stop dividing and differentiate to form
a limited number of TGC which line the implantation chamber, anastomosing to
form a diffuse network of blood sinuses for the early transport and exchange of
nutrients and endocrine signals [39]. These cells are analogous to human extravillous
cytotrophoblast cells [9]. The trophectoderm immediately overlying the ICM, the
polar trophectoderm, continues to proliferate and gives rise to all the remaining
trophoblast cell types of the placenta [20], including SpT, glycogen trophoblast cells,
several labyrinth trophoblast cell types, and a later influx of TGCs (called ‘secondary’
to distinguish them from the initial ‘primary’ group) [16, 40]. Four TGC subtypes
have been identified in the placenta each of which posses specialised functions and
are listed in Table 1.1, these TGC subtypes include parietal TGC (P-TGC), that line
the implantation site and are in direct contact with decidual and immune cells in
the uterus, spiral artery-associated TGCs (SpA-TGC), maternal blood canal-associated
TGCs (C-TGC), and sinusoidal TGC (S-TGC) that are within the sinusoidal blood
spaces of the labyrinth.
These TGC subtypes share common characteristics like their large size,
invasive, phagocytic and secretory nature [39, 41]. Even so, the four subtypes of TGCs
can be distinguished by their anatomical location and gene expression [16]. These
four distinct TGC subtypes are derived from different TE lineages origins at different
periods during placentogenesis [35]. The gene expression markers that correspond
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to these four TGC subgroups are shown in Table 1.1, some of which I utilised in the
characterisation of TGC populations that were present in a culture of differentiated
TSC. P-TGCs arise directly from approximately 60 mural trophectoderm cells in
the blastocyst in a process called primary TGC differentiation, although the several
hundred P-TGCs that are present by mid-gestation, and all of the other TGC subtypes,
arise from the polar trophectoderm through so-called secondary TGC differentiation.
Both P-TGC and C-TGC have mixed developmental origins. In contrast, all of the
Spa-TGC originate from Tpbpa positive cells, whereas all of the S-TGC originate from
Tpbpa negative precursors [29]. The locations of these four types of TGC in the mature
murine placenta are shown (Fig:1.3.).
Table 1.1: TGC subtypes in the mature placenta (modified from [29]).
Subtype Location Temporalappearance
Marker
genes Suggested function
SpA-TGC
Lining maternal
spiral arteries
bringing blood into
placenta
E10.5 Plf
Regulate maternal spiral artery
remodeling and blood flow into
the placenta
P-TGC
Lining implantation
site and outer layer
of parietal yolk sac
E7.5 Pl1, Pl2,Plf
Facilitate implantation and initial
maternal vascular connections,
regulate decidual
cell differentiation, and maternal
physiology
C-TGC
Lining canals that
bring
maternal blood to
base of labyrinth
E10.5 Plf, Pl2
Regulate
maternal vasculature remodeling
and maternal physiology
S-TGC
Within maternal
blood sinusoids of
the labyrinth layer
E10.5 Ctsq, Pl2
Modulation of hormone
and growth factor activity before
they enter
fetal and/or maternal circulation,
regulate maternal physiology
In the mouse, two different phases of trophoblast invasion can be
distinguished, these are either endo- or perivascular, as invasive trophoblast cells
are strictly associated with maternal arteries where they displace endothelial cells
or are located within one or a few cell layers underneath the vascular endothelium
[33, 42, 43, 44]. Endovascular TGCs, invade great distances into the maternal spiral
arteries to replace endothelial cells and express Plf but not Pl1. Endovascular TGCs
more proximal to the placenta express both genes [45]. TGCs produce Pl-1 starting
soon after implantation until mid-gestation and subsequently Pl-2 from mid-gestation
until term [46]. The morphology of endovascular TGCs is also clearly different to that
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Figure 1.3: Locations of TGC subtypes in mature placenta. SpA-TGC, spiral artery
trophoblast giant cell; GlyT, glycogen trophoblast; P-TGC, parietal trophoblast giant
cell; SpT, spongiotrophoblast; S-TGC, sinusoidal trophoblast giant cell; C-TGC, canal
trophoblast giant cell. (modified from [2, 7]).
of interstitial TGCs as they are much smaller and more spindle-like [45].
Only after gestational day (E) 14.5, a different, ‘interstitial’ type of
trophoblast invasion is observed where cytokeratin-positive trophoblast cells are
broadly penetrating into the decidual stroma and are not obviously associated with
maternal blood vessels. Morphological characteristics such as a vacuolated-appearing
cytoplasm, a positive PAS stain and expression of the SpT marker gene Tpbpa
identify these cells as glycogen cells [44]. SpT cells comprise the middle layer of the
placenta sandwiched between the outer secondary TGCs and the inner labyrinth layer
(Fig:1.3.). The function of the SpT layer (or Junctional zone) is poorly understood.
However, it could act as structural support for the developing villous structures of the
labyrinth and is also known to express several unique genes. Precursors for SpT cells
reside within the EPC. However, observations from several mouse mutants suggest
that SpT and TGC can arise from a common EPC precursor [47, 48].
TGCs have diverse functions that are crucial for implantation and subsequent
placental function. The mural trophectoderm-derived TGCs mediate attachment of
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blastocyst to the uterine epithelium, induce uterine decidulization, invade into the
uterine stroma, and anastomose to form the yolk sac placenta for early exchange of
nutrients and endocrine signals between mother and fetus. After implantation, TGCs
produce hormones and cytokines for maintenance of the feto-maternal interface and
regulation of maternal adaptations to pregnancy [29]. The four TGC subtypes have
a variety of functions, and these TGC exert their functions through a multitude of
paracrine and endocrine mechanisms (Table 1.1.). These paracrine and endocrine
effects of TGC, including the responsible signalling molecules are shown (Fig:1.4.).
This figure demonstrates the diverse roles TGC play in the initiation and maintanence
of pregnancy, from implantation and vascular remodelling to modulating maternal
immune physiology and adaptive behaviour. Some of the TGC functions may
be mediated by their ability to produce Pregnancy-specific glycoproteins (PSG), as
suggested by the prominent association of at least one PSG with the endothelial lining
of vascular spaces surrounding the implantation site from E8.5 to E11.5 [49]. TGC
function depends on successful differentiation from TSC. In order for trophoblast
proliferation and differentiation to occur properly, a specific microenvironment must
exist to support the maintenance of the trophoblast stem cell population [50], which
relies on a complex regulatory signalling mechanisms, which are discussed in the next
section.
1.1.3 Trophoblast regulatory pathways
ES cells predominantly contribute to the embryo proper and TSC only contribute
to the various trophoblast cell types of the placenta. Along with studies of mouse
mutants these stem cell lines have allowed us to begin to elucidate the transcriptional
networks that define the two earliest cell populations and orchestrate lineage-specific
transcriptional programmes in all their progenitor cells [51]. Like other stem cells, TSC
cells have the ability to self-renew or to differentiate into more specialized, lineage-
specific cell types, depending on reception of appropriate signals [52]. Maintenance
of trophoblast proliferation and self-renewal is dependent on signals from the ICM.
Indeed, ICM cells inserted into an empty sphere of trophectoderm can induce
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secondary sites of proliferation [27]. Pluripotent trophoblast stem cells reside within
the extraembryonic ectoderm and later the chorionic ectoderm [21, 53], and provide
the EPC with progenitors which give rise to the SpT and secondary TGC. Maintenance
of trophoblast proliferation later in gestation is also dependent on close proximity with
the embryonic-derived epiblast as isolated EPC or EXE transplanted ectopically [54].
Signalling pathways establish the transcriptional circuitry that underpins TE identity
and how the core trophoblast transcription factors coordinate lineage commitment,
maintenance of the stem cell niche and eventual differentiation into placental cell
types [55]. Due to the changing nature of embryonic and ExE development, it is
probable that this specialized niche is temporary and exists only for 3–4 days during
post-implantation development [22, 53].
The maintenance of TSC in the early embryo is dependent on FGF signaling
involving the ligand Fgf4, which is a paracrine factor produced by the ICM/epiblast
and signals through MAPK and controls trophoblast proliferation [56]. Fgf4 is
expressed in early embryos, becoming restricted to the ICM of the blastocyst and
later to the epiblast of the early post-implantation embryo [57, 58]. TSC maintenance
is also dependant on the FGFR2 receptor, which is expressed in trophoblastic
tissues, including the ExE and chorion [9, 59, 47]. As mentioned previously, when
cultured in the presence of Fgf4, mouse TSC exhibit sustained undifferentiated
proliferation, without significant expression of the phenotypic markers of placental
trophoblasts, such as Pl-1/Pl-2, or placental prolactin-related proteins. Removal
of Fgf4 results in the arrest of cell proliferation, rapid TGC formation and onset
of hormone gene transcription [21]. Fgf4 expression is induced by the TGFβ-
related protein Nodal. Nodal, along with Fgf4, acts directly on adjacent ExE that
maintains a microenvironment that inhibits premature TSC differentiation [50]. Nodal
plays an important role in trophoblast differentiation, as conceptuses that possess
a hypomorphic mutation in Nodal, result in an expansion of the TGC and SpT
layers, and a decrease in labyrinthine development [60]. The addition of Fgf4 alone
can inhibit the induction of Mash2 but cannot maintain expression of Cdx2, Eomes,
and Err2. Conversely, addition of Nodal or Activin alone cannot inhibit Mash2
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expression in ExE but, in combination with Fgf4, can maintain Cdx2, Eomes, and Err2
expression [50]. Activin or TGFβ1 can also replace MEF conditioned medium for the
maintenance of TSC proliferation in vitro suggesting that constitutive FGF signaling
in TSC selectively inhibits the ability of TGFβ1 to repress c-myc expression, a central
component of the TGFβ1 cytostatic transcriptional response [61]. Fgf4 produced in the
embryonic ectoderm, signals through Fgfr2 to maintain the expression Cdx2, Eomes,
and Err2 and suppression of Mash2 expression in the ExE. Nodal produced in the
epiblast maintains Fgf4 expression and cooperates with Fgf4 to maintain TSC marker
expression in EXE [16]. Mash2 is required for the maintenance of TSC and is essential
for maintaining SpT cells at the expense of TGC differentiation, as in its absence, the
SpT layer is lost and an excess of TGC form [21, 62]. Mash2 overexpression prevents
TGC differentiation and the suppression of Mash2 function, required to allow TGC
differentiation, may occur in vivo by loss of its E-factor partner due to loss of its
expression and/or competition from Hand1 [63].
Once TE and ICM lineages are delineated, it is clear that the POU domain
transcription factor, Oct4, has an important role in ICM fate determination [16].
Regulatory sequences of the Oct4 gene are hypermethylated and associated with a
closed chromatin structure in TSC, whereas these regions are hypomethylated with
an open chromatin structure (acetylated histones) in ES cells, resulting in differential
gene expression [64]. Oct4 has been shown to directly repress the transcription of
several trophoblast-specific genes [65, 66, 67]. Sox2 has a similar function in repressing
the trophoblast cell fate as that observed for Oct4 [68] and works together with Oct4
to regulate down-stream targets expressed in the ICM [69]. It has been shown that
less than a 2-fold increase of Sox2 protein levels in ESC is sufficient to down-regulate
Nanog and drive trophoblast, mesodermal and ectodermal differentiation [70]. Elf5
has an important role as its epigenetic regulation by DNA methylation positions it as a
gatekeeper of cell lineage fate between the trophoblast and embryonic compartments.
Elf5 expression is found from the late blastocyst stage onwards in the EXE where it
maintains the expression of Cdx2 and Eomes [71, 72]. Consistent with its expression
in trophoblast cells, the Elf5 promoter is unmethylated in TSC, but methylated in
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ES cells where Elf5 is not expressed [72]. This differential epigenetic modification of
Elf5 establishes a stable cell lineage barrier between the embryonic and trophoblast
compartments as it restricts the positive transcriptional feedback loop between Cdx2,
Eomes and Elf5 to the trophoblast lineage [55].
TGC differentiation is determined through a similarly complex transcription
factor signalling regulation as is with TSC self renewal. Some of the transcription
factors involved in TGC differentiation are shown (Table 1.2.). TGC differentiation
depends upon the coordinated activity of a family of transcription factors, most
notably basic helix–loop–helix transcription factors (bHLH) [16]. Members of the
bHLH family are thought to function as heterodimers, typically between the cell
subtype-specific factors and the widely expressed E proteins, such as E12/E47 (which
are products of the E2A gene) [73]. While Mash2 restricts differentiation of TGC,
other bHLH genes have the opposite effect. Hand1 promotes the formation of TGC.
The Hand1 transcription factor is required for TGC differentiation as Hand1 deficient
conceptuses die between E7.5 and E8.5 due to a block in TGC formation, placental
defects and noticibly smaller EPC [63, 74]. It has been suggested that Hand1 could
antagonize Mash2 function by competing for E-factor binding in vitro [63]. Other
bHLH factors are implicated in trophoblast development based on specific expression
patterns. Hand1, Stra13 and Gcm1 transcription factors override FGF signaling to
promote terminal differentiation of TSC [75]. Stra13 mRNA expression has been
suggested in TGC in mice, though not well documented [76] and the bHLH antagonist
I-mfa promotes TGC differentiation as shown by targeted deletion of I-mfa in a C57Bl/6
background which resulted in embryonic lethality around E10.5, associated with a
placental defect and a markedly reduced number of TGC. Overexpression of I-mfa in
rat trophoblast (Rcho-1) stem cells induced differentiation into TGC [77], possibly by
inhibiting the function of Mash2. Thus, an opposing network of bHLH transcription
factors and bHLH interacting proteins regulate TGC differentiation.
As already stated these bHLH factors work alongside a number of other
transcription factors that induce TGC formation. These include one of the best-studied
determinants of trophoblast cell fate, which is the caudal-type homeobox gene Cdx2
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Table 1.2: Transcription factors implicated in TGC differentiation
Transcription
factor Relevance to TGCs References
AP-2 TGC differentiation [8, 78]
Hand1 TGC terminal differentiation [8, 63, 75]
Tead4 Trophoblast speciation [79, 8]
Cdx2 Regulates TE differentiation [8, 28, 80]
Gata2/3 Regulates TGC differentiation [29, 81, 82]
Stat3 TGC terminal differentiation [83, 84]
Ik3 Trophoblast invasion [84]
RxR TGC terminal differentiation [8, 32, 35]
Klf4 Promotes TGC differentiation [85, 86]
FoxD3 Inhibits TGC differentiation [28, 87, 88, 89]
NeuroD1 Human CTB differentiation [84, 90]
Gcm1 TGC terminal differentiation [75, 91, 92]
[80]. Cdx2 is required to restrict expression of the pluripotency factors Oct4 and
Nanog to the ICM and, even though Cdx2 null embryos form blastocysts, they fail
to maintain trophectoderm cell identity, instead forming a ball of Oct4 expressing
cells incapable of hatching from the zona pellucida [26], demonstrating that Cdx2
is crucial to maintain a functional TE cell population and is a critical determinant
of trophectoderm identity [93]. Cdx2 is the earliest known factor to have a role in
trophoblast lineage development, although the molecular targets mediating its role
in trophectoderm identity are still unknown [16]. Cdx2 is a common marker used
to distinguish between TE and ICM cells in the mouse [22, 94]. Interestingly Cdx2
expression is lost as TSC differentiate to the TGC cell fate.
Even though Cdx2 and Oct4 play an essential role in inhibitory feedback
signalling in TE lineage differentiation, Tead4, is the transcription factor that exerts
most influence in TE lineage specification. Tead4 is required for specification and
development of the TE lineage, which includes modulation of Cdx2 expression [95, 79].
Tead4 triggers, directly or indirectly, the expression of Cdx2 and other transcription
factors. Once specified, a positive feedback loop involving Cdx2, Eomes, Tcfap2c, and
Elf5 reinforces trophoblast identity. In addition to supporting this network, Gata3, Elf5
and Ets2 subsequently act to drive further differentiation of the lineage into different
placental cell types [55]. The product of the T-box gene Eomes is the earliest-acting
transcription factor known to be required for immediate post-implantation lineage
commitment steps, as mice lacking Eomes gene expression fail to exhibit a proper
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TE to trophoblast transition. While they do implant, they arrest at a blastocyst-
like stage of development [96]. Eomes acts later in TE differentiation than Tead4
and Cdx2 by enhancing Cdx2 expression and promoting the expansion of the EXE
[80, 96]. Eomes can be activated directly by Elf5 and Tcfap2c, and directly or indirectly
by Cdx2 [79]. The AP-2 family members are also involved in the regulation of
human villous cytotrophoblast differentiation. Two of the isoforms, AP-2 α and AP-
2 β, are expressed in the human placenta. AP-2 binding sites are present on the
promoters of other genes in the placenta that affect placental function, such as TGFβ1,
vascular endothelial growth factor (VEGF), matrix metalloproteinases, tissue inhibitor
of metalloproteinases, and the estrogen receptor [97]. AP-2 γ (also termed Tcfap2c) is
important in TGC differentiation since it activates the human prolactin promoter [98].
Trophoblast fate induced by Cdx2 does not require Tcfap2c. However, activation of Elf5
is only achieved in the presence of both factors [99]. Tcfap2c cooperates with Cdx2 to
maintain trophectoderm formation, suggesting that Tcfap2c and Cdx2 act in alternate
pathways and are both required for the full establishment of TS cell identity [55].
Gata2 and Gata3 transcription factors have been implicated in the regulation
of trophoblast-specific genes [82]. Ray et al, 2009, demonstrated that Gata2 expression
was induced during TGC differentiation and hypothesised that Gata3 directly
represses Gata2 in undifferentiated trophoblast cells, and a switch in chromatin
occupancy between Gata3 and Gata2 (Gata3/Gata2 switch) induces transcription
during trophoblast differentiation, which regulates a variety other trophoblast-specific
genes [81]. Gata3-mediated trophoblast fate does not depend on Cdx2 expression.
Considering both these genes are regulated by Tead4, they appear to operate semi-
independently, specifying trophoblast fate through many different pathways and
targets [100]. There are a multitude of other transcription factors whose involvement
have been implicated in TGC differentiation, such as Ets2, Ik3, Stat3, Klf4, NeuroD1.
In addition to cell intrinsic factors, extrinsic factors also influence TGC formation.
Retinoic acid, for example, can promote TGC formation both in vitro and in vivo [101],
similar to the effects of overexpression of the retinoic acid responsive gene Stra13 [75].
These complex regulatory pathways and the genes that convey these signals have
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been reviewed extensively by [102, 75, 16, 103, 51, 8, 55, 22]. Detailed studies of the
cellular and molecular mechanisms governing TSC and TGC formation should give
insights into human gestational diseases that are associated with human extravillous
cytotrophoblast cells [104].
1.2 CEA superfamily: CEACAMs and PSGs
1.2.1 Ceacams
The carcinoembryonic antigen (CEA) family, which includes two mutligene
subfamilies; the CEA-related cell adhesion molecules (CEACAMs) and the Pregnancy-
specific glycoproteins (PSGs), are members of the immunoglobulin superfamily [105].
The CEACAM/PSG primordial gene is thought to be common to both primates
and rodents, but subsequent gene duplications have arisen independently in both
organisms [106]. Gene duplication and conversion is known to be critical to the
evolution of gene families [107, 108]. Kammerer et al, state that gene families are
formed through gene duplications produced by environmental adaptation, which
provide new raw genetic material that can be modified by natural selection, without
losing the function of the original gene [109]. Haig et al, in 1993, hypothesised
that antagonism between maternal and fetal genes in the placenta that regulate
maternal resource allocation and investment in pregnancy, represents an environment
of evolutionary conflict and therefore drives the evolution of these genes [110]. It has
been shown that the CEA family, with a subset of other placentally associated genes
experience positive selection and rapid evolution based on their pattern of sequence
divergence [111].
The CEA subgroup members are cell membrane associated and are expressed
in normal and cancerous tissues with notably CEA showing a selective epithelial
expression [112]. The nomenclature of the CEACAM family has changed; for example,
the original biliary glycoprotein (Bgp), later classified as the CD66a antigen, has now
become CEACAM1 (for current and historic nomenclature of the CEACAM family
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see [113]). Two different groups identified and characterized CEA complementary
deoxyribonucleic acid (cDNA) in 1987 [114, 115]. There are 12 human and 15
mouse CEACAM proteins (Fig:1.5.), CEACAM family members are characterized
by a membrane distal IgV-related, N-domain and variable number of IgC2-related
domains. A 20 amino acid (aa) leader-like peptide is encoded by the first exon of
all CEACAM members, and the second exon codes for the first N-terminal domain
(or N-domain) of the mature protein. This N-domain resembles the immunoglobulin
variable portion of an Ig molecule, whereas the other exons individually code for the
Ig-constant-like domains [116]. CEACAM domain structure shows more variability
between family members than the PSGs.
These proteins are linked to the membrane by either a glycophosphatidyl
anchor, or by a transmembrane anchor. The cytoplasmic domain can harbour
immunoreceptor tyrosine-based inhibition motifs (ITIM), immunoreceptor tyrosine-
based switch motifs (ITSM) or ITAM [117]. CEACAMs have a high level of
alternatively spliced transcripts. CEACAM1 is the most widely expressed member of
the CEA gene family and CEACAM1 is expressed on a number of different cell types
including epithelial, endothelial and in a variety of immune cells including B cells, T
cells, NK cells, dendritic cells (DC), macrophages and granulocytes [118, 119, 120, 121]
and mediates cell–cell adhesion [122]. These interactions are predominantly mediated
by the IgV-like N-terminal domain and appear to involve one of the two β-sheets
(the CFG-face) of the Ig-fold [123]. Tan et al, revealed that based on crystal structure,
the degree of variability in sequence of the N-terminal domain for all available
mammalian CEA molecules shows that, within the CEA family, most of the variation
occurs on the CFG faces of these molecules [124].
Structural and functional analyses show that homotypic and heterotypic
adhesion is the most prominent function of these extracellular domains, whereas the
cytoplasmic domain is involved in cell growth inhibition and signal transduction
[125]. CEACAM1 was found to be one of the pivotal receptors promoting the
signalling of immune cells, which is supported by its prominent homophilic adhesion
function. CEACAM1, thus seems to be a receptor targeted by pathogens to infect
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cells and simultaneously disrupt well coordinated immune responses. The function
of CEACAM family members as pathogens receptors, as well as their support of a
successful outcome of pregnancy, suggests that pathogen-mediated and fetal-maternal
conflict-induced selection are potential key drivers of CEA family evolution [109].
CEACAM5 has been found to possess high expression in adenocarcinomas and other
cancers, while CEACAM1 expression is down regulated in many tumors and it has
been shown to have a function in tumor-suppression [126]. CEACAMs have diverse
roles, with functions in shaping the architecture of epithelia, modulation of T cells and
tumor suppression [113].
1.2.2 Pregnancy-Specific Glycoproteins
PSGs are members of a rapidly evolving multigene family [111], and are the most
abundant fetal protein in the maternal blood at term in pregnancy [127]. The
maternal serum level of these proteins increases with gestation progression and
reaches up to 200-400 µg/ml at term, far exceeding the concentration of human
chorionic gonadotropin (hCG) and α-fetoprotein [127, 128]. PSGs are produced by
cells of the trophoblast lineage; syncytiotrophoblast in higher primates and SpT or
TGC in rodents [129, 130, 131]. Just like the CEACAMs, murine Psgs are clustered
on chromosome 7 in a region syntenic to human chromosome 19q13.2 [132, 133].
PSGs, like many placental hormones, are found in multi-gene families in all species
in which they are detected [134]. There are 11 human PSGs, 17 murine Psgs, and 8
rat PSGs. PSGs have been found in a multitude of species that possess haemochorial
placentation, like the bat [109]. More recently evidence for their expression in horse
has been gathered by searching for evidence of secreted CEACAM related genes in
the genome and identifying two related Expressed Sequence Tags (ESTs) from horse
trophoblast cDNA libraries [109]. Their expression is localised to the highly invasive
portion of the placenta and low PSG levels in maternal serum has been correlated
with poor pregnancy outcomes, particularly in diseases characterised by placental
insufficiency. This indicates that they may play a fundamental role in the formation
and maintenance of the maternofetal unit [129, 135, 136, 137, 138, 139, 140, 141, 142,
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143]. Their importance to the maintenance of pregnancy is further underlined by
the observation that the application of anti-PSG antibodies or vaccination with PSG
induces abortion in mice and monkeys, respectively, and reduces the fertility of non-
pregnant monkeys [144, 145]. However these are old papers and the reliability of the
antibodies used is questionable.
In terms of domain architecture and arrangement, PSGs are very similar
to the CEA-related Cell Adheasion Molecules (CEACAMs) possessing a series of Ig
domains in varying numbers and also being highly glycosylated. Comparison of the
domain organization of rodent and human PSGs reveals a remarkable evolutionary
divergence between species. The Ig domain structure of the human and rodent
PSGs differs between species: Human PSGs contain one V-like Ig domain (N),
C2-like Ig domains (A and B) and relatively hydrophilic tails (C), with domain
arrangements classified as type I (N-A1-A2-B2-C), type IIa (N-A1-B2-C), type IIb (N-
A2-B2-C), type III (N-B2-C) and type IV (A1-B2-C). In contrast, rodent PSGs typically
have three or more N domains followed by a single A domain. All rat PSGs,
with the exception of PSG36 (N1-N2-N3-N4-N5-A), are of the N1-N2-N3-A domain
arrangement [146]. In contrast, the murine Psg family has 14 members which encode a
common structure of three Ig variable (IgV)-like domains (N-domains) and a single Ig
constant (IgC)-like domain (A-domain) (N1-N2-N3-A) arrangement, and Psg24, Psg30
and Psg31 which have an expanded structure created by the duplication of (IgV)-like
domains. Psg24 with (N1-N2-N3-N4-N5-A), Psg30 with (N1-N2-N3-N4-N5-N6-N7-A)
and Psg31, which possesses a unique duplicated N1 domain, and has a (N1-N1-N2-
N3-N4-N5-N6-N7-A) domain arrangement. At the amino acid level the N1 domains
of rodents and the N-terminal domain of human PSGs have high similarity. The
relatively smaller number of PSG genes identified in the rat (compared to the mouse)
and the higher level of gene homogenisation implied by split decomposition analysis
suggests that the rat PSG gene family has not expanded or diversified as extensively
as the mouse [146]. The rodent and primate PSGs and CEACAMs common ancestor
was most likely similar to CEACAM1, which is the only CEA family member with
homologous gene structure in the human, rat and mouse that encodes all types of
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extracellular domains present in CEACAM and PSG proteins [146, 147, 148, 106].
One of the most striking differences between the CEACAMs and the PSGs
across species is the lack of a C-terminal membrane targeting component in PSGs.
In CEACAMs a hydrophobic transmembrane sequence or GPI anchoring leads them
to attach to the cell surface as opposed to PSG, which appear to be secreted because
most of them lack hydrophobic C-terminal domains suitable for membrane anchorage
[106]. The schematic arrangement of the immunoglobulin and immunoglobulin-like
domains of the 17 mouse, 8 rat and 10 human proteins are shown (Fig:1.6.), which
demonstrates the high level of structural conservation based on protein sequence
similarity between members of the different PSG families across species. Much current
work has focused on human PSGs due to their possible relevance to disorders of
pregnancy. Nevertheless, the investigation and analysis of rodent PSG is significant
due to the extensive conservation of expression of these genes in trophoblast, the
independent gene family expansions of these genes in mammalian lineages that
possess haemochorial placentation, and the implicated conservation of immmune
functions during pregnancy [146].
Due to the high levels of conservation of expression and structure, one may
assume that human and rodent PSGs share a common function. As the N1 domain
is the only domain of identical type (IgV-like) and position (first domain) common to
rodent and human PSGs, it probably plays a major role in determining a conserved
function. The tripeptide sequence Arg/Gly/Asp (RGD) found on the CFG face
in the N1 domain human PSGs is known to be responsible for the interaction of
some extracellular matrix proteins with cell surface receptors of the integrin family
[149, 150, 151]. PSG1 is the only human PSG that contains a KGD tripeptide motif,
rather than RGD tripeptide motif present in the N-domain of the protein. Unlike most
primate PSG N domains, rodent PSG N1 domains do not possess an RGD tri-peptide
motif, but do contain RGD-like motif sequences, which are not found to be conserved
in the N2 and N3 domains of rodents. In rodents, and especially in mice, the RGD
motif is replaced by a motif which contains a highly conserved Gly residue flanked by
a positively and/or a negatively charged amino acid (R/HGE/K) located in the first
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Figure 1.6: Schematic representation of Pregnancy-Specific Glycoprotein domain
organisation in (A) Mouse Psgs are composed of 3 – 8 IgV-like N domains and one
IgC-like A domain. The relative position of potential N-glycosylation sites indicated
by lollipops [148]. (B) Rat PSGs are composed of 3 – 5 IgV-like N domains and one
IgC-like A domain and (C) Human PSGs are composed of 1 IgV-like N domain, 2 or
3 Ig-C-like domains. (Not to scale) Human PSG5 also has a larger NA1A2B2 variant.
(modified from http://www.carcinoembryonic-antigen.de/).
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N domain [152, 106]. To asses the prevalence of conservation of this integrin binding
motif across in PSGs across a variety of species, I aligned the N terminal IgV-like
domain of Human, Chimpanzee, Baboon, Mouse and Rat PSG families. There is a high
level of conservation of this motif throughout Old World primates and rodents species
(Fig:1.7.). As predicted chimpanzees (Pan troglodytes) shared the highest level of RGD
motif conservation within the 10 PSG protein coding genes that they posses (PSG1-
11). The Baboon (Papio hamadryas) showed slight deviance from this motif, only one
third of the 15 member PSG family (PSG56-PSG70) harbouring an RGD motif, whereas
the remaining members have predominantly (QGD/RCD/RCH) motifs, with PSG70
possessing a unique PAE motif in the Baboon PSG family. This motif conservation
is maintained but with a higher level of deviance in the rat (Rattus norvegicus), with
the eight rat PSG (PSG36-PSG43) family members having (RH/GRA/EKD) motifs.
Conserved RGD and RGD-like tri-peptide motifs in the majority of PSGs suggest
that they may function like snake venom disintegrins, which bind integrins and
disrupt tissue architecture of prey [153]. This integrin-binding motif that is thought to
mediate interactions with the extracellular matrix [154] and immune cells [155]. This
partial conservation of an evolutionary important integrin binding motif composed of
RGD and RGD-like tri-peptides in primate and rodent N and N1 domains, therefore
supports a role for these conserved motifs in PSG function [146].
To ensure that I was working with the correct sequences for these genes
and transcripts, a current and detailed list of PSG accession numbers from the main
publicly accessible genome browsers was compiled using all of the known PSG
sequences and using the online NCBI BLAST sequence alignment tool. Each PSG
accession number was checked and its corresponding sequence was BLASTed against
entries from the three most commonly used sequence databases. A table of PSGs that
correctly aligned to their corresponding sequences and annotations was constructed
(Table 1.3.). This is an updated version of the accession table found in McLellan et
al, 2005 [148]. Even though this current table is as up-to-date as possible, there are
a few sequences that are not yet properly annotated, especially in the rat genome.
The rat genome still requires completion as it has many regions of the genome yet
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Figure 1.7: Functional conservation of integrin-interacting ’RGD’-like tri-peptide
motif between species. ClustalW alignment of ’RGD’-like tri-peptide motif in N-
terminal IgV-like domain of Human, Chimpanzee, Baboon, Mouse and Rat PSG
families.
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unsequenced. This comprehensive accession table will aid in further studies of the
PSG multi-gene families.
1.2.3 PSG function
The exact physiological functions of PSGs are not known. A conserved function
between human and mouse PSGs has been proposed, due to conservation of structure
and expression patterns. The fact that PSGs are synthesized by CTB and TGC, and are
secreted from the outermost layer of the placenta that aggressively invades the uterine
wall during placentation, implicates the PSG families role in structural modulation
at the feto-maternal interface. Given that the PSGs are heavily glycosylated and
the protein sequences are evolving rapidly, it is possible that PSGs function in a
similar way to the ruminant PAGs. Indeed, the glycosylated PAG [156, 157] and PSG
[148, 49] proteins are both implicated in immunological roles. The discovery that PSGs
induce cytokines in human and murine macrophages has led to the consideration that
human PSGs may function to modify maternal immune responses. Over a decade
of published work has shown PSGs to be pro-angiogenic and immunomodulatory
hormones that can directly induce various cytokines from several cell types in a
cross-species reactive manner and suggests that PSGs exert an influence on cytokine
polarization in pregnancy [158, 159, 160, 161, 162, 12, 163, 164, 13, 165, 166]. Table
1.4 outlines the published cytokine responses reported for individual PSGs and the
responsive cell types. These anti-inflammatory cytokines promote a tolerogenic
decidual microenvironment, and expression of the anti- inflammatory cytokines IL-
10 and TGFβ1, by peripheral blood mononuclear cells (PBMC) and placenta has been
associated with successful human pregnancy [167, 168, 169, 160].
Motrán et al, performed complex in vivo studies demonstrating that PSG
alternatively activates antigen presenting cells which then polarize maternal T-cell
differentiation to the ’less-damaging’ Th2-type phenotype compatible with successful
pregnancy [12]. Recently, the same group treated DC with PSG1, which promoted the
enrichment of Th2-type cytokines, IL-17-producing cells, and Treg cells from CD4+
T cells from DO11.10 transgenic mice [166]. In parallel to their immunomodulatory
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role, it has been indicated that some members of the murine and human PSG family
may be involved in placental angiogenesis. It was found that PSG1 induces the
formation of tubes by endothelial cells and members of the human and murine PSG
induce the secretion of TGFβ1 and VEGF-A [170, 13, 171]. A possible role of PSGs
in uteroplacental angiogenesis is further supported by the finding that incubation
of endothelial cells with Psg22 resulted in the formation of tubes in the presence
and absence of VEGFA [165]. PSGs role in vasculogenesis and angiogenesis may be
required for the establishment and maintenance of the fetoplacental blood supply. It
has also been shown that PSG genes can be categorized as early-responsive genes in
cellular senescence models [172, 173], as all PSGs were upregulated in HeLa cells upon
the addition of 5-bromodeoxyuridine in replicative senesence.
Recent work from our laboratory has demonstrated that PSG1 has other
functions apart from cytokine induction, immune modulation and angiogenic
stimulation (Table 1.4.) [158, 159, 160, 161, 162, 12, 163, 164, 13, 165, 166]. Moore and
colleagues have shown that PSG1 exhibits a novel anti-thrombotic function, facilitated
through the binding of many PSG1 domains to the α-2b-β-3 platelet integrin, which
inhibits the platelet-flibrinogen interaction. Moore hypothesised that PSGs, evolved
to prevent thrombosis at the placental surface or in the maternal circulation during
pregnancy. PSG secreted into maternal blood would have to be at an elevated
concentrations to counteract maternal fibrinogen which circulates in high levels in
the maternal blood (2 mg/ml). This maybe an alternative explanation for the high
PSG expression levels during pregnancy that was previously thought to be due to the
Maternal-Foetal-Conflict theory (MFC) [174]. To date PSGs have been implicated in
a variety of functions, from immune modulation, to angiogenic and anti-thrombotic
molecules. Further study needs to be performed to discern whether all PSGs have a
common function, or if individual PSGs perform specific functions, in accordance to
their spatio-temporal expression patterns. One of only a few PSG receptors identified
to date is the integrin-associated cluster of differentiation 9 antigen (CD9) receptor.
CD9 is a member of the tetraspanin family, which is an important membrane protein
with four transmembrane domains and two extracellular domains. Tetraspanin family
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Table 1.4: Published cytokine responses for PSGs
PSG Cytokines Responsive Cell Types
1 IL-6 [160, 166], IL-10 [160], TGFβ1 [160, 12,163, 13, 166], VEGF-A [13]
monocytes/macrophages,
dendritic, endothelial,
trophoblastic
6 IL-6 [160], IL-10 [160], TGFβ1 [160] monocytes/macrophages
11 IL-6 [160, 163], IL-10 [160], TGFβ1 [160] monocytes/macrophages
17 IL-6 [163], IL-10 [163], TGFβ1 [163] macrophages
18 IL-10 [159] macrophages
19 TGFβ1 [164] macrophages
22 TGFβ1 [165], VEGF-A [165] dendritic, natural killer
23 TGFβ1 [170] VEGF-A [170]
monocytes/macrophages,
dendritic, endothelial,
trophoblastic
members have been implicated in a variety of cellular and physiological processes,
such as cell aggregation and motility, signalling, and fusion [175]. Dveksler and
colleagues show that Psg17 and Psg19 bind to CD9 [161]. They also found that
the amino acids involved in CD9 binding reside in the region of highest divergence
between the N1-domains of murine Psgs [176]. In macrophages CD9 was found to
bind the N1 domain of both Psg17 and Psg19. The interaction of Psg17 and CD9 was
found to be necessary for the induction of secretion of anti-inflammatory cytokines
[164]. Psg17 has also been shown to prevent sperm–egg fusion by interrupting the
binding of CD9 to a ligand on the sperm surface [162]. Unlike mouse Psg17 and
Psg19, human PSG does not require CD9 to induce cytokine production from mouse
macrophages [164].
It was also recently discovered that the murine Psgs Psg22 and Psg23 and
human PSG1 do not bind to CD9, but instead bind to heparan and chondroitin
sulfate proteoglycans (HSPG) [171, 165]. Specifically, PSG1 binds syndecans 1-4 and
glypican-1 on the surface of cells [171]. Proteoglycans (PGs) consist of a protein core
and covalently attached glycosaminoglycan (GAG) chains [177]. The syndecans are
considered hybrid PGs since they contain mixtures of the two major types of GAG
chains found in animal cells, heparan sulfate and chondroitin sulfate. There are
four members of the syndecan family, syndecan-1 (CD138), syndecan- 2 (fibrogycan),
syndecan-3 (N-syndecan), and syndecan-4 (ryudocan or amphiglycan). The other
major family of membrane PGs comprises the glypicans (-1 to -6), which contain
glycosylphosphatidylinositol anchors instead of a membrane-spanning segment [178].
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This binding of PSG1 to GAGs on the surface of endothelial cells mediates tube
formation implicates a PSG-GAG interaction that mediates certain PSG angiogenic
functions [171]. The finding that syndecan-1 regulates two critical integrins in
angiogenesis, α-v-β-3 and α-v-β-5 [179], further supports the role of syndecans in
angiogenesis. The presence of multiple possible PSG receptors, suggests multiple
functions for PSGs interacting through these different receptors. The identification
of receptors for every PSG in this multigene family will help our understanding of
individual PSG function, and about the function of the family as a whole.
1.2.4 PSG expression
As stated previously, human PSGs are tightly linked on the long arm of chromosome
19 and it has been shown that they are coordinately expressed in the placenta [180].
Individual PSG member expression study is demanding due to their high degree of
sequence identity and the lack of specific antibodies for each PSG protein. Human
PSG transcripts and proteins increase in trophoblast cells undergoing differentiation
[135, 181] and are detectable until term. They are secreted by the syncytiotrophoblast
and are detected 3-4 days after fertilization, concordant with blastocyst implantation
[182]. PSG1 has been identified as the most active transcript up-regulated (70
fold) during the in vitro cell differentiation of CTB to syncytiotrophoblast [183].
Specific transcripts for PSG1, PSG3, PSG5, PSG7 and PSG9 genes were detected in
differentiated JEG-3 and CTBs while they were undetectable or had low expression
level in undifferentiated cells [181]. It has been reported that all human PSG mRNAs
can be detected in placenta at different levels, although due to the similar nature
of PSGs at the amino acid level, it is difficult to determine the protein expression
pattern because of high cross-reactivity with monoclonal Abs [180, 184, 185]. Present
data suggest that the whole PSG locus is activated in CTB that differentiates into
the syncytium pathway, although they reach different abundance levels. It was
initially hypothesised that PSGs were expressed exclusively in the placenta [129],
but it has been described that human PSGs are also expressed in the non-pregnant
state including breast cancer, choriocarcinomas, peripheral blood cells, and bone
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marrow cells [186, 187, 188]. High expression of PSGs in breast cancer have been
correlated with a poor prognosis [187]. It is interesting to note that syncytium-
like trophoblast cells express very little PSG9 mRNA and, conversely, up-regulation
of PSG9 expression, but not any other PSG member, was found in colorectal
carcinogenesis [189, 190].
There are 17 mouse Psg family members with different expression levels at
different stages of development, with Psg22 has been identified as an earliest Psg
expressing gene in the mouse placenta [146, 49]. Psg22 mRNA was detectable around
the embryonic crypt on E5.5 and became most prominent at E10.5 coinciding with
placental formation, indicating that TGC are the main source of Psg22 during the early
develoment of the foetal-maternal interface [165]. Employing qRT-PCR with primers
that amplify all mouse Psgs, it was found that in TGC, there is increased Psg expression
between E8 and E11 with Psg transcript levels doubling from E8 to E9 and from E9 to
E10. In EPC, there is a fivefold increase in Psg transcript levels between E9 and E11.
However, absolute levels in the EPC are low, with E10 TGC having approximately
sixfold higher levels than E10 EPC [49]. Moore and colleagues also discovered that
Psg22 is the most abundant transcript in the first half of pregnancy, with Psg16, Psg21
and Psg23 accounting for 90% of transcript abundance in the second half of pregnancy
[191]. The early expression of Psg22, together with its pro-angiogenic effects suggest
that this protein may play an important role modulating the ability of DC and NK
cells to induce the early vascular adaptations required for successful implantation
and placentation [165]. Psg gene expression data in mouse pregnancy implies that
different family members show different expression levels between E11 and E18,
implying the possibility of divergent functions of individual Psgs in the mouse [148].
Kromer et al, [129], tested for Psg17, Psg18 and Psg19 mRNA and found that murine
Psg transcripts are detectable by means of RT-PCR analysis in the placenta and the
pooled tissues of embryo but not in adult tissues, including kidney, lung, testis,
ovary, liver, brain, thymus, heart, and spleen. Although non-placental murine Psg
expression was realised when Psg18 was found to be highly expressed in the follicle-
associated epithelium (FAE) overlaying Peyer’s patches (PPs) [192] implicating Psg18
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in the modulation of the mucosal immune system, and a Psg16 brain specific transcript
was also recently detected [193]. Further study needs to be performed regarding the
expression of other murine Psg family members in non-placental cell types, including
the gatrointestinal tract (GIT).
1.2.5 PSG regulation
Despite such extensive knowledge about the structure and function of the murine Psg
genes, relatively little information is available about regulation of the murine Psgs
at the transcriptional level or the promoter regions that infer this regulation. It was
established that the biosynthesis of PSGs is mainly regulated at the transcriptional
level, with an increase in their expression during placental development [194].
Very little information has been generated concerning the regulatory mechanisms
that control the individual murine Psgs. A comprehensive review of the literature
regarding the regulation of human and mouse PSGs can be viewed in Table 1.5. What
information is known regarding PSG regulation is mostly concerned with Human
PSGs, and more precisely PSG5, as the 5’-flanking sequence of the PSG5 gene has
been characterized and used as a model for studies of PSGs regulation due to the
strong homology of promoter sequences among the different family members [195].
The Human PSG genes are extremely similar and that similarity extends to their
Table 1.5: Published regulators of PSG expression
Regulator PSG ResponsiveCell Lines References
Cpbp PSG5 Jeg3 [196]
Klf4 PSG5 Jeg3, HeLa [86, 197]
Klf6 PSG3,PSG5 Jeg3 [86, 198]
Sp1 PSG5 Jeg3, HP-A1 [189, 199, 197]
RxR PSG5 Jeg3, [200]
XBP1, IRE1a Psg18,Psg28 SM-10, MEF [201]
putative control regions [189]. Human PSGs do not have conventional promoters, as
promoters of human PSG genes are highly homologous and lack any obvious TATA-
box, typical Initiator elements, or large GC-rich sequences [202, 195]. Human PSGs
have been defined to possess minimal promoter regions, spanning from -172 to -34 bp
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[189]. Previous work on the Human PSG promoters has shown that PSG5 expression is
dependant on a functional ubiquitous specificity protein 1 (Sp1) binding site located
in the minimal core promoter element of all human PSGs (-140 to -147). This SP1
site has been shown to activate PSG5 promoter constructs, and is coexpressed with
PSG5 in human placental villi, particularly the syncytiotrophoblast layer, stressing its
important role in the regulation of PSG5 [199]. It has also been shown that in general,
activation of the minimal basal promoter activity in PSG5 in the HP-A1 cells requires
minimal promoter lengths (172 bp upstream of the transcription start site) and the
presence of Sp1 or Sp1-like elements and that the RARE motif is involved not only in
basal promoter activity but also in PSG activation upon trophoblast differentiation.
Using gene promoter-reporter transfections and X-ChIP assays, Blanchon et
al, demonstrated that Kruppel-like factor 4 (KLF4) is an activator of the PSG5 promoter
by binding to a KLF consensus like binding which includes the Core Promoter Element
region (-147/-140) [197]. Furthermore, linking previous data showing the binding
of Sp1 transcription factor to a GT-box (-443/-437) and co-transfection assays with
KLF4 and Sp1, they were able to comprehensively demonstrate the robust combined
activity of these two factors on the PSG5 promoter. This transcriptional regulation
of PSG5 by KLF4 and the Sp1 transcription factor is synergistically co-activated by
KLF4 and Sp1, and has been shown to require two intact DNA regions: the -148/-133
promoter sequence (TS1 site bearing the CPE-box) for KLF4 and the -443/-437 (GT-
box) upstream element, for Sp1 [197]. The interaction of KLF4 with a house-keeping
transcription factor such as Sp1 to regulate the placental-specific expression of PSG5 is
reminiscent of situations previously described in which tissue-specific and ubiquitous
transcription factors interact to control specific gene expression [203]. Racca et al, [198],
have also shown that Kruppel-like factor 6 (KLF6) is also involved in the activation
and regulation of PSG3 and PSG5 promoters in Jeg3 cells, further supporting the role
of the KLF family in PSG regulation. This group demonstrated increased expression
of both human hCG and PSG genes using overexpression studies of KLF6.
Further investigation of this core promoter element (CPE), has revealed that
this site partially overlaps a putative Retinoic acid Response Element (RARE) site,
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conserved between positions -161/-145 in PSG genes, indeed, this RARE/CACCC-
box composite element is almost identical in the 11 human PSG genes [200]. This
implicated the existence of an RXRa-mediated pathway leading to PSG gene activation
through this conserved RARE motif. Retinoic Acid (RA) is the active derivative of
vitamin A (retinol), and exerts its effects through two families of receptors, retinoid
acid receptors (RARs) and retinoid X receptors (RXRs), which act as ligand-inducible
transcription factors [204]. Some observations suggest that RA may be involved in
placental development. For example, RARs and RXRs show localized expression in
the placenta [32], and RA promotes TSC toward the TGC fate [101]. Lopez-Diaz
et al, [200], have demonstrated that RXRα does bind to PSG5 CPE and that 9-cis
Retinoic acid induces PSG5 expression in JEG-3 cells, thus, it seems possible that
cells committed to differentiate into syncytiotrophoblast are able to respond efficiently
to RXR signaling, leading to increased transcriptional response of PSG genes [200].
The region (-178/-49) of the PSG3 promoter contains several consensus DNA binding
sites, among them are a RARE motive and a putative binding site for the Ets-family
transcription factor GABP. It was shown using luciferase assays that the RARE binding
site is required for basal promoter activity while the GABP binding site is involved in
the induction of PSG3 transcription during differentiation [181].
Expression of PSG genes is regulated by the interaction of transcription
factors with positive and negative DNA elements in the PSG promoters as shown
by [189]. Transcriptional control was further investigated in primary CTB cultures
indicated the presence of a functional repressor element located upstream -251 nt, as
it had been described for PSG5 in non-placental cells [181, 205]. PSG5 regulation is
not only mediated by transcriptional level control via DNA binding factors, [205],
Panzetta-Dutari et al, have described cis and trans acting negative elements, that
function in repressing PSG5 transcription, irrespective of the cell type. All PSG family
members were found to be clearly up-regulated by addition of 5-bromodeoxyuridine
in HeLa cells. Likewise, all PSG family members were clearly up-regulated in
normal human fibroblasts during replicative senescence. Promoter analysis of the
PSG1, PSG4, and PSG11 genes in HeLa cells did not possess a cis-regulatory element
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
35 John Michael Williams
1. INTRODUCTION 1.2 CEA superfamily: CEACAMs and PSGs
responsive to 5-bromodeoxyuridine in their 50bp-flanking sequences. These results
suggest that the PSG genes are regulated at a level of higher order chromatin structure
[173].
Inositol requiring enzyme-1a (IRE1a) is an endoplasmic reticulum (ER)
located transmembrane RNase whose activation leads to the production of the
transcription factor X-box binding protein 1 (XBP1) [206]. Oikawa et al, have recently
shown that following treatment with thapsigargin, a typical ER stressor that activates
the IRE1a–XBP1 pathway, or using overexpression of wild type IRE1a or XBP1, both
Psg18 and Psg28 were upregulated in SM-10 cells [201]. Through Psg28 promoter
region deletion constructs, they identified two important regions whose individual
deletion reduced promoter activity, firstly, the (-500/-480) upstream region, and the
second was positioned in the (-180/-140) upstream region. As these two regions did
not contain any previously identified XBP1-responsive elements, nor XBP1 binding
sites, it is likely that XBP1 up-regulates the Psg28 promoter in an indirect manner,
possibly through up-regulation or activation of intermediate factors [201]. This is one
of the first molecules to be implicated in the regulation of murine Psgs.
This section has discussed the multitude of genes and mechanisms involved
in the regulation of PSG expression, the majority of which, do so at the transcriptional
level. To date, there has been little data generated in the literature published
concerning the epigenetic control of this multigene family, although it has been
suggested that a fine-tuning complex mechanism that may include specific long-range
acting chromatin factors, transcriptional regulation and transcript stability controls the
expression of each PSG gene member [181]. In the next section I will discuss the ways
in which epigenetic regulation modulates gene transcription, especially through the
use of non-coding ribonucleic acid (ncRNA) transcripts.
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1.3 Chromatin
1.3.1 Epigenetics and the role of chromatin
Epigenetics has a been the focus of research in recent years, as it is concerned with
the contextual information that is superimposed on the relatively stable underlying
genomic sequence, by the modification of DNA (and ribonucleic acid (RNA)) and
the modulation of chromatin structure [207]. Gene regulation through epigenetics is
essential for producing variance of cell types during mammalian development, and is
crucial for sustaining the stability and integrity of the expression profiles of different
cell types [208]. Chromatin is the state in which DNA is packaged within the cell
through the association with histone proteins [209]. The inheritance of chromatin
states such as “active” (euchromatic) or “silent” (heterochromatic) domains forms the
foundation of epigenetics [210]. The nucleosome is the fundamental unit of chromatin
and it is composed of an octamer of the four core histones (H3, H4, H2A, H2B)
which are wrapped around 147 base pairs of DNA. The core histones are primarily
globular except for their N-terminal “tails,” which are unstructured. The amino
acid sequence of these N-terminal tails is highly evolutionary conserved. This level
of conservation implicates a selective force which maintains the sequence of the N-
termini. This conservation is due to the tails undergoing multiple post-translational
modifications. These modifications subsequently can modulate chromatin structure
[211]. Chromatin architecture is altered by methylation of the DNA and by various
types of modifications to histones (the so-called ‘histone code’), including compound
patterns of acetylation, methylation, phosphorylation, ubiquitinylation, sumoylation,
ADP-ribosylation, carbonylation, de-imination and proline isomerization at various
residues, (reviewed extensively by [212, 208, 213]). The remarkable intricacy of
covalent histone modifications is exacerbated by the presence of histone variants in
numerous organisms. These histone modifications convey additional possibilities
for the cell to diversify the overall composition of the nucleosome and its covalent
modification potential [214]. In eukaryotic organisms, chromatin is involved in
many different processes, from development, cognition, ageing to disease progression.
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Understanding how chromatin directs gene expression remains to be an important
focus of research [215].
1.3.2 Long Noncoding RNAs (lncRNA)
Advances in technology have assisted in the high resolution analysis of the human
and mouse transcriptomes [216], illustrating that the transcriptome of the mammalian
genome is much larger than originally thought [217, 218]. Proteins and related protein-
coding genes have been at the centre of biological research for years. Nonetheless, the
development of bioinformatical methods and advanced RNA sequencing technology
for compiling the transcriptome, has illustrated that besides protein-coding genes,
the majority of the mammalian genome is transcribed, and many noncoding RNA
(ncRNA) transcripts contribute to a variety of biological roles [219, 220]. The discovery
of extensive transcription of large RNA transcripts that do not code for proteins,
termed long noncoding RNAs (lncRNAs), provides a new insight in the pivotal
role of RNA in gene regulation [221]. Advancing technologies, including RNA-Seq,
are not confined to the identification of protein-coding RNA transcripts, and have
facilitated in the discovery of many novel lncRNA transcripts. These transcripts were
generally believed to be “junk,” but current studies suggests that the majority of these
RNAs are essential in regulating gene expression at various levels [222]. Currently,
these lncRNAs are defined as RNA genes, which are larger than 200 bp but do
not appear to have coding potential. However, the size cutoff clearly distinguishes
lncRNAs from small regulatory RNAs, including micro RNAs (miRNAs), transfer
RNAs (tRNAs), or piwi RNAs (piRNAs). LncRNAs have also been classified using
the anatomical characteristics of their gene loci. For instance, lncRNAs are often
defined by their position relative to neighbouring protein-coding genes. (Fig:1.8.
A-D) shows the four main lncRNAs that have been described to date. Antisense
lncRNAs (A), are lncRNAs whose transcription commences inside or 3’ of a protein-
coding gene, are transcribed in the antisense direction of protein-coding genes, and
share an overlap of at least one coding exon. Intronic lncRNAs (B), are lncRNAs
whose transcription commences inside of an intron of a protein-coding gene in either
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Figure 1.8: Anatomy of long non-coding RNA (lncRNA) loci. (A) Antisense lncRNA
- lncRNA sequence overlaps with the antisense strand of a protein coding gene.
(B) Intronic lncRNA - lncRNA sequence is derived entirely from within an intron
of another transcript. (C) Divergent lncRNA - lncRNA sequence is located on the
opposite strand from a protein coding gene whose transcription is initiated less than
1000 base pairs away. (D) Intergenic lncRNA - lncRNA sequence is not located near
any other protein coding loci. Modified from [221, 223].
direction and terminate without overlapping exons. Bidirectional lncRNAs (C), are
transcripts that initiate in a divergent or bidirectional fashion from the promoter of a
protein-coding gene; and although not exactly defined, generally initiate transcription
within a few hundred nucleotides of the neighbouring promoter. Intergenic lncRNAs
(D) which are sometimes termed large intervening noncoding RNAs or lincRNAs,
are lncRNAs that possess separate transcriptional units and are over 5 kb from their
protein-coding gene neighbours [221]. At present, lncRNAs are defined by their
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size and anatomical properties, as previously stated but are also characterised by
their protein coding potential. Whether an RNA transcript functions by coding for
protein in any of its 3 frames is fundamental to the definition of lncRNA [221]. A
new method of characterising lncRNAs, termed guilt by association, which associates
protein-coding genes and lnRNAs that possess concordant expression patterns and are
therefore presumed to be co-regulated, has enabled a comprehensive understanding
of lncRNAs [224]. Employing gene-expression analyses, this approach identifies
protein-coding genes and regulatory pathways that correspond with the lncRNA
under investigation. Using data generated from these concordantly expressed protein
coding genes, the functions and regulatory mechanisms of the lncRNA is inferred.
Expression patterns of lncRNAs are associated with numerous key cellular processes,
including immune responses [225], pluripotency [226], and regulation of the cell cycle
[227]. To date, it has been shown that almost a third of lincRNAs associate with
chromatin-modifying complexes [228]. This association of lncRNA with ribonucleic-
protein complexes is the mechanism in which they exert their influence on the
regulation of gene expression [221]. A recent study has revealed a number of
interesting properties of lncRNAs. These properties include being predominantly
positioned neighbouring developmental regulators, enhancement of tissue-specific
expression patterns, possessing many orthologous Large intergenic non-coding RNAs
(lincRNAs) between human and mouse, and the abundant presence of lincRNAs in in
genetic loci that are associated with genetic traits but contain no protein-coding genes
[229].
Despite the extensive data being generated concerning expression of these
lncRNAs, the functional roles for lncRNAs have remained mostly elusive. lncRNAs
were once thought of as the “dark matter” of the genome, due to our lack of
functional knowledge regarding these RNA transcripts [219]. Recently, a number of
examples have arisen to suggest that the co-transcription of non-coding transcripts
influences neighbouring gene transcription. These lncRNAs have been shown to be
involved in both repression and enhancement of gene transcription through many
different mechanisms. To date, the known functions of lncRNAs have been reviewed
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extensively [219, 221]. They have reviewed four mechanisms in which lncRNAs
regulate gene transcription. The four proposed mechanisms in which lncRNAs are
hypothesised to work are shown (Fig:1.9. A-D).
LncRNAs can act as decoys that act as a sink to remove DNA-binding
proteins, such as transcription factors, thus repressing neighbouring gene expression.
One example of lncRNAs acting as decoys is the recent example, PANDA, which
is induced in a p53-dependent manner. PANDA interacts with the transcription
factor NF-YA to limit expression of pro-apoptotic genes implicating lncRNAs in the
control of cell growth [227]. Other examples of decoy lncRNAs include TERRA
which regulates and protects chromosome ends [230], and MALAT1 which is involved
in alternative splicing regulation mediated through splicing factor phosphorylation
[231]. LncRNAs can act as scaffolds, to facilitate in the formation of protein complexes
or to bring these proteins in proximity to the loci. HOTAIR is an example of a
scaffold lncRNA which regulates epigenetic states, through binding of both PRC2
and LSD1-CoREST complexes via specific RNA domains [224]. TERC is another
scaffold lncRNA which regulates telomerase catalytic activity through the formation
of protein complexes that are essential for telomerase function [232]. LncRNAs can
act as guides to recruit proteins such as chromatin modification enzymes to the loci,
through specific RNA-DNA or RNA-protein interactions. These guide lncRNAs,
such as Xist, Air and Kcnq1ot1 [233, 234] are involved in dosage compensation and
imprinting. Another example of guide lncRNAs is lincRNA-p21, which acts as a
repressor of transcription, mediated through interactions with hnRNP-K which results
in p53-dependent transcriptional responses to DNA damage [225].
lncRNAs are involved in enhancer-regulating gene activation (eRNAs),
through chromosome looping in which cases they may interact directly with distal
genomic regions. One activity-regulated neuronal enhancer was independently
identified as an enhancer that drives the activity-regulated transcription of arc/arg3.1,
a gene that regulates synaptic function [235, 236, 237]. This arc enhancer which is
located 7 kb upstream of the transcriptional start site (TSS), is necessary to drive
activity-regulated arc transcription [238, 239]. HOTTIP is yet another example of
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lncRNAs that are associated with gene activation and euchromatin. HOTTIP is
located on the distal 5’ end of the HOXA gene cluster and binds with the WDR5
protein to activate histone H3 lysine 4 trimethylation. Through chromosomal looping
of HOTTIP, thus bringing HOTTIP in the proximity of a number of HOXA cluster
genes. This maintains histone H3 lysine 4 trimethylation and facilitates target gene
activation [240]. This implicates eRNAs in the regulation of genes that are responsible
for a number of essential developmental processes. Further research is needed to
gain a comprehensive understanding of the roles and mechanisms of these complex
lncRNAs in vivo.
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1.4 Summary and Aims
Since the first discovery of the PSG family in the serum of normal pregnant women
in 1970, there has been extensive research carried out in the expression, regulation
and function of these complex multigene families, in a variety species possessing
hemochorial placentation. Nevertheless, the molecular mechanisms implicated in
their specificity of placental expression and their trophoblastic regulation are still
poorly understood. An extensive analysis of murine Psg expression patterns in
trophoblast lineages, particularly Psg22, has not been carried out. Furthermore, it
is still unknown whether the murine Psgs, which exhibit differing RGD-like integrin
binding motifs, possess the same functions and regulation mechanisms. Therefore,
the aims of this thesis are:
1. Define and comprehensively map the rodent PSG loci
2. Understand expression of murine Psgs in TGCs, and trophoblastic lineage
tissues, especially Psg22, which has been shown to have the highest expression
levels of Psgs in the first half of pregnancy
3. Investigate the functions of Psg22 protein in vitro
4. Determine the regulatory mechanisms involved in the expression of Psg22
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Materials and Methods
2.1 Materials
All chemicals used were purchased from Sigma Aldrich unless otherwise stated. All
restriction enzymes were purchased from New England Biolabs (NEB, Ireland). T4
DNA ligases were purchased from New England Biolabs. High Fidelity Phusion
2 Hot Start Thermostable DNA Polymerase was purchased from ThermoScientific.
Plasmid DNA isolation, gel purification and nucleotide clean-up kits were purchased
from QIAGEN. All oligonucleotide primers for polymerase chain reaction (PCR) were
purchased from MWG Eurofins (Eurofins MWG Operon, Germany). All bacterial
media constituents were purchased from Sigma Aldrich (Sigma-Aldrich, Ireland).
Perfectly Blunt Cloning kit and Escherichia coli bacterial strains used were both
purchased from Novagen (Merck, Germany). All plastics and mammalian tissue
culture materials were purchased from Starstedt. DNA ladders and protein markers
were purchased from New England Biolabs.
2.2 Bioinformatics
All PSG sequences (genomic, coding sequences (CDS), and amino acid (aa)) were
taken from publically accessible genome browsers; National Centre of Biotechnology
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Institute (NCBI) (http://www.ncbi.nlm.nih.gov/), University of California, Santa
Cruz (UCSC) (http://genome.ucsc.edu/), and the Ensembl Genome browser
(http://www.ensembl.org/index.html). Using these databases, a comprehensive
accession table of all known rodent and human PSGs was compiled. I compiled
available sequence data for all rodent PSGs and used sequence alignment software
tools to locate the entire mouse and rat PSG gene families on their respective
loci. Sequence alignments were performed using the online NCBI BLAST sequence
alignment tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the online ClustalW
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) alignment software. Also using
ClustalW alignment software and the MEGA Molecular Evolutionary Genetics
Analysis software MEGA5 (http://www.megasoftware.net/), I aligned individual
species PSG families for mouse, rat and human PSG coding sequences (CDS) and
constructed Phylogenetic trees (Neighbour-joined pairwise comparison phylogenetic
trees). The evolutionary history was inferred by using the Maximum Likelihood
method based on the Tamura-Nei model [241]. The bootstrap consensus tree inferred
from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed
[242]. The percentage of replicate trees in which the associated taxa clustered together
in the bootstrap test (1000 replicates) are shown next to the branches [242]. All
major branches yielded values of 95–100%. The scale bar represents 0.1 nucleotide
substitutions per site.
Open Reading Frame (ORF) predictions were performed using the online
ORF prediction softeware. This ORF prediction softeware is available from
NCBI, (http://www.ncbi.nlm.nih.gov/projects/gorf/gorf.html). PSG promoters
were analysed for putative transcription factor binding sites along a 2 kb region
upstream of the Transcriptional Start Site (TSS) using the online MatInspector
programme (Genomatix Software Suite, Germany) (http://www.genomatix.de/).
Protein domain structure prediction was carried out using the online SMART
(a Simple Modular Architecture Research Tool) software (http://smart.embl-
heidelberg.de/). All primers were designed using the online Primer-Blast software
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) unless otherwise stated. Primer
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analysis and the potential of secondary structures in primers designed was assessed
using the online NetPrimer software (http://www.premierbiosoft.com/netprimer/).
shRNA oligonucleotides were designed using the PSICOOLIGIOMAKER1.5 software
programme which is available from the Jacks Lab (http://web.mit.edu/jacks-
lab/protocols/pSico.html) to design the target sequences.
2.3 Molecular Biology
DNA purifications, agarose gel electrophoresis, cloning, PCR, RT-PCR, qRT-PCR
and bacterial transformation were performed using standard molecular biology
techniques or according to the relevant kit instructions.
2.3.1 Mice and Tissues
Mouse tissues were obtained from the Biological Services Unit, University College
Cork. Mouse strains used were CD1, C57BL/6J, 129/Sv. Embryonic (E) stage refers to
the gestational age of the embryo. The morning on which the vaginal plug was found
is counted as day one (E1) of gestation. Human term placenta and human esophageal
RNA (Ambion® FirstChoice® Human Total RNA Survey Panel, Life Technologies,
AM6000) was kindly provided by Aine Fanning, Dept. of Medicine, UCC.
2.3.2 Cell culture
E2 mouse embryos were flushed from mated superovulated CD1 uterine horns as
described elsewhere [243]. Embryos were placed in M2 medium microdots under
mineral oil in embryo culture dishes. After two days M2 medium was replaced with
M16 medium. Embryos were maintained in M16 medium under mineral oil until
they reached E5 blastocyst stage. Some embryos were harvested at E5 and the rest
were cultured until E11 to allow for blastocyst outgrowths to form, then harvested
for RNA extraction and cDNA synthesis. The RAW-246.7 murine macrophage cell
line was maintained in T75 flasks in Dulbecco’s modified Eagle’s medium (DMEM)
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containing 10% fetal bovine serum; 1% penicillin/streptomycin and 1% L-glutamine.
The human THP-1 monocytic cell line was maintained in T75 flasks in RPMI-1640,
0.05 mM 2-mercaptoethanol; 10% fetal bovine serum; 1% penicillin/streptomycin and
2 mM L-glutamine. JAR human choriocarncinoma cells were maintained in T75 flasks
in DMEM containing 10% fetal bovine serum; 1% penicillin/streptomycin and 1%
L-glutamine. Rat choriocarcinoma Rcho-1 trophoblast cells were a kind gift from
M.J. Soares, Kansas. They were maintained in a subconfluent condition in T75 flasks
with an RPMI-1640 medium supplemented with 10% fetal bovine serum, 50 uM 2-
mercaptoethanol, 1 mM sodium pyruvate, 2 mM glutamine, 100 U/ml of penicillin,
and 100 µg/ml of streptomycin. Differentiation was induced by growing the cells to
confluence and subsequently replacing the 10% FBS supplementation with 1% donor
horse serum. 3T3 mouse embryonic fibroblast cells were maintained in T75 flasks
in DMEM containing 10% fetal bovine serum; 1% penicillin/streptomycin and 1% L-
glutamine.
Primary mouse embryonic fibroblasts (MEF) were derived from E12.5
C57BL/6J mouse embryos as described in [244], embryos were dissociated and then
trypsinized to produce single-cell suspensions in T175 flasks. These single cell
suspensions were expanded, leaving only primary MEFs remaining. These were
aliquoted and frozen at -80°C until ready to be used to harvest conditioned MEF
medium, to be used as a trophoblast stem cell medium supplement. MEFs were
maintained in DMEM containing 10% fetal bovine serum, 1% penicillin/streptomycin
and 1% L-glutamine. Primary MEF cells were grown to confluence in T75 cell culture
flasks and then treated with 10 µg/ml mitomycin C (MMC) for 3 hours. MMC
containing medium was removed, cells were washed three times in PBS, and then
fresh complete DMEM medium was added to the cells. MEF cells were used to
condition medium for three days and then the medium was harvested, sterile filtered
with a 0.2 µm syringe filter and then stored at -80°C until ready to use.
In the mouse, TSC are readily obtained by culturing cells from the
extraembryonic ectoderm of implanting embryos or from outgrowths of cultured
blastocysts and can be maintained in a pluripotent state in culture in the presence of
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FGF4, heparin, and fibroblast conditioned medium, without which these cells begin
to differentiate into the various trophoblast subtypes [21, 245]. Trophoblast stem cell
lines (TS-GFP and TS-R26) were kindly donated to us by Dr. Myriam Hemberger
(Babraham Institute, Cambridge, UK). The TSC line (TS-EXE) was kindly donated
by Dr. Tilo Kunath (University of Edinburgh). TSC were maintained as described
previously [246, 21]. TSC cell medium contained RPMI 1640 medium supplemented
with 20% fetal bovine serum; 2 mM L-glutamine; 1 mM sodium pyruvate; 100 mM 2-
mercaptoethanol; 50 U/ml penicillin and 50 µg/ml streptomycin. TSC seeded in T75
flasks were kept in an undifferentiated state using 70% fibroblast conditioned medium
(FCM) +FGF4H medium. This medium constituted of TSC medium (described above)
containing 70% MEF-conditioned medium and 25 ng/ml FGF4 and 1 µg/ml heparin.
TGC were differentiated from TSC by culturing undifferentiated TSC in TSC medium
without 70FCM+FGF4H for 6 days [21]. The transcriptional induction of Pl2, a
prolactin family members that is only expressed in TGC, confirmed differentiation
toward the TGC lineage [247].
The Freestyle™ 293-F cells were grown in suspension in Freestyle™ 293
Expression Medium, by shaker culture, in the presence of Antibiotic Antimycotic
Solution (AAS) at 10 ml/L for two passages, and then Freestyle™ 293-F cells were
grown without AAS to a density of 1 x 106 cells/ml. Freestyle™ 293-F cells were
maintained at 37°C in a humidified 8% CO2 shaking incubator. All reagents were
obtained from Sigma-Aldrich, UK, unless otherwise stated. Cells were maintained in
a humidified 5% CO2 incubator unless otherwise stated, and were split regularly to
ensure exponential rates of growth.
2.3.3 Cell Transfections and Treatments
All cell transfections were carried out using Lipofectamine 2000 (Invitrogen, 11668-
019), and OptiMEM (Invtirogen, 31985-062) as per manufacturers instructions. Cells
were grown to 90% confluency in 24 well plates and were cultured for 48 hours post-
transfection. Psg22 shRNA vectors were transfected into subconfluent TSC, using
Lipofectamine 2000, in serum free medium for 6 hours, after which the medium
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was changed to the differentiating GC medium and these transfected TSC cells were
differentiated into TGC as described above. Untransfected TSC, an empty pSicoR
vector, and a nonsense shRNA pSicoR construct were used as negative controls
alongside the two Psg22 shRNA vectors being tested.
LacZ transfections were performed using Lipofectamine 2000 (Invitrogen,
11668-019), and OptiMEM (Invitrogen, 31985-062) as per manufacturers instructions.
Jar cells were seeded at a density of 5 x 104 cells/ml in 24 well plates. An empty
LacZ vector was used as negative control for LacZ expression and a pCMV-SPORT-β-
Gal construct (Life Technologies, 10586-014), was used as a positive control for LacZ
expression in Jar cells. A Sprouty3 promoter LacZ construct was also used as a positive
control. Three Psg promoter LacZ constructs were tested, Psg20, Psg22 and Psg23.
Retinoic acid treatment of undifferentiated TSC cell lines (TS-EXE and TS-
GFP) was performed using 5 µM ATRA (Sigma, R2625-100MG) and 5 µM 9-cis RA
(Sigma, R4643-1MG) solubilised in 95% ethanol (EtOH), in 70FCM+F4H medium to
induce differentiation to TGC. 5 µM EtOH was used as vehicle for control treatments.
TSC seeded to a density of 5 x 104 in 24 well plates were incubated with ATRA
or 9-cis RA for 24 and 48 hours in a humidified 5% CO2 incubator at 37°C. Cells
were harvested for RNA extraction and cDNA synthesis. For Psg22 purified protein
treatments, RAW-246.7 and THP-1 cells around 90% confluence were incubated with
10 µg/ml Psg22 Long and 10 µg/ml Psg22 Short protein isoforms for 24 hours
and then cell culture supernatant was harvested for ELISA. A Strep-His peptide
(WSHPQFEKLEHHHHHHHH) (Eurogentec, Belgium) was used as a control for the
Strep-His tag introduced to the C-terminus of the proteins expressed from the pQE-
Trisystem-His-Strep-1 expression vector. This ensured that this introduced tag did not
induce TGFβ1 expression in these cell lines.
2.3.4 PAC screen
A P1-Artificial Chromosome (PAC) 129/Sv RPCI.21 library was screened to obtain a
Psg23 positive clone, Psg23 was chosen as it is positioned in the centre of the major Psg
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
50 John Michael Williams
2. MATERIALS AND METHODS 2.3 Molecular Biology
cluster. The RPCI-21 PAC Library has been constructed with female 129S6/SvEvTac
mouse spleen genomic DNA (partially MboI digested) and was cloned between the
BamHI sites of the pPAC4 vector [248]. The average insert size is 147 Kbp. The library
consists of approximately 128,899 clones in 336 microtitre plates. The plate numbers
run from 337 to 672. The PAC library has been gridded onto 22x22 cm positively
charged nylon filters for hybridization screening purposes. Each filter contains 36,864
colonies which represents 18,432 independent clones spotted in duplicate in a 4x4
clone array. Seven filters cover the whole library. This provides a 6-9 fold coverage
of the mouse genome.
A probe approximately 2 kb upstream of Psg23 (879 bp) was amplified from
murine 129/Sv genomic DNA
using primers: Psg23 Probe F: 5’-TCCTGTCCCCACTAACCTTG-3’ and Psg23 Probe
R: 5’-TGACAACCCCACACAAGAAA-3’. Amplified DNA was purified and cloned
into pGEM-T Easy Vector (Promega, USA, A1360). Positive clones were sequenced
and the 879 bp probe was removed from its vector backbone using SalI and NcoI.
The Psg23 probe was radiolabelled (α-P32) dCTP (3000 Ci/mmole; Amersham) and
the library was screened by hybridising P32-radiolabeled Psg23 probes to the library
filters using Southern Blotting Hybridisation described elsewhere [248]. The blots
were washed with 0.5X SSC and 0.1% SDS at 65°C and exposed to Kodak x-ray film
(Kodak, USA) overnight at -80°C and results were analysed using the online clone
identification protocol. Positive PAC clones were purchased from BACPAC resources
at the Children’s Hospital Oakland Research Institute (C.H.O.R.I, USA). Positive PAC
clones were cultured, plasmid DNA was prepped using the Qiagen Large Construct
kit (Qiagen, UK, 12462), as per manufacturers instructions, and characterised using
gene specific primers. The primers used in the PAC characterisation are listed in Table
2.1. To characterise the PAC clone further, End Sequencing of the PAC was performed.
Purified PAC DNA was sent to GATC (GATC Biotech, UK) to be sequenced using the
T7 and SP6 promoter sequencing primers located on the pPAC4 plasmid and were
provided by the company.
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Table 2.1: PAC characterisation Primers
Primer Sequence
Psg23 Upstream F 5’-TCCTGTCCCCACTAACCTTG -3’
Psg23 Upstream R 5’-TGACAACCCCACACAAGAAA-3’
Psg23 Downstream F 5’-TGGCAATGAGGAAATCAACAC -3’
Psg23 Downstream R 5’-GAGGGAGGAAAGAAGTCAGAGA -3’
Psg25 Specific F 5’-ACCCTCCACACACTGCTCTGCT-3’
Psg25 Specific R 5’-AGCAAACAAGGACACATGACACCA-3’
Psg27 Specific F 5’-CCATCCTGCCTGGTGCCTGC-3’
Psg27 Specific R 5’-CTCTCCCAGGGGTGGCCCTC-3’
Psg23 Specific F 5’-AGGGAGACCCACACTCACAC-3’
Psg23 Specific R 5’-AGGTAGTCCATGCCAGCAGT-3’
Psg21 Specific F 5’-GTCACATGACCCTGCCTTTT-3’
Psg21 Specific R 5’-GCAGAGGGGACCAAATTACA-3’
Psg20 Specific R 5’-GGAGTCAGCAGGTGTCAGCCC-3’
Psg20 Specific F 5’-TGAGCTGTGGGTGGTGGGGT-3’
2.3.5 Polymerase Chain Reaction
All Polymerase Chain Reactions (PCR) were performed using standard molecular
techniques, using either Finnzymes Phusion Hot Start High Fidelity DNA Polymerase
(ThermoScientific, F-530S) or Finnzymes Phusion 2 Hot Start High Fidelity DNA
Polymerase (ThermoScientific, F-549S). PCR reactions were amplified using a G-Storm
thermocycler (G-Storm, UK) in 50 µl reaction volumes. Reactions contained 10 µl of
5x GC Buffer, 1.2 µl of dNTPs (NEB, N0447L), 1.5 µl Forward primer, 1.5 µl Reverse
primer, 2 µl DMSO, x µl template, 0.5 µl Phusion DNA Polymerase, made up to 50
µl with ddH2O. Cycling conditions were 98°C for 3 minutes, 98°C for 30 seconds, x°C
annealing for 40 seconds, 72°C for 1 or 2 minutes, 72°C for 10 minutes final extension.
All PCR products were resolved on an agarose gel, composed of agarose and Tris-
borate EDTA (TBE) buffer, using gel electrophoresis at 90 V for 50 minutes. PCR
products were visualised using the UV Gel-doc system.
2.3.6 RNA extraction
Cells were lysed and RNA extracted at room temperature using TRI Reagent (Sigma,
93289-100ML). Phase separation was achieved by addition of chloroform, mixing
vigorously and centrifugation at 12000xg for 15 minutes at 4°C. Nucleic acids present
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in the upper aqueous phase were removed to a fresh 1.5 ml centrifuge tube and
RNA was precipitated using ice-cold isopropanol. Nucleic acids were incubated at
room temperature for 10 minutes. RNA was harvested by centrifugation at 1200x g
for 5 minutes at 4°C. Supernatant was carefully removed and pellets were dried for
10 minutes at room temperature before resuspension in RNase-free ddH2O. Nucleic
acid concentration and purity was determined by spectrophotometry at 260 nm and
260/280 nm respectively.
2.3.7 Reverse Transcriptase Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) was used to determine
expression of transcripts in a variety of cell lines and tissue types. First strand cDNA
was synthesised using 1 µg total RNA in a 20 µl reaction using random hexamer
priming and the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
UK) as per protocol. RT-PCR was performed using either Finnzymes Phusion
Hot Start High Fidelity DNA Polymerase (ThermoScientific, F-530S) or Finnzymes
Phusion 2 Hot Start High Fidelity DNA Polymerase (ThermoScientific, F-549S). RT-
PCR reactions were amplified using a G-Storm Thermocycler (G-Storm, UK) in 50 µl
reaction volumes. Reactions contained 10 µl of 5x GC Buffer, 1.2 µl of dNTPs (NEB,
N0447L), 1.5 µl Forward primer, 1.5 µl Reverse primer, 2 µl DMSO, x µl template,
0.5 µl Phusion DNA Polymerase, made up to 50 µl with ddH2O. Cycling conditions
were 98°C for 3 minutes, 98°C for 30 seconds, x°C annealing for 40 seconds, 72°C
for 1 or 2 minutes, 72°C for 10 minutes final extension. Annealing temperatures
were specific for each primer set, and an RT-PCR gradient protocol was employed to
determine the optimal annealing temperature for each primer set. RT-PCR using gene
specific primers for three marker genes of differentiation, was used to confirm whether
TSC had differentiated correctly into TGC. Marker genes used to determine correct
differentiation were: Eomes, a trophoblast stem cell marker, TpbpA, a SpT marker, and
Prolactin2 (Pl2), which is a TGC specific marker gene. Primers used are described in
[44], and are listed in Table 2.2.
For identification of PSG transcript relative frequency in a variety of cell types
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Table 2.2: Differentiation Marker Primers
Primer Sequence
Eomes F 5’-TGATCATCACCAAACAGGGC-3’
Eomes R 5’-ACTGTGTCTCTGAGAAGGTG-3’
Pl-2 F 5’-TCCTTCTCTGGGGCACTCCTGTT-3’
Pl-2 R 5’-CCATGAAGGCTTTTGAAGCAAGATCA-3’
TpbpA F 5’-TGAAGAGCTGAACCACTGGA-3’
TpbpA R 5’-CAGGCAGTTCATATGTTGGG-3’
and tissues, expression surveys were performed using cloning and sequencing of RT-
PCR products. Primer sets that amplify all known murine Psgs were designed in
Wynne et al, 2006 [49]. A degenerative primer set: PsgF and PsgR, which amplifies
all known murine Psg were designed, although Psg22 and Psg25 are of identical
sequence in the amplicon generated by these primers. An amplicon of 124 bp was
generated which was confirmed by gel electrophoresis on a 1.5% agarose gel. In order
to distinguish between Psg22 and Psg25 and to ensure that there was no preferential
amplification of any particular Psg, the above experiment was repeated using the
primer set Psg-all2: Psgall2F and Psgall2R. An amplicon of 176 bp was generated
which was confirmed by gel electrophoresis on a 1.5% agarose gel. For human tissue
samples, two primer sets that amplify all known human PSGs were designed - PSGV4
and PSGV5. As above, two primer sets were designed to ensure that there was no
preferential amplification of any particular PSG. Primer sequences are listed in Table
2.3. Amplicons were gel extracted using a Qiagen Gel Extraction Kit (Qiagen UK) and
blunt cloned into the multiple cloning site (MCS) of the pSTBlue-1 cloning vector and
transformed into NovaBlue Singles competent cells (Novagen, UK). Colonies were
picked and cultured overnight in LB containing ampicillin at 50 µg/ml and plasmid
DNA was extracted using a Qiagen spin mini-prep kit (Qiagen, UK). 10-20 individual
recombinant clones containing the inserts of correct size from each amplification were
sequenced (GATC Biotech, Germany).
2.3.8 BY564540 antisense transcript characterisation
Once I had identified the BY564540 antisense transcript as an interesting putative
enhancer element by bioinformatical methods, it was necessary to discern whether
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Table 2.3: PSG expression survey primers
Primer Sequence
PSGF 5’-TYCAYCCDKTGGHTCTTCAAYA -3’
PSGR 5’-CACAYYGRTAMTYTCCASCATC-3’
Psg-All2F 5’-GTGTTGACAATCTGCCAGAGAATCTT -3’
Psg-All2R 5’-CTCCTGGGTGACATTTTGGATC -3’
Human PSG V4 F 5’-AGAGACCATGGGAACCCTCT-3’
Human PSG V4 R 5’-ATTCTGGATCAGCAGGGATG-3’
Human PSG V5 F 5’-AGCAGGGATGCATTGGAATA-3’
Human PSG V5 R 5’-ACAGCGCATCAAATGGAAG-3’
this EST was expressed and if so, to map the length of this antisense transcript. The
original BY564540 EST and BLAST result sequences were used to design EST specific
primers to investigate if the BY564540 EST and its three BLAST results were expressed
in TSC and TGC. Primers used can be seen in Table2.4. Once it had been established
that the BY564540 EST was expressed, an investigation concerning the length of the
BY564540 antisense transcript utilising RT-PCR primer walking was undertaken. RT-
PCR was performed as described above. Primers used in the primer walking of the
BY564540 antisense transcript are shown in Table 2.5 and primers used in the primer
walking of the BLAST 1 antisense transcript are listed in Table 2.6. Primers were
designed to amplify the antisense cDNA transcripts in a direction specific manner.
Table 2.4: BY564540 EST and BLAST result expression primers
Primer Sequence Product Tm
BY564540 Internal EST F
BY564540 Internal EST R
5’-AGATCCCAAGACTGCAGGAA-3’
5’-GGCCCTCATCATAAGCACAT-3’ 170 bp 57°C
BY564540 EST BLAST1 F
BY564540 EST BLAST1 R
5’-TCCCAAGACTGAACGTACTAT-3’
5’-TTTTTTGGGCCTGAGAATCT-3’ 137 bp 58°C
BY564540 EST BLAST2 F
BY564540 EST BLAST2 R
5’-TCCCAAGACTGCAGGAACTAC-3’
5’-ATCCTTGAACCTGAGAATCT-3’ 137 bp 57°C
BY564540 EST BLAST3 F
BY564540 EST BLAST3 R
5’-TCCCAAAACTGCATTCATTAA-3’
5’-CTCCCTGGGTCCAAAAATCT-3’ 137 bp 57°C
2.3.9 Quantitative Real Time Polymerase Chain Reaction
Quantitative Real Time Polymerase Chain Reaction (qRT-PCR) was performed as
per [49], using the ABI PRISM 7900 sequence detection system (SDS) and the SYBR
GREEN qPCR kit (Applied Biosystems, Foster City, CA, USA). RNA was extracted
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Table 2.5: BY564540 transcript characterisation primers
Primer Sequence Product Tm
BY564540 Internal EST F
BY564540 Internal EST R
5’-AGATCCCAAGACTGCAGGAA-3’
5’-GGCCCTCATCATAAGCACAT-3’ 170 bp 57°C
BY564540 Internal EST F
BY564540 AS3 F
5’-AGATCCCAAGACTGCAGGAA-3’
5’-TGCAAACAGTTATGGGGGAC-3’ 669 bp 59°C
BY564540 Internal EST R
BY564540 AS3 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-AGCGCCCTGTCTGGTTCCCT-3’ 247 bp 58°C
BY564540 Internal EST R
BY564540 4 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-ATCCTACCAGTGGCTCTCAT-3’ 270 bp 62°C
BY564540 Internal EST R
BY564540 5 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-CAGAAGGAGATGCCCAGTGA-3’ 293 bp 59°C
BY564540 Internal EST R
BY564540 6 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-AAGTCTCATAAGCATTCAGAACA-3’ 367 bp 60°C
BY564540 Internal EST R
BY564540 7 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-ACCATTGCCTGAAGGAGAGGA-3’ 473 bp 57°C
BY564540 Internal EST R
BY564540 8 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-TGGATACTTGGCTGGAGACAGA-3’ 681 bp 58°C
BY564540 Internal EST R
BY564540 9 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-GTAACCAAGTGATAGAGGACAAGGA-
3’
1015 bp 58°C
BY564540 Internal EST R
BY564540 10 R
5’-GGCCCTCATCATAAGCACAT-3;
5’-AGGGGAACATCAGCAGGTCA-3’ 1436 bp 56°C
BY564540 A1 F
BY564540 11 R
5’-TGACTGGGACTTGTTTACCTGAT-3;
5’-AGGAAGGCATGAGCAGATGA-3’ 682 bp 58°C
BY564540 A2 F
BY564540 11 R
5’-AAGCGTCGGATGAACTGACAA-3;
5’-AGGAAGGCATGAGCAGATGA-3’ 787 bp 59°C
BY564540 A2 F
BY564540 12 R
5’-AAGCGTCGGATGAACTGACAA-3;
5’-GCAGTTCAGGAGAGCAGAGCA-3’ 918 bp 60°C
BY564540 A3 F
BY564540 13 R
5’-TGTTGAACCCCCTGCTGTAG-3;
5’-TGGAGACAGACAGTGTGCTTCA-3’ 772 bp 57°C
BY564540 A3 F
BY564540 14 R
5’-TGTTGAACCCCCTGCTGTAG-3;
5’-TGCTCAGTCACTTCCACTCTCA-3’ 1829 bp 56°C
BY564540 A3 F
BY564540 15 R
5’-TGTTGAACCCCCTGCTGTAG-3;
5’-TCAGAGGACTTTGGGCTTCT-3’ 6229 bp 60°C
BY564540 A3 F
BY564540 16 R
5’-TGTTGAACCCCCTGCTGTAG-3;
5’-TGCTCTGTGGAATCCTCTACTCA-3’ 7131 bp 59°C
from cell lines and tissues as previously described. First strand cDNA was synthesised
using 1 µg total RNA in a 20 µl reaction using random hexamer priming and the
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, UK, 4368814).
The SYBR GREEN PCR master mix consists of Amplitaq Gold DNA polymerase,
optimised PCR buffer, 25 mM MgCl2, dNTP mix and AmpErase Uracil N-Glycosylase
(UNG). All qRT-PCR reactions were performed in MicroAmp® Optical 384-Well
Reaction Plates (Life Technologies, 4343370). PCR amplifications were performed
in a total volume of 10 µl in triplicate wells. The following PCR protocol was used
for all qRT-PCR reactions: denaturation program (95°C for 10 min), amplification
and quantification program repeated for 40 cycles (95°C for 15 s, 58°C for 30 s,
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Table 2.6: BY564540 BLAST1 transcript characterisation primers
Primer Sequence Product Tm
BY564540 EST BLAST1 F
BY564540 EST BLAST1 R
5’-TCCCAAGACTGAACGTACTAT-3’
5’-TTTTTTGGGCCTGAGAATCT-3’ 137 bp 56°C
BY564540 BLAST1 3.2 F
BY564540 BLAST1 3.3 R
5’-TTGGTATCTCAACAGCATCTTAATA-3’
5’-TGAGACCCAGAAGGAGATGC-3’ 863 bp 60°C
BY564540 EST BLAST1 F
BY564540 BLAST1 3.2 F
5’-TCCCAAGACTGAACGTACTAT-3’
5’-TTGGTATCTCAACAGCATCTTAATA-3’ 730 bp 60°C
BY564540 EST BLAST1 R
BY564540 BLAST1 3.3 R
5’-TTTTTTGGGCCTGAGAATCT-3’
5’-TGAGACCCAGAAGGAGATGC-3’ 270 bp 60°C
BY564540 EST BLAST1 R
BY564540 BLAST1 3.6 R
5’-TTTTTTGGGCCTGAGAATCT-3’
5’-TGGTTCACAGACACCTGAGAA-3’ 682 bp 60°C
BY564540 EST BLAST1 R
BY564540 BLAST1 3.7 R
5’-TTTTTTGGGCCTGAGAATCT-3’
5’-TTCATTAAGACTGACTCCAAGA-3’ 1152 bp 60°C
BY564540 EST BLAST1 R
BY564540 BLAST1 3.8 R
5’-TTTTTTGGGCCTGAGAATCT-3’
5’-TAAGGTTATTTCTCTTTGGTCC-3’ 1611 bp 60°C
BY564540 EST BLAST1 R
BY564540 BLAST1 3.9 R
5’-TTTTTTGGGCCTGAGAATCT-3’
5’-TTTCACTCTTCTAAGTTCTCATAA-3’ 2248 bp 60°C
BY564540 EST BLAST1 R
BY564540 BLAST1 4.0 R
5’-TTTTTTGGGCCTGAGAATCT-3’
5’-CAGAAGCAGTTTAGGAGAGCAGA-3’ 2600 bp 60°C
BY564540 BLAST1 4.0 F
BY564540 BLAST1 4.1 R
5’-TTTAGTCCATGACTTGCCAGG-3’
5’-CACCCTTTCATCCCCAGAGTA-3’ 700 bp 60°C
BY564540 BLAST1 4.2 F
BY564540 BLAST1 4.2 R
5’-TTTTCCTGGTTCAAGGGTGT-3’
5’-AGGGAATTTGTAGGGACCAGA-3’ 764 bp 60°C
BY564540 BLAST1 4.2 F
BY564540 BLAST1 4.3 R
5’-TTTTCCTGGTTCAAGGGTGT-3’
5’-TTAACGCTCACATTGCTGTCTA-3’ 1187 bp 60°C
60°C for 1 minute with a single fluorescence measurement), melting curve program
(60°C – 95°C with a heating rate of 1°C per 30 s and a continuous fluorescence
measurement). Thereafter, PCR products were identified by generating a melting
curve, which was also used to assess the occurrence of putative PCR artefacts
(primer-dimers) or non-specific PCR products. Normalisation of expression levels
to the housekeeping gene, hypoxanthine-guanine phosphoribosyl transferase (Hprt),
was used to avoid discrepancies caused by variations in input RNA or in reverse
transcription efficiencies. Results were described as mean Psg expression relative to
mean Hprt expression. Primers used for qRT-PCR reactions are shown in Table 2.7.
Three biological replicates of each cell line were evaluated, using three technical qRT-
PCR replicates.
2.3.10 Vector construction
A number of vectors used in this work were constructed as follows: Psg22 short-
hairpin RNA (shRNA) vectors were constructed as described in [249, 250]. The shRNA
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Table 2.7: Quantitative Real-Time PCR primers
Primer Sequence
Psg19 QRT F 5’-TCCAGTGCCACCACATGCTGTC-3’
Psg19 QRT R 5’-TGCACGGCCACTGATGATAGACTCT-3’
Psg21 QRT F 5’-AAACTGTGAATGGATTTCGGG-3’
Psg21 QRT R 5’-TGGAAGGAGGGAATTGGGTA-3’
Psg22 QRT F 5’-CGCATGGCCAGTTGGCCATT-3’
Psg22 QRT R 5’-AAAGCGGGGGAAATAGTTGTAGTA-3’
Psg23 QRT F 5’-GAGCCTGTCCCCGTCAAAGTGT-3’
Psg23 QRT R 5’-GAAATGCCTCTGCCCTGCTATAGT-3’
Hprt QRT F 5’-CTATAAGTTCTTTGCTGACCTGCT-3’
Hprt QRT R 5’-ATCATCTCCACCAATAACTTTTATGT-3’
oligonucleotide target sequences were designed using the PSICOOLIGIOMAKER1.5
software programme. Psg22 coding sequence (CDS) was used as input sequence
for the template. This programme predicts all the potential 19-mer oligonucleotide
target sequences, and returns the sense and antisense oligonucleotides (5’ to 3’
orientation) required for gene silencing. These target sequences are listed in Table 2.8.
The murine U6 promoter sequences (F 5’-TGTGCTCGCTTCGGCAGCACATATACT-
3’ and R 5’-AGTATATGTGCTGCCGAAGCGAGCACA-3’) were incorporated before
the shRNA target sequences to stabilize the shRNA and possesses downstream
restriction sites (HpaI and XhoI) to allow the efficient introduction of oligonucleotides
encoding shRNAs into the pSicoR-GFP vector. The CD8 oligonucleotide stem loops
(F 5’-TTCAAGAGA-3’ and R 5’-TCTCTTGAA-3’) were used as described in [249].
Oligonucleotides were composed of U6 promoter sequence, CD8 stem loop, followed
by the Psg22 shRNA target sequence. Oligonucleotide target sequences were aligned
against the mouse genome using the BLAST programme to ensure that these target
sequences were Psg22 specific. Two target oligonucleotides predicted to result in
effective short-hairpin formation and gene silencing were picked, named Psg22shRNA
1 and Psg22shRNA 2. These target oligonucleotides targeted both splice variants
of Psg22. 5’ phosphorylated oligonucleotides were purchased from MWG (MWG
Eurofins, Germany). To construct the Psg22 shRNA vectors, each oligonucleotide
pair (Sense and Antisense) were initially annealed. 1 µl sense oligo (100 µM) and
1 µl antisense oligo (100 µM) were annealed in 25 µl 2x annealing buffer (200 mM
potassium acetate, 60 mM HEPES-KOH pH 4, 4 mm Mg-acetate) for 4 minutes at 95°C,
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10 minutes at 70 °C and then the reaction mix was slowly cooled to 4°C. Annealing of
oligonucleotides was confirmed by gel electrophoresis in a 2% agarose gel. pSicoR
purified plasmid was digested with HpaI and XhoI in parallel to oligonucleotide
annealing. Correctly annealed oligonucleotides were then ligated into the purified
digested pSicoR vector for three hours at room temperature using T4 ligase. 2 µl
of each ligation reaction, Psg22 shRNA 1-pSicoR and Psg22 shRNA 2-pSicoR, were
transformed as per protocol into Novegen competent cells. Positive clones were
obtained, and sent to GATC for sequencing. Sequencing was performed using the
Psg22 shRNA sequencing primer: 5’-TGCAGGGGAAAGAATAGTAGAC-3’. Positive
sequenced clones were then cultured and purified using the Endofree Plasmid Maxi
Kit (Qiagen, 12163) as per protocol and stored at -20°C.
To assess the promoter activity of Psg promoters, Psg promoter LacZ
reporter vectors were constructed as follows. Psg promoter regions, spanning
a region 2 kb upstream of the transational start site (ATG), of Psg20, Psg22,
and Psg23 were amplified using primers with incorporated NotI restriction
sites for ease of cloning. These primers were: Psg 2 kb Promoter F: 5’-
ATAAGAATGCGGCCGCTTTGTGGTGTTGAACCCCCT-3’ and the Psg Promoter R:
5’-ATAAGAATGCGGCCGCATCTCTTCTCACTGTACTGGCCTTT-3’. Psg promoter
sequences were amplified from PAC3 purified DNA as described in PCR protocols
above. Annealing temperature used was 68°C. The PCR products were digested
with NotI for three hours at 37°C and purified using the Qiagen PCR purification
kit (Qiagen, 28104) as per protocol. A LacZ reporter vector was digested with NotI
for three hours at 37°C and gel extracted using the Qiagen Gel extraction kit (Qiagen,
28704) as per protocol. Purified digested PCR products were ligated into purified
digested LacZ vector using T4 ligase, at 16°C for 10 hours. Ligations were transformed
into Novegen competent cells. Positive clones were obtained, and sent to GATC
for sequencing using the T7 promoter primers supplied by the company. Positive
sequenced clones were then cultured and purified using the Endofree Plasmid Maxi
Kit (Qiagen, 12163) as per protocol and stored at -20°C.
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Table 2.8: Psg22shRNA 1 and Psg22shRNA 2 target oligonucleotide sequences
Primer Sequence
Psg22shRNA 1 Sense 5’-GAAGAGAGATATTGTTCAT-3’
Psg22shRNA 1 Antisense 5’-ATGAACAATATCTCTCTTC-3’
Psg22shRNA 2 Sense 5’-GGACAGCACAGTTCGAATA-3’
Psg22shRNA 2 Antisense 5’-TATTCGAACTGTGCTGTCC-3’
2.3.11 Quantification of splice variants and antisense transcripts
Identification of an alternative splice variant of murine Psg22 led to the investigation
of the expression of this variant relative to the full length Psg22 transcript expression
in a variety of trophoblastic cell lines and tissues. Relative splice variant transcript
quantification was performed as described elsewhere [251, 252], employing a dual
insert plasmid containing specific regions of both transcripts to construct a standard
curve for qRT-PCR analysis. Using E10 dissected TGC cDNA as template, transcript
specific primers (Psg22 Variant F and R) were designed to amplify a 608 bp region from
the full length transcript and a 248 bp region from the truncated splice variant. Each
RT-PCR amplicon was then individually gel extracted using the Qiagen gel extraction
kit (Qiagen, 28704) and ligated into pSTblue1, using T4 ligase (Novagen perfectly
blunt cloning kit, Merck, 70182-3) into the EcoRV restriction site in the MCS. Positive
clones were picked and grown overnight in 5 ml LB with carbenicillin (50 µg/ml) at
37°C in shaking incubator. These overnight cultures were then miniprepped using
the Qiagen Minispin kit (Qiagen, 28704) as per protocol. Plasmid DNA was then sent
to GATC (GATC Biotech, Germany), to verify correct sequences had been inserted.
These regions were then excised from the pSTBlue1 plasmids using restriction
endonucleases EcoRI for the Psg22 Long fragment; and KpnI and XhoI for the Psg22
Short fragment. These products were gel extracted using the Qiagen gel extraction
kit (Qiagen, 28704) and ligated sequentially into the MCS of pBluescript SK+ (Agilent
Technologies, UK, 212205) plasmid using the same restriction endonucleases used to
excise the fragments from pSTBlue1. Positive clones were picked and grown overnight
in 5 ml LB with carbenicillin (50 µg/ml) at 37°C in shaking incubator. These overnight
cultures were then miniprepped using the Qiagen Minispin kit (Qiagen, 28704) as per
protocol. The dual insert pBluescript SK+ plasmid was then sent to GATC (GATC
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Biotech, Germany), to verify that both sequences had been correctly inserted. Once
both inserts had been correctly cloned and sequence verified, a standard curve was
constructed using serial dilutions of the template plasmid. Two standard curves are
generated from the same serial dilutions, thus providing complete equality of both
curves as described [251]. Correctly diluted dual insert vector standard curves were
used to perform relative quantification of each transcript using qRT-PCR. qRT-PCR
was performed as described in the qRT-PCR section above. Primers used in the
cloning of the dual transcript vector (Psg22 Variants primer set) and in the qRT-PCR
reactions (Psg22 Long and Psg22 Short primer sets) are described in Table 2.9.
Identification of the BY564540 EST antisense transcript led to the
investigation of the expression of this transcript relative to the full length Psg22
transcript expression in a variety of trophoblastic cell lines and tissues. Relative
quantification of these transcripts was performed as described elsewhere [251],
employing a dual insert plasmid containing specific regions of both transcripts to
construct a standard curve for qRT-PCR analysis. Using E10 dissected TGC cDNA
as template, transcript specific primers, EST BY564540 (EST7R and IESTF primer
set) and Psg22 (Psg22 Variants primer set), were used to amplify a 473 bp region of
the BY564540 EST transcript and a 608 bp region of the Psg22 transcript. Each RT-
PCR amplicon was then individually gel extracted using the Qiagen gel extraction
kit (Qiagen, 28704) and ligated into pSTblue1 using T4 ligase (Novagen perfectly
blunt cloning kit, Merck, 70182-3) into the EcoRV restriction site in the MCS. Positive
clones were picked and grown overnight in 5 ml LB with carbenicillin (50 µg/ml)
at 37°C in shaking incubator. These overnight cultures were then miniprepped
using the Qiagen Minispin kit (Qiagen, 28704) as per protocol. Plasmid DNA
was then sent to GATC (GATC Biotech, Germany), to verify correct sequences had
been inserted. These regions were then excised from the pSTBlue1 plasmids using
restriction endonucleases EcoRI for the Psg22 Long fragment; and KpnI and XhoI for
the BY564540 EST antisense transcript fragment. These products were gel extracted
using the Qiagen gel extraction kit (Qiagen, 28704) and ligated sequentially into the
MCS of pBluescript SK+ (Agilent Technologies, UK, 212205) plasmid using the same
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Table 2.9: Splice variant quantification primers
Primer Sequence
Psg22 Variants F 5’-GGAGGTATCCTCTGAGCTTCTCA-3’
Psg22 Variants R 5’-TTCTGTGCCGAGCAATCTCAA-3’
Psg22 Long F 5’-TTCTGCTCACAGCCTCCCTCT-3’
Psg22 Long R 5’-ACCCCTCTATACCAGACAAAGACTCGAA-3’
Psg22 Short F 5’-TCTGCTCACAGCCTCTCTTTTCA-3’
Psg22 Short R 5’-TTGTACCAGAGAAGCGATTGAAGA-3’
Table 2.10: Psg22 and BY564540 antisense transcripts quantification primers
Primer Sequence
Psg22 Variants F 5’-GGAGGTATCCTCTGAGCTTCTCA-3’
Psg22 Variants R 5’-TTCTGTGCCGAGCAATCTCAA-3’
BY564540 EST - IEST R 5’-GGCCCTCATCATAAGCACAT-3’
BY564540 EST - EST7R 5’-ACCATTGCCTGAAGGAGAGGA-3’
Psg22 QRT F 5’-CGCATGGCCAGTTGGCCATT-3’
Psg22 QRT R 5’-AAAGCGGGGGAAATAGTTGTAGTA-3’
BY564540 EST - IEST F 5’-AGATCCCAAGACTGCAGGAA-3’
BY564540 EST - IEST R 5’-GGCCCTCATCATAAGCACAT-3’
restriction endonucleases used to excise the fragments from pSTBlue1. Positive clones
were picked and grown overnight in 5 ml LB with carbenicillin (50 µg/ml) at 37°C in
shaking incubator. These overnight cultures were then miniprepped using the Qiagen
Minispin kit (Qiagen, 28704) as per protocol. Dual insert pBluescript SK+ plasmid
was then sent to GATC (GATC Biotech, Germany), to verify correct sequences had
been inserted. Once both inserts had been correctly cloned and sequence verified,
a standard curve was constructed using serial dilutions of the template plasmid as
described [251]. Correct standard curves were used to perform relative quantification
of each transcript using qRT-PCR and the standard curve created with the dual insert
vector. qRT-PCR was performed as described above. Primers used in cloning (Psg22
Variants and BY564540 IEST R-EST7 R primer sets) and in the qRT-PCR reactions
(Psg22 Long and BY564540 IESTFR primer sets) are described (Table 2.10.).
2.3.12 ELISA
For the ELISAs, cells were plated in triplicate wells for each treatment in 24 well plates
and incubated in a 37°C humidified incubator with 5% CO2. Raw246.7 cells and THP-
1 cells were seeded at a density of 1 x 106 cells/ml per well. Cells were treated on
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the following day in 300 µl of fresh media for 24 hours. Cells were also treated with
recombinant PSG1 protein as positive control, and Strep-His peptide as a negative
control. After treatments, the supernatants were collected and centrifuged at 3000
rpm for 5 minutes to remove cell debris. For TGFβ1 ELISA, supernatant was activated
as per the manufacturer’s instructions. Induction of TGFβ1 in human monocytic and
murine macrophage cell lines by recombinant Psg22 proteins was quantified using
the Human/ Mouse TGFβ1 ELISA Ready-SET-Go Kit (eBiosciences, 88-7449) as per
manufacturers instructions. This ELISA is engineered for quantification of mouse or
human TGFβ1 protein levels from supernatants from cell cultures. This ELISA has a
sensitivity of 60 pg/ml.
2.3.13 β-Galactosidase Assay
The quantification of β-galactosidase activity from LacZ-reporter constructs was
performed using the Pierce Mammalian β-Galactosidase Assay Kit (ThermoScientific,
75707). The Thermo Scientific Mammalian β-galactosidase Assay Kit provides
a colorimetric method for lysing cultured mammalian cells and measuring β-
galactosidase activity. This kit was used to quantify LacZ expression driven by
Psg-promoter-LacZ constructs in transfected cell lines. Psg-promoter-LacZ vectors
were constructed as described below. Empty LacZ vector was used as a negative
control, and the pCMV-SPORT-βGal construct (Life technologies, 10586-014) was
used as a positive control, as this construct drives LacZ expression through the
strong cytomegalovirus (CMV) promoter. Jar cells were plated in 24 well plates
at a density of 2x105 cells/ml and cultured as described above. Cells were
transfected using Lipofectamine2000 as described above and cultured for 24 hours
post-transfection. The Mammalian β-Galactosidase Assay Kit was used as per
manufacturers instructions. The absorbance was read at 405 nm every hour until
the absorbance remained static using a Spectramax384 Plus Absorbance Microplate
Reader (Molecular devices, USA).
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Table 2.11: Chromatin accessibility primers
Primer Sequence
Psg22 CA F 5’-CCCTTCCCAGAGCACTGAGGACACA-3’
Psg22 CA R 5’-AGCACTGACATGCCCCCAGAGAACA-3’
Psg23 CA F 5’-CCACGTCCAGGAGTCAGCAGATGTC-3’
Psg23 CA R 5’-GAGGGAGGAAAGAAGTCAGAGA-3’
BY564540 CA F 5’-GGGCCTGAGAATCTGGCTGCTGAAA-3’
BY564540 CA R 5’-TGTGCTCTCCATGCTGAGACCCAGA-3’
B1 CA F 5’-GGCCTGAGAATCTGGCTGCAGAAAC-3’
B1 CA R 5’-TGCTCTCCATGCTGAGACCCAGAAG-3’
BY564540 2kbUP CA F 5’-TTGAGCGTTCCTGGCTCTGAGTGTC-3’
BY564540 2kbUP CA R 5’-CCTGGGCCTCCTGCATCAGTTAAGA-3’
BY564540 2kbDWN CA F 5’-GCACCCCAACACATGCGAAAACCTA-3’
BY564540 2kbDWN CA R 5’-GTTTCCATCTCCAGCGTTGCCTCAC-3’
B1 2kbUP CA F 5’-GCCTTGACTTCCTGCAGGGCTACAC-3’
B1 2kbUP CA R 5’-CTCACTGGCCCATGTCTGGTGTCTC-3’
B1 2kbDWN CA F 5’-GCTGAGTATGCATCTCCCCCAGGTC-3’
B1 2kbDWN CA R 5’-CAGCCAAAGCCAAACCAGGAGACTG-3’
Gadph Control F 5’-CAGCTCCCCTCCCCCTATCAGTTCG-3’
Gadph Control R 5’-ACCAGGGAGGGCTGCAGTCCGTATT-3’
Rho Reference F 5’-AGGTCACTTTATAAGGGTCTGGGGG-3’
Rho Reference R 5’-AGTTGATGGGGAAGCCCAGCACGAT-3’
2.3.14 Chromatin Accessibility assay
Chromatin accessibility in specific genomic regions of the murine Psg locus was
measured using the EpiQ Chromatin Accessibility Assay kit (BioRad, 172-5400)
as per manufacturers instructions. TSC lines (TS-R26 and TS-GFP) and their
differentiated TGC, MEFs, and 3T3 cells were grown as previously described. In
situ nuclease digestion was performed, cells were lysed and qRT-PCR was performed
using the Roche Lightcycler 480 system (Roche, UK, 05015243001) as per protocol.
Primers used were designed according to the manufacturers instructions and using
Primer3 software (http://frodo.wi.mit.edu/). Primer efficiency was calculated by the
formation of a serial dilution standard curve and efficiency was analysed using the
EpiQ Chromatin Kit Data Analysis Tool software. The murine Reference (Rhodopsin,
Rho) and Control (Glyceraldehyde 3-phosphate dehydrogenase, Gadph) gene primers
used were supplied with the kit. All primer sequences are described in Table 2.11.
Percentage Chromatin Accessibility was then quantified using the EpiQ Chromatin
Kit Data Analysis Tool software supplied with the kit as per protocol.
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2.3.15 Polysome fractionation
This technique is a slight modification of previously reported methods [253]. This
technique allows the fractional determination of a specific mRNA (Psg22) and whether
this transcript is bound to ribosomes or exists as a free mRNA particle. This
gives an estimation of the transcripts translational efficiency. In this technique free
mRNAs and polysome-bound mRNAs are separated by the principle of sedimentation
velocity in a sucrose gradient. Cycloheximide (C7698, Sigma) was used to immobilize
ribosomes on mRNAs. While free mRNAs will not enter the gradient, the migration of
ribosome-bound transcripts is directly proportional to their loading with ribosomes,
due to increase in density of polysomes over free mRNAs [253]. E10 CD1 dissected
TGC tissue (approx. 20 mg) was used as a sample. Sample processing involved
pulverization of the tissue with a precooled mortar and pestle. This step requires
maintaining the tissue frozen: the mortar is filled with liquid nitrogen with the pestle
inside. Once cold, the tissue is added and then pulverized until a fine powder
is obtained, adding more liquid nitrogen when necessary. This powder was then
lysed using 1 ml of a NP40 lysis buffer (20 mM Tris-HCl pH 7.5, 250 mM NaCl,
15 mM MgCl2, 20 mM DTT, 100 µg/ml cycloheximide, 0.5% Triton-X, 24 U/ml
DNase, 20 U/ml Rnasin, 40 mM VRC, and 1% NP40). Nuclei were then removed by
microcentrifuging at 12000 xg for 10 seconds at 4°C. Cytoplasmic extract was loaded
onto 11 ml 10-60% sucrose gradients (10 and 60% m/v sucrose, 20 mM Tris-HCl pH7.5,
250 mM NaCl, 15 mM MgCl2, 1 mM DTT, 100 µg/ml cycloheximide).
Sucrose gradients were made as described elsewhere [254]. Gradients were
then run for three hours at 38,000x g at 4°C in a Beckman Coulter SW41Ti Swinging-
bucket rotor in an Ultracentrifuge with no brake applied. After centrifugation, 40 x
300 µl fractions were collected carefully from the top and stored at -80°C. Total mRNA
in each fraction was determined using A260/280 UV spectrometer. The 40 fractions
were added to their neighbouring fraction to create 20 fractions, which were then
used for RNA extraction. Fractions 20-40 are diluted with ultrapure H2O to allow
for dilution of concentrated sucrose. Each fraction was supplemented with 30 µl of 0.5
M EDTA (pH 5.1), 30 µl of 10% SDS (to allow dissociation of ribosomes), and 600 µl of
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phenol-chloroform-isoamyl alcohol mixture acidic pH (4-5). Samples were vortexed
and then the upper aqueous phase was placed into a new tube supplemented with
60 µl 3 M NaOAc pH5.1, 2 µl GlycoBlue, and 1 ml isopropanol. This was stored at
-80°C overnight. Fractions were thawed and microcentrifuged at 12,000 xg for 15
minutes at 4°C. The pellets were then washed with 80% EtOH, the pellet was then
dried the pellet and dissolve it in 50 ul H2O. Purified RNA concentrations were then
determined using UV Spectrometer at A260 nm, and stored at -80°C. RNA was then
used in cDNA synthesis as described above and qRT-PCR was used to determine
which sucrose fractions contained Psg22 transcripts and the translational efficiency
of Psg22. Psg22 qRT-PCR primers and Hprt qRT-PCR primers were used to amplify
transcripts of interest, primer sequences are listed (Table 2.7.).
2.3.16 Protein production
Both splice variant isoforms of Psg22 were amplified by RT-PCR from E15
placental cDNA synthesised with Applied Biosystems High Capacity cDNA
synthesis kit (Applied Biosystems, Life Technologies, UK, 4368814) incorporating
the restriction sites NcoI and PmlI. Primers used were: Psg22 ORF F: 5’-
CATGCCATGGAGGTATCCTCTGAGCTTCTCAGCAATG-3’ and Psg22 ORF R: 5’-
CACGTGCCTCATTCATCACAGTCAGCCTGACTGG-3’. This primer set amplified
two transcripts, yielding products of 1425 bp and 1069 bp respectively. These products
were gel extracted using the Qiagen gel extraction kit (Qiagen, 28704) and ligated
into pSTblue1 using T4 ligase (Novagen perfectly blunt cloning kit, Merck, 70182-3)
into the EcoRV restriction site in the MCS. Positive clones were picked and grown
overnight in 5 ml LB with carbenicillin (50 µg/ml) at 37°C in shaking incubator. These
overnight cultures were then miniprepped using the Qiagen Minispin kit (Qiagen,
28704) as per protocol. Plasmid DNA was then sent to Macrogen (Macrogen, The
Netherlands) for sequencing. Positive sequences revealed that this RT-PCR product
was indeed a splice variant of Psg22. Positive clones were cultured, miniprepped,
and then purified plasmid was digested with restriction endonucleases NcoI (R0193S)
and PmlI (R0532S) in NEBuffer 1 and BSA at 37°C for 2 hours. Digests were ran
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through a 0.8% agarose gel, and the correct bands were excised and gel purified
using the Qiagen gel extraction kit. Purified products were then ligated into NcoI-
PmlI digested empty pQE-TriSystem-His-Strep1 expression vector (Qiagen, 32942).
Ligations were performed at 16°C overnight in a G-storm thermocycler. Ligations
were then transformed into NEB Turbo Competent cells (NEB, C2984H) as per
protocol and transformation reactions were then plated onto Agar plates with 50
µg/ml carbenicillin and X-gal (70 µg/ml) and IPTG (80 µM). Plates were placed
in 37°C incubator overnight. Positive colonies were picked and grown in 5 ml LB
with carbenicillin (50 µg/ml) at 37°C in shaking incubator overnight. Overnight
cultures were miniprepped using Qiagen Minispin kit (Qiagen, 28704) as per protocol.
Plasmid DNA was digested with NcoI (R0193S) and PmlI (R0532S) in NEBuffer 1
and BSA at 37°C for two hours. Digest reactions were run through 0.8 agarose gel.
Correct digestion patterns confirmed correctly cloned inserts. Positively digested
clones were then sent to GATC (GATC Biotech, Germany) for sequencing using
sequencing primers: Psg22 Seq1 F: 5’-GTTATTGTGCTGTCTCAT-3’ and Psg22 Seq1
R: 5’-ATCGATCTCAGTGGTATTTGTG-3’. Positive sequencing data confirmed that
both Psg22 transcripts, Psg22-Long and Psg22-Short were cloned correctly in-frame
into pQE-TriSystem-His-Strep1 expression vector.
To produce recombinant Psg22 protein isoforms, endotoxin-free plasmid
DNA was purified from Psg22 Long and Short pQE bacterial cultures using the
Endofree Plasmid Maxi Kit (Qiagen, 12163). All subsequent steps were carried out
using confirmed endotoxin-free reagents and tissue culture flasks. The DNA was
transiently transfected into Freestyle™ 293-F cells (Life Technologies, K9000-01) using
Freestyle™ MAX reagent Life Technologies, 16447750). The Freestyle™ 293-F cells
were grown in suspension in Freestyle™ 293 Expression Medium (Life Technologies,
12338-001), by shaker culture, to a density of 1 x 106 cells/ml. The plasmid DNA
was diluted in OptiPRO™ Serum Free Medium (Invitrogen, 12309-050) at a ratio of
1 µg DNA in 20 µl OptiPRO™ for every 1 ml of cells. Freestyle™ MAX reagent
was also diluted in OptiPRO™ at the same ratio (1 µl Freestyle™ MAX reagent in
20 µl OptiPRO™ per ml of cells). The diluted DNA and Freestyle™ MAX reagent
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were then combined, mixed gently and incubated at room temperature (RT) for 20
minutes. The mixture was added to the cell suspension and the cells were cultured for
a further 72 hours. The culture was then centrifuged at 1,000 rpm for 5 min at RT to
separate the protein-containing medium from the cells, and the medium was frozen in
aliquots at -80°C. Recombinant Psg22 proteins were purified from cell culture medium
by affinity chromatography using Qiagen Ni-NTA resin (Qiagen, 30210). Imidazole
(Sigma-Aldrich; St. Louis, Missouri, I5513-25G) was added to the culture medium to a
final concentration of 10 mM to reduce non-specific binding. Ni-NTA resin was added
to the medium at a ratio of 1 ml resin suspension (corresponding to 0.5 ml resin bed
volume) to 100 ml medium. The medium and resin were then batch bound overnight
on a rotating wheel at 4°C. The medium and resin mix was then passed through a
disposable polypropylene column (Pierce, Thermo Fisher Scientific; Ireland, 29924)
and the resin was washed with wash buffer (500 mM NaCl, 20 mM NaH2PO4, pH
6, until the absorbance at 260 nm reduced to 0. Protein was then eluted from the
column with increasing concentrations of imidazole in wash buffer, 4 x 1.5 ml 50 mM
fractions, 5 x 1.5 ml 200 mM fractions, 4x 1.5 ml 300 mM fractions and 3 x 1.5 ml
500 mM fractions. Psg22 proteins were generally observed to elute in the five 200 mM
fractions and the 300 mM fractions. These Psg22 containing fractions were then pooled
and concentrated to a volume of 4 - 6 ml using a Millipore Amicon® Ultra Ultracel 10K
centrifugal filter (Millipore, Ireland, UFC901024). The concentrate was then dialysed
against three changes of 2 L of phosphate buffered saline (PBS) at 4°C. The protein was
then further concentrated to a volume of 1 - 2 ml depending on the starting volume
of culture medium. Purified recombinant protein was quantified by the Extinction
Coefficient method, purity was checked by polyacrylamide gel electrophoresis using
Coomaisse blue staining (Sigma, G1041), and tested for LPS contamination using
Limulus Amebocyte Lysate QCL-1000 (Cambrex BioScience; Karlskoga, Sweden).
Purified proteins were then aliquoted and frozen at -80°C.
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2.3.17 Polyacrylamide Gel Electrophoresis SDS-PAGE and
immunoblotting
Protein extracts were prepared by washing cells with PBS and lysing in lysis buffer
(Tris HCl, pH 7.4, 150 mM NaCl, 1% NP40, and the protease inhibitors PMSF (1
mM), pepstatin (1 µM) and aprotinin (1.5 µg/ml). After incubation at 4°C for 20
minutes nuclear and cellular debris were removed by microcentrifugation at 14,000
rpm for 15 minutes at 4°C. Total protein was quantified using BCA Protein Assay
Kit (Merck, 71285) according to manufacturer’s protocol and lysate was stored at
-80°C. For all Coomaisse stained gels and western blotting, protein preparations
from HEK293 cell lysates and purfied proteins were resolved by sodium dodecyl
sulphate (SDS)-polyacrylamide gel electrophoresis and transferred to a nitrocellulose
membrane. Proteins were mixed with Laemmli sample buffer (10% glycerol, 2% SDS,
0.01% bromophenol blue, 5% 2-mercaptoethanol, 50 mM Tris, pH 6.8) and boiled at
95°C for 5 minutes prior to gel loading. Proteins were separated using the Bio-Rad
Mini-Protean II gel electrophoresis system. Gels were resolved initially at 20 milliamps
until the protein had passed through the stacking gel and then at 35 milliamps for
approximately 1.5 hours until the dye front had reached the bottom of the gel. For
Coomassie stained gels, the gel was removed from the electrophoresis apparatus and
incubated in Coomassie blue stain (1 g/L Coomassie brilliant blue R-250, 25% 2-
propanol, 10% acetic acid) for at least 1 hour before being destaining in a solution
of 7% acetic acid and 25% EtOH for 2 hours. Gels were then imaged using the protein
gel module of the Odyssey infrared scanning system (LI-COR).
For Western blotting, the gel was removed from the electrophoresis apparatus
and pre-equilibrated in Transfer buffer (48 mM Trizima, 38 mM glycine, 0.037% SDS,
10% EtOH). The gel was then placed on top of a piece of nitrocellulose of the same
size as the gel and sandwiched between three sheets of identically-sized filter paper
that were pre-equilibrated in Transfer buffer. Bubbles were removed using a roller and
proteins were transferred using the Bio-Rad Trans-Blot semi-dry transfer system at 18
V for 26 min. Transferred protein was confirmed with Ponceau Red staining and the
membrane was then blocked in 5% non-fat dry milk (Marvel) in PBS containing 0.1%
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Tween (PBS-T) for 1 hour at RT. Membranes were probed with either rabbit anti-His-
Tag pAb diluted 1:1000 in 5% milk or rabbit anti-Psg22N1A mAb diluted 1:800 in 5%
milk and PBS overlaid onto the membrane for at least 1 hour with rocking or overnight
at 4°C. Following this, the membrane was washed (three 5 minute washes) with TBS-T
(TBS supplemented with 0.1% Tween-20). Secondary antibody goat anti-rabbit IRDYE
680 (LI-COR) was then diluted 1:1000 in a 5% milk/TBS solution and overlaid onto the
membrane for at least 1 hour with rocking. The membrane was washed again (three 5
min washes) with TBS-T and then a final wash in TBS. Membranes were then imaged
using the membrane module on the Odyssey infrared scanning system (LI-COR).
Protein molecular weight markers were purchased from New England Biolabs unless
otherwise stated. Recombinant murine Psg17N1 and Psg22N1A proteins and murine
anti-Psg antibodies were obtained as a gift from G. Dveksler. Recombinant Psg17N1
protein was produced as described previously in [164]. Recombinant Psg22N1A
protein was produced as described in [165]. Rabbit polyclonal anti-Psg22N1A and
rabbit polyclonal anti-Psg17N1 antibodies were generated by GenScript (USA), as
described in [165]. These anti-Psg antibodies were tested by Western immunoblot
for cross-Psg reactivity, and/or cross-species reactivity. Western immunoblots were
carried out as described above using 2 µg of each purified recombinant protein,
including mouse Psg22 Long and Short isoforms, Psg22N1A, and Psg17N1, human
PSG1, PSG9 and BSA standard as samples.
2.3.18 Data and Statistical Analysis
All graphs were created using GraphPad Prism Software (GraphPad Software Inc,
La Jolla, CA, USA). p values were determined by means of one way ANOVA and
Bonferroni’s multiple comparison post-test, with p<0.05 being deemed statistically
significant. (n=) number of biological replicates.
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Chapter 3
Results
3.1 Bioinformatics and Expression
3.1.1 Introduction
To improve our understanding of the rodent PSG multigene families, a complete map
of the PSG loci in mouse and rat, is essential. In this chapter I investigated the structure
and organisation of the rodent PSG loci using sequence data and bioinformatic
techniques. Discerning the correct PSG locus structure will help in our understanding
of PSG evolution and this complex multigene family’s expansion. Using phylogenetic
tree building software I constructed phylogenetic tree alignments of both murine and
rat PSG families to discern if these species had orthologous relationships and whether
they underwent similar family expansions. I found that the uncharacterised mouse
Psg31 and Psg32 genes were incorrectly annotated as a pseudogene (LOC381852)
and a hypothetical gene (Psg-ps1), respectively. RT-PCR products were cloned
and sequenced to confirm expression of these genes in E15.5 murine placenta. I
investigated further the expression patterns of Psgs in a variety of trophoblastic tissue
lineages and TSC lines using cloning of RT-PCR products and qRT-PCR. PSG staining
was detected in immunohistochemical sections of human gastrointestinal tract (GIT)
(A. Houston & T. Moore, personal communication). I investigated whether PSGs were
expressed in the murine and human GIT by RT-PCR and qRT-PCR methods. I found
3. RESULTS 3.1 Bioinformatics and Expression
that Psg22 had an alternative splice transcript, and investigated the abundance of this
transcript relative to the primary full lenght Psg22 transcript in TSC, differentiated
TGC, and a variety of trophoblastic tissues. As Psg22 is the most abundant Psg
transcript in the first half of pregnancy, I investigated whether this transcript was
being translated efficiently using a polysome fractionation assay utilizing a sucrose
gradient. These experiments have generated a set of expression data which will
enhance our knowledge of this complex multigene family.
3.1.2 Reviewing the human and rodent PSG loci: Structure, organisation
and orthology
Following initial investigations concerning the correct PSG locus organisation by
McLellan et al, 2006 [148], I wanted to investigate if these predictions agree with
the current build of the human and rodent genomes. Previous locus organisation
predictions were based upon PSG sequence-specific oligonucleotide probing of YAC
clones and large cosmids, genome walking and previous genome builds, and since
then the genome assemblies have been resequenced, and better organised and
annotated. Currently, the human genome build is the Genome Reference Consortium
GRCh37 build. The current mouse genome build is the Genome Reference Consortium
GRCm38 and the current rat build is the RGSC Rnor5.0 assembly. All of these genome
assemblies were published in 2011 and are the most current genome assemblies for
each of these species. The mouse Psg locus is on proximal chromosome 7, while the
rat PSG locus is located on rat chromosome 1. Using existing sequence data from
RefSeq libraries (NCBI), Ensembl and UCSC genome browsers, an accession table of
all known mouse, rat and human PSG was compiled (Table 1.3). Using this data,
all known murine Psg mRNA sequences from each of these databases, and using
the BLAST program, every known mouse Psg was aligned to an approximately 2
Mb sequence taken from NCBI:M38:7:17566974 to 19627308 of mouse chromosome 7.
Also using all known rodent PSG mRNA sequences from each of these databases, and
using the BLAST program, every known rat PSG was aligned to an approximately 1.3
Mb sequence taken from NCBI: RGSC3.4:1:77301714 to 78604399 of rat chromosome
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Figure 3.1: Rodent and human PSG loci structure and organisation. (A) Murine Psg
locus on chromosome 7 including exon number, distance between Psg genes, genomic
size, and strand orientation. (B) Rat PSG locus organisation on chromosome 1. The
distance between rat PSG and their genomic size is omitted due to incompleteness of
the rat genome. (C) Human PSG locus organisation on chromosome 19q13.2. F, gene
in forward strand; R, gene in reverse strand.
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1. From these data I produced updated maps of the rodent PSG loci showing
gene length, distances between genes, and the orientation of each PSG in the loci.
Rodent and human PSG loci maps are shown (Fig:3.1.). The identification of syntenic
regions, which are blocks of genes or other markers demonstrating an evolutionary
conserved order, and the quantification of evolutionary relatedness between genomes
in terms of chromosomal rearrangements is one of the main research goals in
comparative genomics [255]. With the advent of advanced sequencing technologies
there has been continued growth of genomic sequence data from different species
within public databases, and comparative mapping using bioinformatical tools has
become increasingly important in the identification of functionally related genes
within regions of interest across a range of species. Comparative genome mapping
approaches are based on the sequence conservation between species and allow the
data generated in model organisms such as the mouse and rat to be related to the
human genome.
From our locus maps (Fig:3.1.A&B) we can see that the PSG loci of both
the mouse and rat are quite similar in structure. Both loci contain a Major
Histocompatibility Complex 1-like (MHC1-like) leukocyte (Mill1 and Mill2) gene
flanked PSG cluster, although this cluster of PSG genes in the rat has not undergone
as big an expansion of family members as in the mouse Psg major cluster which
contains 11 of the 17 murine Psg. Or the rat PSG family has undergone a contraction
compared to the common ancestor. We can also see that all the murine Psg located
in this Mill1/2 flanked major Psg cluster are structurally similar, each containing 5
exons that contribute to three N domains and 1 A domain. The distances between
murine Psg genes in the major Psg cluster are shorter in comparison to the murine
Psg genes located outside the major cluster. There is approximately 450 kb between
Psg29 and Psg32, likewise, there is approximately 425 kb between Psg31 and Psg18
which is located in the major Psg cluster. Psg16 has the longest murine Psg gene
length of approximately 60 kb in comparison to the rest of the murine Psg famliy
members which are on average about 10 kb long. The orientation of the rodent PSG
genes that are flanked by the MHC1-like leukocyte 1 and 2 genes (Mill1 and Mill2), are
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located on the reverse DNA strand, with the exception of the mouse Psg22 gene which,
perhaps significantly, is the most abundant Psg transcript in the TGC in the first half of
pregnancy [49]. This is evidence that Psg22 has undergone an independent inversion
event during the Psg family expansion. With Psg22 located on the positive strand,
and the remainder of the Mill1 and Mill2 flanked Psgs located on the negative strand,
this gene specific inversion event, differentiates Psg22 from the rest of the murine
Psg family. This inverted orientation may help to explain how Psg22 has increased
expression relative to its family members. The human PSG locus also has varying
distances between each PSG gene, some being only 6 kb apart, while others can be
approximately 80 kb apart (Fig:3.1.C). It is of note that the human PSGs are smaller
than mouse Psgs, and are between 9 kb and 20 kb long. All human PSG genes are
located on the reverse strand, similar to the rodent loci.
To assess the homology between the rodent PSGs, phylogenetic analysis was
performed using full length CDS sequences of both mouse and rat PSGs. Species
specific PSG family trees were constructed to assess PSG homology in mouse, rat
and human PSG families. These NJ trees (Fig:3.2.), and are constructed as previously
described. The murine Psgs that are contained in the major Psg cluster are located
on one major branch of the tree, while the Psgs located outside this major Psg cluster
are branched together (Fig:3.2.A). Rat PSG37 and PSG39 branch together (Fig:3.2.B).
This phlyogenetic analysis has also shown that there are orthologous relationships
between certain mouse and rat PSG gene family members when an NJ tree of both
rodent species is constructed (Fig:3.3.A). It was first suggested in McLellan et al, 2005,
that these orthologous relationships existed, but these trees were constructed using
incomplete PSG family sequences. Using the current rodent PSG CDS sequences
and loci structure, neighbour-joined pairwise comparison phylogenetic trees were
constructed, which were bootstrapped 1000 times and all major branches yielded
values of 95–100%. These rodent orthologous relationships have been supported in
my tree construction. Using the new rodent loci maps, we can see the synteny between
mouse and rat PSG families is occurring before the major mouse Psg cluster (Fig:3.3.B).
The physical localisation of the 6 PSG genes in rat (PSG38, PSG41, PSG36,
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Figure 3.2: Phylogenetic trees of (A) murine CDS sequences, (B) rat CDS sequences
and (C) human PSG AA sequences. Phylogenetic trees (Neighbour-joined pairwise
comparison phylogenetic trees) were constructed using the MEGA4.0 software
programme (http://www.megasoftware.net/). Data were bootstrapped 1000 times
and all major branches yielded values of 95–100%. The scale bars represent 0.1, 0.5, or
10 nucleotide substitutions per site.
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Figure 3.3: Rodent PSG orthologous relationships. (A) Phylogenetic tree of rodent
PSG CDS sequences. Phylogenetic trees (Neighbour-joined pairwise comparison
phylogenetic trees) were constructed using the MEGA4.0 software programme
(http://www.megasoftware.net/). Data were bootstrapped 1000 times and all
major branches yielded values of 95–100%. The scale bar represents 0.1 nucleotide
substitutions per site. (B) Mouse and rat PSG loci synteny map showing orthologous
relationships between these species before the Mill1/2 flanked PSG cluster.
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PSG40, PSG42 and PSG43) and mouse (Psg16, Psg24, Psg29, Psg32, Psg30, and Psg31)
showed a conserved order before the Mill1/2 cluster of PSG genes. Murine and
rat genes localised within this chromosomal segment are shown (Fig:3.3.B). My
phylogenetic analysis has revealed five orthologous relationships between rodent
PSGs. These orthologous relationships can be seen as Mouse Psg16 branches distinctly
with rat PSG38. Mouse Psg24 and rat PSG36 cluster together, and there is also
supporting evidence of this orthology in that both these PSGs contain 5 N domains.
Mouse Psg29 branches with rat PSG40, and mouse Psg32 can be seen branching with
rat PSG42. There is also orthologous relationships between mouse Psg30 and Psg31
with rat PSG43. All orthologous relationships occurs before the Mill1/2 cluster of
PSGs in both rodent families and this orthology occurs in PSGs that are located on
the forward strand. It is worth mentioning that rat PSG37 and PSG39 cluster on the
same branch, and that this branch is closer to the murine Mill1/2 flanked cluster of
Psgs than to the rest of the rat PSG family members. There is a high confidence in the
orthology demonstrated in the multi-species PSG phylogenetic tree as bootstrapping
scores of 99-100% for each major branch shows that these branching points are robust.
These updated locus and synteny maps will correct annotation in Ensembl database
and facilitate future functional studies of this complex gene family.
3.1.3 Obtaining a Psg containing PAC clone - Mus musculus 129/Sv PAC
library screen
To obtain a Psg containing PAC clone, a P1-derived Artificial Chromosome (PAC)
library was screened for a Psg23 positive clone. Psg23 was used because it is located
in the centre of the major murine Psg cluster, and is relatively close to Psg22. It
was also chosen, as this major Psg cluster may be knocked out in the future. The
RPCI-21 PAC Library has been constructed with female 129S6/SvEvTac mouse spleen
genomic DNA (partially MboI digested) and was cloned between the BamH1 sites of
the pPAC4 vector [248]. The average insert size is 147 Kbp. The library consists of
approximately 128,899 clones in 336 microtitre plates. The plate numbers run from
337 to 672. The PAC library has been gridded onto 22x22cm positively charged nylon
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filters for hybridization screening purposes. Each filter contains 36,864 colonies which
represents 18,432 independent clones spotted in duplicate in a 4x4 clone array. Seven
filters cover the whole library. This provides a 6-9 fold coverage of the mouse genome.
A 879 bp probe was designed approximately 2 kb upstream of Psg23, (Fig:3.4. A).
Primers that amplified this region were designed and the PCR was performed using
an 129/Sv genomic template. This PCR product was then cloned and sequenced.
The probe was then excised from the positive clone using restriction endonucleases
Sal1 and Nco1. The RPCI-21 PAC Library was then screened using the probe
hybridised to the 7 filters that cover the entire library. Positive signals were detected
and analysed using the positive signal orientations to obtain correct clone numbers
as per manufacturers instructions (Fig:3.4. C & D). 10 clones were picked based
on signal strength. A mixture of weak, mid strength and strong positive signals
was picked and ordered. The 10 clones were named PAC1 to PAC10 for ease of
reference. The 10 positive PAC clones were cultured and prepped, using the Qiagen
Large Construct kit as per protocol. Psg23 specific primers were designed upstream
and downstream of Psg23, these primers were used to determine which of the ten
positive PAC clones contained Psg23 sequence. The Psg23 specific upstream primers
amplified the correct product for Psg23 in all ten PAC clones (Fig:3.4. E). Although
only two of the PAC clones contained the positive Psg23 sequence product for the
Psg23 downstream primers. PAC3 was chosen to continue with characterisation, as it
contained Psg23 sequences amplified by Psg23 specific PCR primers. The PAC3 clone
is clone 647-D4 in the RPCI-21 PAC Library. To determine which other Psgs were
present on the PAC3, gene specific Psg primers were designed and PAC3 DNA was
used as PCR template.
There are a number of other Psg family members located on PAC3, including
Psg25, Psg27, Psg23, Psg21, Psg20 and Psg22 (Fig:3.4. F). To determine the exact Psg
locus boundaries of PAC3, purified PAC3 DNA was sent to GATC (GATC Biotech,
Germany) for End Sequencing [248] using the T7 and SP6 promoter sequencing
primers on the pPAC4 plasmid backbone (Fig:3.4. B). End sequencing revealed that
the region of the Psg locus present on PAC3 stretched from downstream of Psg26
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Figure 3.4: 129Sv PAC filter library screen. (A) Psg23 specific probe located 2kb
upstream of Psg23. (B) pPAC4 plasmid map. (C) Probe hybridisation positive
signal. (D) PAC positive signal orientations. (E) Psg23 specific primers upstream and
downstream. (F) Psg specific primers for characterisation of PAC3 (G) PAC3 clone end
sequencing.
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to the middle of Psg22 exon2 (Fig:3.4. G). The End sequencing of this PAC3 clone,
has generated sequence data regarding the orientation of Psg22 located on this clone.
End sequencing has confirmed the inverted orientation of Psg22 located on this PAC
clone. This clone is derived from 129S6/SvEvTac mouse spleen genomic DNA, and
the public genomic databases are based on C57BL/6J mouse genomic DNA, both
of which have demonstrated that this Psg22 inversion is not strain specific. More
research needs to be undertaken to define whether this inversion event is common to
all mouse strains. After characterising the PAC3 clone comprehensively, this clone was
now ready to be used in the Psg Knockout vector construction as a source of isogenic
homologous arms that will flank the KO vector to enable homologous recombination.
Due to time constraints a Psg KO vector was not produced, although this PAC clone
was used in other experiments during the course of this research.
3.1.4 Investigating the structure and expression of Psg31 and Psg32
In McLellan et al, 2005 [148], two novel murine Psg genes were identified. Named
Psg31 and Psg32 as per nomenclature [256], these transcripts were incorrectly
annotated as a pseudogene (LOC381852/Gm5155) and a hypothetical gene (Psg-ps1),
respectively on the NCBI databases. There was also conflicting data regarding exon
number for Psg31 in the public databases. Psg-ps1 was previously considered to be a
pseudogene, based on a point deletion at nucleotide position 30, downstream from
the canonical Psg translational start site [106]. The open reading frame of Psg32
initiates 105 bp upstream of the site of the mutation to an alternative ATG site.
BLAST analysis of the public EST and Trace Archive EST databases yielded many
mRNA clones that contain this region in addition to downstream exons. Hence, this
gene is clearly expressed, and we now propose to rename Psg-ps1 as Psg32 hereafter.
[148]. To provide a better understanding of these two genes, correct accession,
sequence and expression data were generated to fully complete the Psg locus. Using
the online BLAST alignment programme, all known Psg31 sequences were BLASTed
against a 2 Mb chromosome 7 sequence. This generated a full length genomic map
of Psg31 on the locus sequence and from these data I have been able to discern
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Figure 3.5: Expression of Psg31 and Psg32. (A) Graphical representation of primer
sites in Psg31 and Psg32 and predicted gene structure. (B) Primer sequences (red) and
intial sequencing returned from cloned and sequenced RT-PCR products. Psg31 and
Psg32 are expressed in E15 CD1 placenta tissues.
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that there are 10 exons contained in Psg31. The current model of Psg31 evolution
is that Psg31 evolved from a duplication of the whole of the ancestral Psg30 gene
followed by a subsequent internal duplication of the N1 domain [146]. Predicted
domain structures of Psg31 and Psg32 are shown (Fig:1.6.A). There was also no data
regarding whether these novel Psg transcripts were expressed in murine placenta. I
wanted to ascertain the correct exon number in Psg31, and to discern whether Psg31
and Psg32 are expressed in murine placenta. Gene specific primers were designed
to amplify overlapping sequences in Psg31 and a specific primer set to amplify the
whole Psg32 CDS. (Fig:3.5.B). E15 placental cDNA was synthesised, and RT-PCR was
performed. Cloning and sequencing of RT-PCR products confirmed that Psg31 has
ten exons and that Psg31 and Psg32 are expressed in E15 placental cDNA. (Fig:3.5.A&
B) shows primer locations on these genes and the positive sequences. I found that
the previously uncharacterised mouse Psg31 and Psg32 genes were expressed in
E15.5 murine placenta. This expression data is important as it shows that there are
17 transcribed Psg genes in the mouse. It also gives us a better understanding of
the structure of both Psg31 and Psg32. Psg32 is structured like the majority of the
murine Psgs, containing five exons contributing to three Ig-V-like domains and a Ig-
C-like domain. Psg31 is the largest of the murine Psgs, containing 10 exons which
contribute to 8 Ig-V-like domains and a Ig-C-like domain. This Psg31 gene, which is
closely related to Psg30 but, uniquely amongst murine Psg genes, has a duplicated N1
domain.
3.1.5 Differentiated TSC as a model for endogenous Psg22 expression
It has been reported previously that the primary site of murine Psg expression occurs
in TGC [148, 49, 165], although at present there is no immortal murine TGC line and
there is a distinct lack of trophoblast cell lines that fully recapitulate the behaviour
of early placental trophoblast [55]. To obtain a source of endogenous Psg expression
in vitro, a cell line model expressing endogenous Psg needed to be established. As
mentioned previously, TSC will differentiate primarily into TGC and SpT [44]. To
determine whether Psg22 expression is dynamically regulated during trophoblast
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differentiation, we used TS-EXE and TS-GFP trophoblast stem cells as a model system.
I obtained two trophoblast cell lines, TS-EXE and TS-GFP as described elsewhere
[21, 44] and attempted to differentiate these TSC lines into predominantly TGCs.
It has been reported that retinoic acid (RA) contributes to TGC differentiation
with the suppression of the SpT formation. TSC cells treated with RA for 48 hours
exhibited attenuated growth and extensive morphological change [101]. It has also
been reported that RA, specifically 9-cis retinoic acid upregulates PSG5 expression
in humans through a functional Retinoic Acid Responsive Element (RARE) motif
shared by all human PSG genes [200]. So using RA as a tool to differentiate TSC,
TSC cells were treated with 5 µM retinoic acid (both all-trans retinoic acid (ATRA)
and 9-cis retinoic acid (9cisRA) for 24 hours and 48 hours respectively. EtOH was
used as a vehicle control. TSC cells were also subjected to a conditioned media
withdrawal (withdrawal of FGF4, heparin and MEF conditioned medium) protocol
of differentiation as described [21]. RNA was extracted and cDNA synthesised as
described in materials and methods. RT-PCR was performed using this cDNA as
template to examine the molecular markers of TGC differentiation. Marker genes used
to determine differentiation were: Eomes, a TS cell marker, TpbpA, a SpT marker, and
Prolactin2 (Pl2), which is a TGC specific marker gene. Primers used are described in
[44], and are listed (Table 2.3.).
The trophoblast marker Eomes, has a low level of expression in both TS cell
lines treated with RA 24 and 48 hours and Eomes is highly expressed in both TS cell
lines treated with vehicle control after 48 hours (Fig:3.6.A). Even though Eomes is still
being expressed in the RA treated cells, a proportion of the cell population has been
differentiated into TGCs as can be seen from the expression of Pl-2, 24 and 48 hours
post treatment. As expected there is some expression of the SpT marker TpbpA, as
these cell lines do not produce a pure population of TGC, as can be seen with the low
level expression of SpT marker TpbpA after 24 and 48 hours respectively. The vehicle
control treated TSC shows that these TSC are differentiating towards the SpT fate as
there is faint expression of Pl2 but high expression of TpbpA post treatment. From this
experiment we can see that the RA treated TSC are indeed differentiating towards a
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Eomes
Pl2
TpbpA
A
B
Eomes: Trophoblast stem cells
Prolactin2: Giant cells
TpbpA: Spongiotrophoblast
Figure 3.6: Molecular characterisation of differentiated TSC. (A) RT-PCR of TSC
differentiation markers expressed in retinoic acid treated cells. Differentiation markers
used were: Eomes - trophoblast marker, Pl-2 - TGC marker and TpbpA - SpT marker.
(B) RT-PCR of undifferentiated TSC (TS-EXE, TS-GFP) and 6 day conditioned medium
withdrawal differentiated TSCs (GC-EXE, GC-GFP) using differentiation marker
primers.
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Figure 3.7: Differentiated TSC model of endogenous Psg22 expression. Relative
quantification of Psg22 expression normalised to Hprt expression in TS-EXE (A&C)
and TS-GFP (B&D) cell lines. Psg22 expression is induced by 6 day FCM media
withdrawal and retinoic acid (5 µM all trans retinoic acid (A&B) and 9-cis retinoic
acid (C&D) for 24 and 48 hour treatments). (n=3).
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TGC fate, although there is some proportion of the population differentiating towards
a SpT cell fate. The 6 day conditioned medium withdrawal protocol has differentiated
TSC to TGC and SpT cells as can be seen in the relatively high expression of Pl2 and
TpbpA in the cells which have undergone the 6 day conditioned medium withdrawal
protocol (Fig:3.6.B). Both the RA treatments and the 6 day conditioned medium
withdrawal protocol has produced a TGC population in vitro.
The relative levels of Psg expression in both these protocols needed to be
assessed to determine which protocol produced a similar level of Psg transcription
to dissected placental tissues. To assess Psg expression levels, qRT-PCR was used to
compare Psg expression in RA treated TSC, 6 day conditioned medium withdrawal
TSC, and E15 CD1 placenta. Psg22 qRT-PCR primers (Table 2.7.) were used. The
relative Psg22 expression in RA treated TSC, (ATRA or 9cisRA), 24 and 48 hours
post treatment is shown (Fig:3.7.A-D). Low levels of Psg22 expression was detected
in undifferentiated TSC populations. This is consistent with the observation that a
small percentage of TSC undergo differentiation to TGC even in the presence of FGF4
[21].
The RA treatment has induced Psg22 expression but only marginally
compared to undifferentiated TSC, even after 48 hours post-treatment. Interestingly,
there was not much difference in the Psg22 induction levels shown between the
9cisRA and the ATRA, which is surprising given that [257] stated that Trans-
activation analyses show that although all three RXR receptors respond to a variety
of endogenous retinoids, 9-cis RA is their most potent ligand and is up to 40-fold
more active than ATRA. Psg22 expression in these RA treated cell lines has failed
to induce Psg22 to endogenous placental levels. In contrast, the 6 day conditioned
medium withdrawal differentiation protocol induced Psg22 expression to levels that
are comparable to endogenous Psg22 expression in E15 placental tissues. From
this expression data, it is evident that RA does induce Psg22 expression marginally
after 48 hours. Higher doses and longer post-treatment time points may boost RA
induction of Psg22 expression. The 6 day conditioned medium withdrawal TSC
differentiation protocol demonstrated the best ability to mimic placental endogenous
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Psg22 expression in TGC cell lines, and is the differentiating protocol used in the rest
of this work.
3.1.6 Expression survey of PSG transcript abundance - cloning screens
Comparative expression studies of multigene families provides important insights
into biological processes that have potential or known importance for our
understanding of the mechanisms of development. I undertook a PSG expression
survey of a variety of trophoblast and TGC derived tissues. Previous studies have
shown that Psg21 and Psg23 gene transcripts together constitute the bulk of Psg gene
expression in the SpT [191, 148]. It has also been shown that Psg22 is the most
abundant transcript in TGC [49]. To determine whether specific Psg gene transcripts
similarly dominate in TGC derived from differentiated TSC lines, two degenerate
primer sets were designed to amplify all known mouse Psgs [49], (Table 2.2.). As
previously described, RT-PCR amplicons were cloned into pSTBlue1 cloning vector
and positive clones were sequenced. I investigated relative Psg transcript frequency
in two TSC lines - TS-EXE and TS-GFP. cDNA was synthesised from extracted total
RNA, and used as template in RT-PCR reactions. 10 positive clones from each primer
set amplifying template from each TSC line was sequenced and it was found that
in the TS-EXE cell line, Psg22 was the most abundant transcript, although there was
also a variety of other Psg transcripts expressed in this TSC line, including Psg16,
Psg20, Psg23, Psg27 and Psg28 (Fig:3.8.A). In TS-GFP cell line, the most abundant
Psg transcript was Psg27, although, as for TS-EXE cell line, there was also a variety
of Psg transcripts expressed, including Psg17, Psg20, Psg22/25, Psg27, and Psg28. In
contrast, TGC (GC-EXE and GC-GFP) that have been differentiated from these TSC
lines, clearly show that Psg22 is the most abundant Psg transcript in differentiated
TGC (Fig:3.9.A&B). 80% of clones sequenced in both GC cell lines were either Psg22 or
Psg25 transcripts. This Psg expression survey of two TSC lines and their derived TGCs
has shown that there is a variety of Psg transcripts expressed in undifferentiated TSC
but Psg22 is the most abundant transcript present in differentiated TGC. This data
is consistent with previous results demonstrating predominant Psg22 expression in
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dissected TGC [49].
To compliment the results of our survey of Psg expression in undifferentiated
TS cells and their differentiated TGC, I employed the same experimental procedures in
isolated mouse C57BL/6J E5 blastocysts, and E11 blastocyst outgrowths. As described
in the introduction, E5 blastocysts contain predominately TE, including an abundance
of TSC, whereas by E11, the blastocyst outgrowth is predominantly comprised of
differentiated TGC. Similar to undifferentiated TSC lines, E5 blastocysts contain a
variety of Psg transcripts, the majority being Psg22/Psg25, but also including Psg16,
Psg17, Psg18, Psg20, Psg23, Psg27, and Psg28 (Fig:3.10.A). A Ceacam9 transcript was
also amplified with the PSGFR primer set although this is unsurprising as CEACAMs
exhibit homology to PSG sequences in a variety of species and this primer set consists
of degenerate sequences. In contrast to E5 blastocysts, the major Psg transcript in E11
blastocyst outgrowths is Psg22 as in differentiated TGC, with 65% of clones sequenced
being Psg22.
3.1.7 Investigating Psg expression in the gasterointestinal tract
Early research on tissue-specific expression of Psg, indicates that murine Psg
expression is detected exclusively in TGC and SpT of the placenta [129, 130, 131].
Although expression of Psg18 was described [192], in follicle-associated epithelium
(FAE) above Peyers’ patches (PP) in the GIT, and more recently, the report of a brain
specific transcript of Psg16 by [193] led to the hypothesis that PSGs were not expressed
exclusively in the placenta [129]. To determine whether murine Psg expression was
located elsewhere in the GIT, a Psg expression survey of eight different GIT tissue
samples was undertaken. The same primer sets to amplify all known murine Psg as
utilised in the TSC/TGC and blastocyst expression surveys were employed to assess
Psg expression in both male and female GIT. Eight tissues were used in this survey
covering the length of the GIT, including oral cavity, esophagus, stomach (pylorus),
small intestine, ileum, caecum, and rectum. Tissues were dissected from two male
and two female CD1 mice, RNA was extracted and cDNA was synthesised. RT-
PCR amplicons were cloned into pSTBlue1 cloning vector and positive clones were
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Figure 3.8: Murine Psg expression survey of two TSC lines (A) TS-EXE and (B) TS-GFP.
RT-PCR performed with TSC cDNA, using primer sets PSGFR and PsgAll2FR that
amplify all known murine Psg. 20 clones for each cell line were sequenced. Returned
sequences were BLASTed against predicted Psg amplicons.
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Figure 3.9: Murine Psg expression survey of two TGC lines (A) GC-EXE and (B) GC-
GFP. RT-PCR performed with TGC cDNA using primer sets PSGFR and PsgAll2FR
that amplify all known murine Psg. 20 clones for each cell line were sequenced.
Returned sequences were BLASTed against predicted Psg amplicons.
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Figure 3.10: Murine Psg expression survey of (A) E5 blastocysts and (B) E11 blastocyst
outgrowths. RT-PCR performed with blastocyst cDNA using primer sets PSGFR
and PsgAll2FR that amplify all known murine Psg. 20 clones for each primer set
amplifying each blastocyst stage were sequenced. Returned sequences were BLASTed
against predicted Psg amplicons.
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sequenced. Four positive clones from each tissue sample, for each primer set were
sent to GATC (GATC Biotech, Germany). Returned sequences were BLASTed against
predicted Psg amplicons to determine which transcript was present in each clone
using the online BLAST software. The Psg expression survey has shown that a variety
of Psg transcripts are expressed in all GIT tissues investigated (Fig:3.11.A& B). Both
primer sets were able to amplify a variety of Psg transcripts. The PsgAll2FR primer
set amplified seven of the seventeen mouse Psg, including Psg18, Psg21, Psg22, Psg23,
Psg25, Psg26 and Psg28. The PSGFR primer set amplified fourteen of the seventeen
Psgs. The Psg amplified by this primer set were Psg16, Psg18, Psg19, Psg20, Psg21,
Psg22/25, Psg24, Psg26, Psg29, Psg28, Psg29 and Psg31. Psg21 was found to be the most
abundant transcript amplified by the PsgAll2FR primer set in all tissues, comprising
of 40% of clones sequenced. Psg22/25 transcripts were the major transcripts amplified
by the PSGFR primer set. Moreover, Psg31 was also demonstrated to be expressed
in rectal tissue, supporting our results that Psg31 is expressed and is a functional
member of the Psg family (Fig:3.11.B). Synder et al, (2001), states that PSG released by
the placenta plays a pivotal role in the induction of the Th2 response [160]. Kawano
et al (2007), suggests that this hypothesis could apply to the mucosal immune system
as well [192]. The bias toward Th2 response in PPs is essential for the production
of secretory IgA and the tolerogenic response to commensal bacteria as well as food
antigens [258]. The suggestion that Psg expression throughout the GIT is involved in
the promotion of oral tolerance, complements their role as immunomodulators in the
placenta.
To further elucidate the expression of Psg in the GIT, qRT-PCR was utilised
to quantify the relative levels of Psg expressed in the GIT in relation to placental Psg
expression levels. qRT-PCR was performed, using the degenerative PsgAll2FR primer
set. Esophageal, ascending colon and E15 placental tissue was used as template.
Results were described as mean Psg expression relative to mean Hprt expression.
Normalisation of expression levels to the housekeeping gene, (Hprt), was used to
avoid discrepancies caused by variations in input RNA or in reverse transcription
efficiencies. The results show that Psg is expressed in the GIT and can be quantified
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Figure 3.11: Murine Psg expression survey of gastrointestinal tract (male and female
CD1 mice) using primer sets (A) PsgAll2FR and (B) PSGFR, that amplify all known
murine Psg. Four clones were sent from each tissue sample for each primer set to be
sequenced. (C) Relative quantitative expression of total Psg in murine esophageal
and ascending colon tissue samples in contrast to E15 placental expression using
PsgAll2FR primer set. (n=3).
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Figure 3.12: Human PSG expression survey: (A&B) esophagus and (C&D) term
placenta. RT-PCR performed with esophagus and term placental cDNA and two
primer sets V4 and V5 amplify all human PSG transcripts. 10 clones from each primer
set sequenced.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
95 John Michael Williams
3. RESULTS 3.1 Bioinformatics and Expression
reliably. The relative levels of Psg expression in the esophagus and ascending colon
were considerably lower, about 4 orders of magnitude, than Psg levels found in the
placenta (Fig:3.11.C).
To see if these results could be reproduced in human tissue samples, a human
PSG expression survey was undertaken to analyse PSG expression in the Human
GIT. Two degenerate primer sets, Human PSG V4 and Human PSG V5, (Table 2.2),
were designed to amplify all PSG sequences. Human esophagus and human term
placental cDNA were used as templates. As per previous expression surveys, the
RT-PCR amplicons were blunt cloned into pSTBlue1 cloning vectors. From each
tissue, 10 positive clones were sequenced for each primer set, and returned sequences
were compared against predicted PSG amplicons to assess which PSG transcript was
present in each clone. PSG expression was detected in the human esophagus. PSG1,
PSG6 and PSG9 transcripts were amplified by both primer sets in esophageal tissue
samples, with PSG9 being the most abundant PSG transcript detected (Fig:3.12.A& B).
In comparison, five out of 10 PSGs: PSG1, PSG2, PSG6, PSG8 and PSG9 were found to
be expressed in term placenta using the same primer sets (Fig:3.12.C& D). PSG1 was
found to be the most abundant transcript found in these placental samples. Whether
the human PSGs have the same levels of expression in the esophagus as found in the
placenta needs to be investigated.
3.1.8 Quantitative expression of Psg in trophoblastic lineages
McLellan et al states that because all mouse Psg genes originated from a common
ancestor, and through duplication and subsequent divergence expanded into a
multigene family, the investigation as to whether the expression patterns have also
diversified is relevant to determining the selective forces underlying Psg gene family
expansion [146]. Initial investigations of Psg expression was performed in TSC lines
and their differentiated TSCs. As seen in the TSC and TGC expression surveys, Psg22
is upregulated when TSC cells are differentiated towards a TGC fate. I wanted to
confirm this differential upregulation of Psg22 and other highly transcribed murine
Psg using relative qRT-PCR. Psg gene specific primers were designed using Primer-
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BLAST software to ensure primer specificity, and TSC and their differentiated TGC
cDNA were used as templates. Three biological replicates of each cell line were
evaluated, using three technical qRT-PCR replicates. Normalisation of expression
level to the housekeeping gene, Hprt, was used to avoid discrepancies caused by
variations in input RNA or in reverse transcription efficiencies. Dissociation curves
for the PCR products demonstrated a single specific peak indicating absence of non-
specific amplification.
In this study, the expression of four murine Psg genes; Psg19, Psg21, Psg22
and Psg23 was quantified. These Psg family members were chosen, as Psg22 has
the highest levels of Psg expression in the first half of pregnancy, while Psg21 and
Psg23 share the highest expression levels in the second half of pregnancy [49, 191].
Psg19 was also chosen as it is the closest Psg family member to Psg22 as can
be seen in their phylogenetic branching (Fig:3.2.A). All four Psg genes quantified
show similar increased Psg expression patterns when TGCs are differentiated from
TSC (Fig:3.13.A-D). For each Psg quantified there is an increase of Psg expression
in TGCs compared to their TSC derivatives. Psg19, Psg21, and Psg23 all show
approximately a 4 fold increase of expression upon differentiation (Fig:3.13.A, B,&D).
These three Psgs show the lowest levels of increased expression. In contrast, the
greatest increase of Psg expression upon differentiation is Psg22, (Fig:3.13.C), where
there is a 6 fold increase in Psg22 expression, the greatest increase seen in the GC-
GFP cell line. This data reinforces the finding of the induction of Psg22 expression in
TGCs upon differentiation, as shown in the above Psg expression cloning screens of
undifferentiated and differentiated TSC (Figs:3.8. & 3.9.). The fact that Psg22 has the
highest levels of expression in differentiated TGCs in comparison to the other three
Psg quantified supports the hypothesis of a specific function for Psg22 in TGCs in the
early stages of placental development.
Following on from the quantification of Psg expression in TSC and TGCs, I
investigated Psg expression patterns in a variety of trophoblastic lineages. TGCs and
EPC tissue samples were dissected from E10 and E11 CD1 mice as described elsewhere
[27]. Full placental tissue samples, where only the SpT compartment supports Psg
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Figure 3.13: Relative quantification of Psg expression in TSC lines (TS-EXE and TS-
GFP) and 6 day differentiated TGCs. Psg expression is normalised to Hprt expression.
This demonstrates the induction of Psg expression when TSC are differentiated to
TGCs. (A) Psg19 expression, (B) Psg21 expression, (C) Psg22 expression and (D) Psg23
expression. (n=3).
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
98 John Michael Williams
3. RESULTS 3.1 Bioinformatics and Expression
Figure 3.14: Relative quantification of Psg expression in trophoblastic lineage tissues.
Dissected TGCs (DGC - E10 and E11), ectoplacental cone (EPC - E10 and E11), and E13,
E15 and E17 placental samples. Psg expression is normalised to Hprt expression. (A)
Psg19 expression, (B) Psg21 expression, (C) Psg22 expression and (D) Psg23 expression.
(n=2).
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gene transcription, were also dissected from E13, E15 and E17 pregnant timed-
mated females. A study of Psg expression patterns in these tissues was undertaken,
(Fig:3.14.). As in the previous expression quantification experiment, the expression
of four Psg, Psg19, Psg21, Psg22 and Psg23 was investigated. Unlike in TSC and
TGC differentiation, these four murine Psg exhibited distinctly different patterns of
expression between tissue samples. Psg22 displayed the greatest level of expression
in E10 dissected TGCs, the expression of which is approximately 106 fold greater than
Psg21 and Psg23, and a 103 fold greater than Psg19. This high level of Psg22 expression
is converse to Psg21 and Psg23, which showed low levels of Psg expression at this time-
point in the development of the placenta. Unlike Psg22 and Psg19, whose expression
in dissected TGCs decreased from E10 to E11, expression of Psg21 and Psg23 increased
from E10 to E11. Low levels of Psg transcription were also detected in dissected EPC;
this may represent contamination from adherent TGC or, alternatively, the earliest
manifestation of differentiating SpT from late E10 and E11. In the dissected EPC
samples, Psg22 was the only Psg of the four genes investigated to show a decrease
in expression from E10 to E11. Expression of Psg19, Psg21 and Psg23 all increased
from E10 to E11 in dissected EPC samples. Psg expression patterns differ in dissected
placental samples also. Psg22 expression decreased in placental tissue samples from
E13 to E17. The same can be seen in Psg19 expression although levels of expression
are considerably lower than Psg22. The expression of Psg21 and Psg23 increases as the
placenta develops from E13 to E17. Both Psg21 and Psg23 display the same expression
profile and level of expression in these tissues. Comparatively, Psg22 and Psg19 show
similar expression profiles, except in the EPC tissues. Psg19 expression levels are
similar to Psg21 and Psg23. These corresponding expression patterns for these two
gene sets, follows the phylogenetic relationships between Psg21 and Psg23, and Psg19
and Psg22 (Fig:3.2.A).
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3.1.9 Identification and Quantification of the Psg22 splice variant
expression
A novel Psg22 splice variant was discovered when amplifying the Open Reading
Frame (ORF) of Psg22 to construct a Psg22 expression vector to be used to produce
purified recombinant Psg22 protein as described in materials and methods. Primers
Psg22 ORF F and R amplified two variants of Psg22, named hereafter as Psg22 Long
and Psg22 Short. Amplicons of 1425 bp and 1069 bp were obtained when using E15
placental cDNA as template. RT-PCR products were cloned and sequenced, and
returned sequences were compared (Fig:3.15A&B). The alternative splice variant of
Psg22 contained a deletion of the N1 (IgV-like) domain (Psg22∆N1). This alternative
splice variant had not been described previously and did not feature on any of
the public databases. Both splice variants of Psg22 are expressed in differentiated
TSGs, with low levels of both transcripts being expressed in undifferentiated TSC
(Fig:3.16.A). The discovery of this novel Psg22 splice variant led to the investigation
into the abundance of both of these variants’ expression in trophoblastic tissues
and cell lines. Splice variant transcript quantification was performed as described
elsewhere [251], employing a dual insert plasmid containing specific distinguishable
regions of both transcripts to construct a standard curve for qRT-PCR analysis.
Relative quantification of each variant was performed as described in materials and
methods.
Two TSC lines and their differentiated TGCs were used for Psg22 splice
variant expression analysis by qRT-PCR. The relative abundance of both Psg22
variants in TSC and differentiated TGCs is shown (Fig:3.16.A). Both variants show
the same expression patterns in these cell lines. Although, there is greater than a
100 fold difference in expression levels between the full length Psg22, (Psg22 Long)
and the truncated splice variants (Psg22 Short) in undifferentiated TSC. There is an
upregulation of both Psg22 variant transcript expression, with a 10 fold difference
in expression levels between Psg22 Long and Short transcripts when TSC undergo
differentiation towards the TGC fate.
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Psg22 Long transcript:
ATGGAGGTATCCTCTGAGCTTCTCAGCAATGGGTGGACCTCCTGGCAAAGGGTTCTGCT
CACAGCCTCCCTCTTAACCTGCTGGCTCTTGCCCATCACTGCCGGAGTCACCATCGAAT
CCGTACCACCCAAATTGGTTGAAGGAGAAAATGTTCTTCTACGAGTGGACAATCTGCCA
GAGAATCTTCGAGTCTTTGTCTGGTATAGAGGGGTGACAGACATGAGCCTCGGAATTGC
ATTGTATTCACTTGACTATAGCACAAGTGTGACAGGACCTAAGCACAGTGGTAGAGAGA
CATTGTACAGAAACGGGTCCCTGTGGATCCAAAATGTCACCCGGGAAGACACAGGATAT
TACACTCTTCAAACCATAAGTAAAAATGGAAAAGTGGTATCAAATACATCCATATTCCT
TCAGGTGAACTCCTCTCTTTTCATCTGTGGGCGCCCTTCTCCACCTGCACTCCTCACTA
TTGAATCAGTGCCAGCCAGCGTTGCTGAAGGGGGAAGCGTTCTTCTCCTTGTCCACAGT
CTTCCAGATAATCTTCAATCGCTTCTCTGGTACAAAGGGTTGACTGTGTTTAACAAGGT
TGAGATTGCTCGGCACAGAACAGTCAAGAATTCAAGTGAAATGGGCCCTGCCTACAGCG
GTAGAGAGATAGTGTACAGCAATGGATCTCTGCTGCTCCAGAATGTCACCTGGGAAGAC
ACAGGATTCTACACCCTACAAATTGTGAACAGATATTGGAAAATGGAATTAGCACACAT
TCTTCAGGTGGACACCTCCCTTTCCTCGTGCTGTGACGATTTCAACTCTGTCCAACTGA
GGATCAATCCAGTGCCACCGCATGCTGCTGAAGGGGAAAGGGTTCTTCTCCAGGTCCAT
AATCTGCCAGAAGATGTGCAAACCTTTTTGTGGTACAAAGGCGTCTATAGCACTCAGAG
CTTTAAAATTACAGAGTATAGCATAGTGACAGAGTCTCTCATCAATGGCTATGCACACA
GTGGAAGAGAGATATTGTTCATCAATGGATCCCTGCTGCTCCAGGATGTCACTGAGAAA
GACTCTGGCTTCTACACACTAGTAACAATCGACAGCAATGTGAAAGTTGAAACAGCCCA
TGTGCAAGTCAATGTGAACAAGCTTGTGACACAGCCTGTCATGAGAGTCACGGACAGCA
CAGTTCGAATACAGGGCTCAGTGGTCTTCACTTGCTTCTCAGACAACACTGGGGTCTCC
ATCCGTTGGCTCTTCAACAATCAGAATCTGCAGCTCACAGAGAGGATGACCCTGTCCCC
ATCAAAGTGCCAACTCAGGATACATACTGTGAGGAAGGAGGATGCTGGAGAGTATCAAT
GTGAGGCCTTCAACCCAGTCAGCTCAAAGACCAGTCTCCCAGTCAGGCTGACTGTGATG
AATGAGTGA
Psg22 Short transcript:
ATGGAGGTATCCTCTGAGCTTCTCAGCAATGGGTGGACCTCCTGGCAAAGGGTTCTGCT
CACAGCCTCTCTTTTCATCTGTGGGCGCCCTTCTCCACCTGCACTCCTCACTATTGAAT
CAGTGCCAGCCAGCGTTGCTGAAGGGGGAAGCGTTCTTCTCCTTGTCCACAGTCTTCCA
GATAATCTTCAATCGCTTCTCTGGTACAAAGGGTTGACTGTGTTTAACAAGGTTGAGAT
TGCTCGGCACAGAACAGTCAAGAATTCAAGTGAAATGGGCCCTGCCTACAGCGGTAGAG
AGATAGTGTACAGCAATGGATCTCTGCTGCTCCAGAATGTCACCTGGGAAGACACAGGA
TTCTACACCCTACAAATTGTGAACAGATATTGGAAAATGGAATTAGCACACATTCTTCA
GGTGGACACCTCCCTTTCCTCGTGCTGTGACGATTTCAACTCTGTCCAACTGAGGATCA
ATCCAGTGCCACCGCATGCTGCTGAAGGGGAAAGGGTTCTTCTCCAGGTCCATAATCTG
CCAGAAGATGTGCAAACCTTTTTGTGGTACAAAGGCGTCTATAGCACTCAGAGCTTTAA
AATTACAGAGTATAGCATAGTGACAGAGTCTCTCATCAATGGCTATGCACACAGTGGAA
GAGAGATATTGTTCATCAATGGATCCCTGCTGCTCCAGGATGTCACTGAGAAAGACTCT
GGCTTCTACACACTAGTAACAATCGACAGCAATGTGAAAGTTGAAACAGCCCATGTGCA
AGTCAATGTGAACAAGCTTGTGACACAGCCTGTCATGAGAGTCACGGACAGCACAGTTC
GAATACAGGGCTCAGTGGTCTTCACTTGCTTCTCAGACAACACTGGGGTCTCCATCCGT
TGGCTCTTCAACAATCAGAATCTGCAGCTCACAGAGAGGATGACCCTGTCCCCATCAAA
GTGCCAACTCAGGATACATACTGTGAGGAAGGAGGATGCTGGAGAGTATCAATGTGAGG
CCTTCAACCCAGTCAGCTCAAAGACCAGTCTCCCAGTCAGGCTGACTGTGATGAATGAG
TGA
A
B
Figure 3.15: Psg22 Full length (Long) transcript and Psg22 (Short) transcript splice
variant CDS sequences. (A) Psg22 Full length (Long) transcript CDS sequence (1425
bp). Red nucleotide sequence indicates spliced sequence which contains the N1
domain. (B) Psg22 Short splice variant CDS sequences (1065 bp).
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Figure 3.16: Relative quantification of Psg22 Full length (Long) transcript and
Psg22∆N1 (Short) transcript in (A) TSC lines (TS-EXE and TS-GFP) and 6 day
differentiated TGCs. (n=3). (B) Dissected TGCs (DGC - E10 and E11), ectoplacental
cone (EPC - E10 and E11), and E13, E15 and E17 Placental samples. (n=2).
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The relative abundance of both variants in a number of trophoblast lineage
tissues was then investigated. E10 and E11 dissected TGCs, E10 and E11 dissected
EPC, and three time points (E13, E15, and E17) of full placental tissue were used
as templates for Psg22 splice variant expression analysis in qRT-PCR reactions.
(Fig:3.16.B) shows that both splice variants possess the same expression profile as
total Psg22 in dissected TGCs and dissected EPC (Fig:3.14.C). Psg22 splice variants
are highly expressed in E10 dissected TGCs, and expression of both variants decrease
as the placenta develops. It was found that full length Psg22 has approximately 100
fold higher level of expression than Psg22 Short in all tissues and time-points tested.
The highest levels of the Psg22 Short variant was found in E13 placental samples. Both
variants have higher expression levels in earlier time points in all tissues investigated
and expression decreases as embryonic development progresses. The discovery of
a novel Psg22 transcript variant and the fact that this transcript has a significantly
different level of expression than the full length Psg22, poses the question of whether
these two transcripts encode for proteins with the same function. I will address this
question in the next chapter.
3.1.10 Investigating Psg22 translation efficiency
Expression analysis in trophoblast tissues has shown that Psg22 is highly expressed in
dissected TGCs (Fig:3.8.C). Whether this highly expressed transcript correlates with a
high level of translation was investigated in this section. High levels of transcription
does not always mean that these transcripts are efficiently translated. Discrimination
between actively translated and translationally silent mRNAs in the cell can be carried
out using sucrose-gradient fractionation (polysome gradients), since this technique
allows separation of free ribonucleoprotein particles (ribosome-free mRNA) from
mRNAs bound to ribosomes (polysome-bound mRNA); thus ribosome loading of a
transcript is a robust indicator of translation efficiency [253]. This technique allows for
the determination of the fraction of a specific mRNA bound to ribosomes versus the
fraction existing as free messenger ribonucleoprotein particles (mRNPs), thus giving
an estimate of its translation efficiency. By comparing this parameter between different
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Figure 3.17: Investigating Psg22 translation efficiency - Polysome fractionation of
Psg22 transcripts. Approximately 20 mg of lysed E10 dissected TGC tissue was used as
template. (A) A260 nm readings of 40 fractions. (B) Quantification of Psg22 transcripts
in pooled fractions. Psg22 transcripts are found in the polysome bound fractions
indicating that Psg22 is efficiently translated. (C) Quantification of Hprt transcripts
in pooled fractions as a positive control.
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stimulation or growth conditions, or between different cell types, it is possible to
estimate the degree of translational control. For many mRNAs not all functional
molecules are attached to ribosomes; some exist as free mRNPs. Technically, free
mRNPs and polysome-bound mRNAs are separated by the principle of sedimentation
velocity in a sucrose gradient. While free mRNAs will not enter the gradient, the
migration of ribosome-bound transcripts is directly proportional to their loading with
ribosomes, due to the increase in density of polysomes over free mRNPs. After the
run, the gradient is fractionated and analysed [259].
20 mg of dissected TGC tissue was used as template for this technique,
the tissue was pulverised into a powder under liquid nitrogen, before being lysed,
(ribosomes were immobilised on their transcripts using 100 µg/ml cycloheximide
present in the lysis buffer), cell debris removed, and the supernatant was extracted
and carefully placed on a 11 ml 10-60% sucrose gradient as described previously [254].
Gradients were centrifuged for 3 hours at 38,000x g at 4°C, and 40 fractions were
carefully collected from the top. Total mRNA in each fraction was determined using
a A260/280 UV spectrometer. These UV spectrometer results were plotted to produce
an RNA profile, (Fig:3.17.A). Free mRNPs can be seen in fractions 1-13, while fractions
16-20 contain 80S RNA. Polysome bound RNA can be detected in fractions 30 to 39, as
depicted by the peak in the RNA profile. RNA was extracted and cDNA synthesised.
Fractions containing Psg22 transcripts were determined using qRT-PCR, with Psg22
specific qRT-PCR primers. Hprt specific qRT-pCR primers were also used as a control
for polysome loading. Primer sequences are listed (Table 2.6). Psg22 transcripts
are found in fractions 15 to 20, indicating that these transcripts are heavily loaded
with ribosomes (Fig:3.17.B). Heavy ribosome loading of transcripts demonstrate that
these transcripts are translated. The expression of Hprt in these fractions is shown
in (Fig:3.17.C). Hprt transcripts can be found in fractions 14-18, indicating that these
transcripts are also heavily loaded with ribosomes. Both Psg22 and Hprt have the same
polysome fractionation profile, indicating that both these transcripts are translated.
The fact that Psg22 transcripts have high levels of expression, and these results
demonstrating that Psg22 transcripts are associated with polysomes corroborates the
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hypothesis of Psg22 playing a role in TGCs.
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3.2 Function and Regulation of murine Psg22
3.2.1 Introduction
The determination of the regulatory and functional properties of genes is central to
genetical and biochemical research. To improve our understanding of murine Psgs, I
investigated the mechanisms responsible for the regulation of Psg22 and a possible
functional role for Psg22 protein. I constructed expression vectors that express
both Psg22 variants. Employing a mammalian HEK cell expression system, both
protein isoforms of Psg22 were produced, and purified using affinity chromatography.
The function of these Psg22 proteins was examined, specifically in their ability to
induce anti-inflammatory cytokines, such as TGFβ1 in human and mouse monocytic
and macrophage cell lines. Two Psg22 short-hairpin RNA (shRNA) vectors were
constructed to attempt to knockdown Psg22 expression in vitro.
I investigated the possible mechanisms that are responsible for the tissue-
specific regulation of Psg22, and other Psgs. Transcriptional regulation can occur at
both genetic and epigenetic levels. Genetic regulation is defined as a direct or indirect
interaction between a gene and a transcription factor, and epigenetic regulation
as altering DNA accessibility to transcription factors by chemical modification of
chromatin [260]. The transcription factors that may bind to Psg promoters was
analysed using transcription factor binding analysis software, and the relative
frequencies of transcription factors that are implicated in TGC differentiation and
PSG regulation was examined. The conformation of local chromatin in the regulatory
regions of Psg22 and Psg23 was investigated to determine whether the chromatin
surrounding these regulatory regions was in an open conformation. The mechanisms
responsible for the relatively high expression of Psg22 was not determined by this
promoter analysis, and I hypothesised that an alternative regulatory mechanism is
responsible. During the examination of the Psg22 loci, I found an EST transcript
(BY564540), that is located upstream of Psg22, which may be involved in the regulation
of Psg22 expression. I was able to identify three regions of sequence similiarity to this
EST using online BLAST alignment software. Through the use of expression analysis
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and primer walking RT-PCR, I was able to determine that this EST is expressed in a
TGC-specific manner, is over 6 kb long and is expressed in an antisense manner to
Psg22. Employing qRT-PCR I determined the expression patterns of this EST relative
to Psg22 expression, which demonstrated that these transcripts possess a concordant
expression pattern in trophoblastic tissues and cell lines. Finally I investigated
the local chromatin conformation associated with these antisense transcripts. I
determined that the low-level expression of these transcripts is correlated with the
modulation of local chromatin into an open conformation and with the relative high
expression of Psg22 in a cell-specific manner.
3.2.2 Psg22 protein production
To elucidate if both of the Psg22 protein isoforms share a common function,
endotoxin-free purified recombinant Psg22 proteins were produced as described in
materials and methods. The ORFs of both Psg22 variants were cloned into the pQE-
Trisystem-His-Strep-1 expression vector (Fig:3.18.B) using restriction endonuclease
sites Nco1 and Pml1 incorporated into the primer set used to amplify the ORFs
from E15 placental cDNA (Fig:3.18.A). Positive clones were verified by restriction
digest band patterning and sequencing. Purified plasmid DNA for both variants
was transfected into Freestyle™ 293-F cells as per protocol. The optimum time of
maximal protein concentration post-transfection was discerned using various time-
points post transfection. 1 ml of Freestyle™ 293 Expression Medium supernatant
was removed from the transfected culture flasks at 12, 24, 36, 48, 60 and 72 hours
post-transfection. Supernatant was centrifuged for 5 minutes at 1000 rpm to clear cell
debris. 30 µl of supernatant from each time-point was tested on a Western immunoblot
to assess optimum transfection times for each Psg22 protein isoform. Psg22 Long
protein was detected at 12 hours post-transfection, whereas, Psg22 Short protein was
detected at 24 hours post-transfection (Fig:3.18.C). A Rabbit anti-Poly6xHis antibody
was used to detect the presence of these proteins, as the pQE-Trisystem-His-Strep-1
expression vector incorporates a Strep-His tag onto the C-terminus of the proteins
to facilitate in purification of these proteins from medium supernatant via affinity
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chromatography. I found that 72 hours post-transfection, for both isoforms, is the
optimum time to harvest cell culture medium for protein purification. 20 µg purified
human recombinant PSG1 was used as a positive control for the detection of His-
tagged proteins.
To verify that the Psg22 proteins were being efficiently secreted into the cell
culture medium and not retained in the cells, 30 µl of 72 hours cell culture supernatant,
and 20 µg of 72 hours post-transfection cell lysate were run on a polyacrylamide gel,
and using the rabbit anti-Poly6xHis antibody, I detected recombinant Psg22 in cell
supernatant samples but not in the cell lysates, indicating that both isoforms of Psg22
are secreted (Fig:3.18.D). 250 ml cultures of Freestyle™ 293-F cells were cultured to
a density of 1 x 106 cells/ml, and 72 hours post transfection, transfection medium
was harvested. Psg22 proteins were batch-bound to Ni-agarose beads in the presence
of 10 mM imidazole overnight at 4°C. Psg22 proteins were eluted using increasing
concentrations of imidazole. Batch bound Psg protein medium was run through 10 ml
endotoxin-free polypropylene columns, and isolated Psg22 bound beads were washed
with 6 ml of wash buffer. Washing was complete when no protein was detected with
UV spectrometer in wash flow through. Psg22 proteins were eluted with increasing
concentrations of imidazole (50 mM, 200 mM, 300 mM and 500 mM). 4 x 1.5 ml
fractions of each concentration was collected, and 30 µl of each fraction collected was
run through a polyacrylimide gel and Psg22 proteins were detected using rabbit anti-
Poly6xHis Ab (1:1000 dilution) (Fig:3.18. E). The western immunoblot demonstrates
that the majority of Psg22 protein was eluted in the 200 mM imidazole fractions.
The 200 mM and 300 mM imidazole fractions were pooled together, and added to
10 kDA cut-off protein spin columns, centrifuged at 3600 rpm until concentrated to
2 ml. Concentrated protein solutions were dialysed using dialysis cassettes in 1600
ml endotoxin-free PBS overnight at 4°C. A second round of dialysis was performed
for another four hours in fresh endotoxin-free PBS. Purified protein was concentrated
further to 500 µl, aliquoted, and stored in 0.5 ml Eppendorf tubes at -80°C. Protein
concentration was determined using the extinction coefficient quantification method.
To determine the purity of these Psg22 proteins, 2 µg of each purified protein
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Figure 3.18: Optimisation of Psg22 protein production. (A) Psg22 splice variant
RT-PCR - TS-EXE and GC-EXE cDNA with Psg22 ORF primers. (B) Schematic of
PQE-Trisystem-His-Strep expression vector. (C) Western immunoblots of Psg22 Long
and Short test transfections. (D) Western immunoblot of 72 hours HEK293 post-
transfection supernatant and lysates - rabbit anti-Poly6xHis Ab for both Psg22 protein
isoforms. (E) Western immunoblot of imidazole elutions of purified Psg22 proteins -
rabbit anti-Poly6xHis Ab.
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was run through a polyacrylimide gel which and stained with Coomaisse brilliant
blue dye to visualise the protein bands. Both proteins are present, with the Psg22
Long isoform transfection producing a very pure protein, although there were a few
nonspecific protein bands present in the Psg22 Short protein preparation (Fig:3.19.A).
As reported previously, mutated Psg proteins have been found to produce unknown
higher unspecific bands [170], resulting in protein purity of approximately 90%. The
Psg22 Long transcript produces a protein of 55 kDa, which includes the addition
of the Strep-His tag. Post-translational glycosylation of these proteins increases the
molecular weight by approximately 30% [261]. This post-translational modification
results in a full length protein of approximately 71 kDA. The Psg22 Short transcript
encodes for a protein of 42 kDa, including the Strep-His tag. The Psg22 Short isoform
of this protein after post-translational modification has a molecular weight of 54 kDa.
Fig:3.19.B shows a schematic of Psg22 protein isoforms domain predictions.
N-terminal sequencing was employed to determine the first 5 aa sequence of
these two purified proteins (Alta-Biosciences, UK). It revealed that both proteins are
cleaved at the predicted end of the Leader sequence (Fig:3.19.C), which is at position
34 aa for Psg22 Long, and at position 30 aa for Psg22 Short. The first 5 aa of the Psg22
Long isoform are VTIES, in comparison to the Psg22 Short isoform, which is SPPAL,
resulting in a protein that is 115 amino acids shorter than the full length Psg22 protein.
Both of these proteins are identical, with the exception of the IgV-like N1 deletion,
present in the Psg22 Short protein. As previously discussed, the RGD-like motif that
is located in the IgV-like N1 domain in all rodent and human PSGs, is implicated as a
key motif involved in PSG functionality. The omission of the IgV-like N domain in the
truncated Psg22 Short protein, may have detrimental effects on this Psg22 variants’
function. I therefore tested whether these proteins share the same function, or have
different functions.
Two rabbit polyclonal antibodies, anti-Psg22N1A and anti-Psg17N1, were
kindly donated by G. Dveksler. Western immunoblotting was used to test the
specificity of these antibodies. Recombinant PSG proteins (PSG1, PSG9, Psg22 Long
and Short, Psg22N1A, & Psg17N1) were tested to check for cross-Psg reactivity,
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Figure 3.19: Psg22 protein purification and murine Psg antibody characterisation. (A)
Coomaisse stain of 2 µg purified Psg22 Long and Short protein isoforms. (B) Schematic
of Psg22 splice variant domain organisation. SMART (a Simple Modular Architecture
Research Tool) output. (C) N-terminal sequencing of purified Psg22 proteins – leader
sequence cleavage and first five amino acids sequenced (leader sequence denoted in
red).
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Figure 3.20: Polyclonal anti-Psg antibody characterisation. (A) polyclonal rabbit
anti-Psg17N1 antibody characterisation (B) polyclonal rabbit anti-Psg22N1A antibody
characterisation. 2 µg of each purified recombinant protein, including mouse Psg22
Long and Short isoforms, Psg22N1A, and Psg17N1, human PSG1, PSG9 and BSA
standard, were used as samples. Both primary antibodies used at 1:800 dilution.
Secondary antibody goat anti-rabbit IRDYE 680 (LI-COR) was used at 1:1000 dilution
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and cross-species PSG reactivity. Both antibodies detects, both long and short
isoforms of recombinant Psg22 protein, Psg22N1A, Psg17N1, and human PSG1
(Fig:3.20.A&B). The fact that these antibodies have cross-PSG and cross-species
reactivity is unsurprising given that these antibodies are polyclonal, and PSGs are
cloesly related. The fact that these antibodies cross-react with other murine Psgs,
and possibly the related CEACAMs (which also posses a similar IgV-like N domain),
renders them unsuitable for use in the specific detection of Psg22, and they were not
used further in this study.
3.2.3 Psg22 induction of TGFβ1 - ELISA analysis
TGFβ1 has pleiotrophic effects in regulating T cells, B cells, and macrophages. TGFβ1
has been found to be produced by every leukocyte lineage, including lymphocytes,
macrophages, and dendritic cells, and its expression serves in both autocrine and
paracrine modes to control the differentiation, proliferation, and state of activation
of these immune cells. TGFβ1 has been implicated in immuno-suppression, and it
has been shown that the administration of TGFβ1 suppresses symptoms of certain
experimentally induced autoimmune diseases whereas the administration of anti-
TGFβ1 antibodies exacerbates these conditions [262]. It has also been shown that
TGFβ1 exerts systemic immune suppression and inhibits host immunosurveillance
[263]. TGFβ1 is a proangiogenic factor that plays an important role in the development
of the fetoplacental capillary system during implantation [264]. TGFβ1 has multiple
roles during pregnancy, including regulation of extravillous trophoblast migration
and proliferation and regulation of NK cell function [170]. It has been previously
described that murine Psg proteins (including a truncated Psg22-N1-A protein) induce
TGFβ1 in monocyte and macrophage cell lines [170, 265, 165]. To assess whether the
two Psg22 protein isoforms that have been produced in this study share a common
function, I tested their ability to induce TGFβ1 in a murine RAW246.7 macrophage cell
line and in a human THP-1 monocytic cell line. Induction of TGFβ1 was measured
using an eBiosciences Ready-Steady-Go TGFβ1 ELISA. The RAW246.7 and THP-
1 cell lines were maintained as described in materials and methods. Cells were
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plated in triplicate for each treatment in 24 well plates and incubated in a 37°C
humidified incubator with 5% CO2. Raw246.7 cells and THP-1 cells were seeded
at a density of 1 x 106 cells/ml per well. Cells were treated with 10 µg/ml Psg22
Long and 10 µg/ml Psg22 Short on the following day in 300 µl of fresh media
for 24 hours. Cells were also treated with 10 µg/ml recombinant PSG1 protein as
positive control, and 10 µg/ml Strep-His peptide as a negative control. The Strep-His
peptide (WSHPQFEKLEHHHHHHHH) (Eurogentec, Belgium) was used as a control
for the Strep-His tag introduced to the C-terminus of the proteins expressed from
the pQE-Trisystem-His-Strep-1 expression vector. This ensured that the tag was not
responsible for TGFβ1 expression. After treatments, the supernatants were collected
and centrifuged at 3000 rpm for 5 minutes to remove cell debris. The supernatants
were activated as per protocol as this sandwich ELISA recognizes the mature/active
form of TGFβ1. Samples (but not standards) were acid-treated and then neutralized
to activate the latent TGFβ1 to the immunoreactive form.
In murine RAW246.7 cells (Fig:3.21.A), there is a higher induction of TGFβ1
from the Psg22 Short treatments than with the Psg22 Long protein treatments. Psg22
Short treatments induced TGFβ1 to levels of approximately 290 pg/ml, which is
consistent with previous reports of TGFβ1 induction in RAW246.7 cells by Psg23N1A
[170]. In THP-1 cells (Fig:3.21.B), TGFβ1 induction is much higher than in RAW246.7
cells, as is consistent with previous reports [170]. Induced levels of TGFβ1 by the
full length Psg22 Long protein reach levels of nearly 3000 pg/ml, in contrast to TGFβ1
levels of approximately 6700 pg/ml are induced by the Psg22 Short protein treatments.
The Psg22 Short protein treatments result in over a two fold the induction of TGFβ1
than the full length protein. This is due to these proteins not being used in equimolar
concentrations, resulting in a higher dosage of Psg22 Short than Psg22 Long protein.
Both Psg22 proteins have induced TGFβ1 significantly more than control treatments
(P≤0.001) in RAW246.7 and THP-1 cell lines (Fig:3.19.A&B). Both of these Psg22
protein isoforms share the ability to induce TGFβ1, despite the difference in levels
of TGFβ1 upregulation. This demonstrates that regardless of the fact that the Psg22
Short protein possesses a N1 domain deletion, a region which contains the ’RGD’-like
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Figure 3.21: Induction of TGFβ1 by recombinant Psg22 proteins. (A) Mouse
macrophage RAW264.6 cells were treated with 10 µg/ml of Psg22 Long and Short
recombinant proteins for 24 hours in 24 well plate (n=3). Strep-His peptide used as a
tag control. (B) Human THP1 cells were treated for 24 hours with 10 µg/ml Psg22
Long and Short protein isoforms. 10 µg/ml of human recombinant PSG1 protein
used as control. 24 hours post treatments, cell medium supernatant was collected and
induction of TGFβ1 was measured by ELISA. (n=3). Data was subjected statistical
analyses using a One Way ANOVA and Bonferroni’s Multiple Comparison Post-test.
(***, P ≤ 0.001)
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motif and was previously implicated as playing a role in Psg functionality, both these
proteins are able to induce TGFβ1. This leads to the conclusion that it is not the Psg
N1 domain that is exclusively responsible for the induction of TGFβ1.
3.2.4 Psg22 shRNA vector testing in vitro
Current approaches to study gene function, such as gene targeting via homologous
recombination in murine embryonic stem (ES) cells has been the main approach
used to investigate mammalian gene function in vivo. Even though there has been
recent advances in this technology, it still remains a time-consuming, expensive and
laborious method, that cannot be applied to human tissues. Important advances in
RNA interference (RNAi) technology has produced a less-time consuming method
for producing knockdown of gene expression to investigate gene function in a number
of organisms using plasmid-based RNAi to stably silence gene expression [266, 267].
An RNA polymerase III promoter is used to transcribe a short stretch of inverted DNA
sequence, forming a short hairpin RNA (shRNA) that is processed by Dicer to generate
siRNAs [250]. The Cre-Lox conditional pSico Reverse (pSicoR) vector used in this
research was generated by modification of the pLL3.7 vector, that expresses RNAi
inducing shRNAs under the control of the U6 promoter [250]. The U6 promoter has
been widely used to drive the expression of shRNAs and a U6-based lentiviral vector
for the generation of transgenic mice has been recently described [249]. This vector
was engineered to co-express enhanced green fluorescent protein (EGFP) as a reporter
gene to aid in assessing transfection efficiency. This pSicoR vector allows constitutive
shRNA expression, which can be terminated by a Cre mediated recombination event
[250].
To assess Psg22 function in vivo, two Psg22 shRNA vectors were constructed
and the knockdown of Psg22 expression was performed in vitro using TGC lines
as a source of endogenous Psg22 expression. Oligos that target Psg22 were
generated using the PSICOOLIGIOMAKER1.5 software programme available from
the Jacks’ Lab (http://web.mit.edu/jacks-lab/protocols/pSico.html). Two separate
oligos (Psg22 shRNA construct 1 and 2) were selected based on predicted targeting by
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
118 John Michael Williams
3. RESULTS 3.2 Function and Regulation of murine Psg22
Figure 3.22: Psg22 shRNA construct knockdown of Psg22 expression in TGC lines.
Two Psg22 shRNA constructs, Psg22 shRNA 1 and 2, scrambled shRNA and empty
pSicoR vector controls. (A) Psg22 shRNA knockdown of Psg22 expression in GC-EXE
cells. (B) Psg22 shRNA knockdown of Psg22 expression in GC-GFP cells. (n=1), best
replicate of three independant experiments. Psg22 expression normalised to Hprt.
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PSICOOLIGOMAKER1.5. These oligos were designed to target both splice variants
of Psg22. Oligos were ordered from MWG Eurofins (Germany). Sense and Antisense
oligos were annealed as per Jacks’ lab protocol, and cloned into the pSicoR expression
vector as described in materials and methods. Completed Psg22 shRNA pSicoR
vectors were sent to GATC (Germany) for sequencing to confirm successfully cloned
vectors. Psg22 shRNA vector clones with correct sequences were then tested in vitro in
terminally differentiated TGC lines. To transfect these shRNA vectors efficiently, two
TSC (TS-EXE and TS-GFP) lines were seeded at a 80% confluency. Undifferentiated
TSC were transfected using Lipofectamine2000 as per protocol in serum free medium.
Six hours post-transfection, the serum free medium was replaced with TSC medium,
to induce differentiation to a TGC fate. These cells were grown in TS medium for 6
days, producing a population of cells that contain a majority of TGC. These cells were
then harvested, RNA was extracted, and cDNA was synthesised as per protocols.
Using relative qRT-PCR, the extent of Psg22 expression being knocked down by
the Psg22 shRNA constructs was assessed. Results were described as mean Psg22
expression relative to mean Hprt expression. Primers used for qRT-PCR reactions
are described (Table 2.6.). Three biological replicates of each cell line were evaluated,
using three technical qRT-PCR replicates.
Untransfected TGCs, TGCs transfected with empty pSicoR vector, and TGCs
transfected with an off-target shRNA construct were used as a control. In both
TS-EXE and TS-GFP TSC lines, the empty pSicoR and off-target shRNA pSicoR
control constructs had no affect on Psg22 expression, which indicates that there is
no unspecific knockdown of Psg22 gene expression as a result of the pSicoR vector
backbone. In TS-EXE cells the Psg22 shRNA construct 1, produced the greatest
knockdown in Psg22 expression, with Psg22 shRNA construct 2 producing a slightly
less efficient knockdown (Fig:3.22.A). A similar knockdown of Psg22expression is
found in TS-GFP cells transfected with these constructs. As in TS-EXE, the Psg22
shRNA construct 1, produced a slightly better knockdown of Psg22 expression than
with Psg22 shRNA construct 2 in TS-GFP cells (Fig:3.22.B). These results demonstrate
a knockdown of Psg22 transcript in vitro using Psg22 shRNA vectors. This in vitro
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testing demonstrates that these vectors could be used to knock down Psg22 expression
in vivo.
3.2.5 Investigation of murine Psg Promoters
As stated previously, human PSGs do not have conventional promoters, as promoters
of human PSG genes are highly homologous and lack any obvious TATA-box, typical
initiator elements, or large GC-rich sequences [202, 195]. I investigated whether
murine Psgs possess similar regulatory promoter regions as human PSGs, and what
mechanisms control the regulation of Psg transcription. The genes associated with
regulation of human and murine PSGs, cell lines which have been used to demonstrate
regulation, and published literature citations are listed (Table 1.5.). A database of all
murine Psg promoter sequences was compiled. I analysed a 2 kb in length region
as there was no obvious core promoter for murine Psgs, and the regions that could
be responsible for regulation of Psg expression may lie within this extended 2 kb
promoter region. The length of this 2 kb extended regulatory region was also chosen
as it would allow for analysis of region-specific deletions in later experiments. This 2
kb extended regulatory region spans from -2000 bp 5’ of each Psg to the base before
the translational start site (ATG) designated (-1). I chose to include regions that span
up to the ATG, as some Psgs contain a conserved regulatory region with human PSGs
which is located approximately 180 bp upstream of the ATG site but lies inside the TSS
in the 5’UTR. In all mouse Psgs, the ATG codon is approximately -200 bp downstream
of the TSS located in exon 1. This 2 kb region upstream of the translational start site
of all 17 Psg were analysed. As with the human PSGs, I was unable to find an obvious
TATA box, or GC-rich regions. The homology of these Psg regulatory regions was
analysed. These 2 kb regions were aligned using ClustalW and a neighbour-joined
pairwise comparison phylogenetic tree was constructed as described previously. The
regulatory regions of the murine Psg family showed homology of between 49 - 92%.
To investigate the transcriptional and regulational architecture present on
murine Psg promoters, a database of the putative transcription factor binding sites
implicated in TGC differentiation located on these 2 kb Psg extended promoters was
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compiled, (Table 3.1.). These extended 2 kb regulatory regions were analysed using
the MatInspector programme (Genomatix Software Suite, Germany) which identified
putative transcription factor binding sites and the frequency of these binding sites for
each transcription factor on individual Psg promoters. This analysis was performed
using the MatBase database and the associated MatInspector algorithm implementing
the optimum-threshold default parameter. MatInspector reduces the signal-to-noise
levels associated with putative transcription factor binding analysis by limiting the
number of predicted sites reported and only showing the highest-scoring matrix
match per transcription factor family in the query sequence.
Although there were numerous putative transcription factor binding sites
identified on the 17 murine Psg regulatory regions, this investigation centred
on transcription factors involved specifically in TGC differentiation and known
regulators of PSG expression. The transcription factor binding analysis focused
on 15 transcription factors that have been previously implicated in either TGC
differentiation or human PSG regulation (Table 3.1.). The roles of these transcription
factors in TGC differentiation and the associated published literature regarding
these TGC related transcription factors are highlighted (Table 1.2.). The results of
this Psg extended regulatory region analysis has revealed a variety of transcription
factors binding to different Psg regulatory regions at different locations and with
different frequencies, which may explain the differences in individual Psg expression
regulation.
I was especially interested in transcription factors that bind to the Psg22
promoter that distinguishes this promoter from the rest of the murine Psg family,
which may give an indication of the mechanisms which are responsible for the
increased expression of Psg22. The only transcription factor that binds to Psg22 that
does not bind to the other Psg promoters is FoxD3. FoxD3 is a member of the forkhead
transcription factor family and has been implicated in the suppression of TGC
differentiation [28, 87, 88, 89]. FoxD3 is generally considered to be a transcriptional
repressor and to be involved in the maintenance of pluripotency. However, FoxD3 can
also function as a transcriptional activator [268], and additional roles for FOXD3 are
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emerging particularly with regard to the differentiation of migratory cell phenotypes.
Putative FoxD3 transcription factor binding sites are located at the end of the analysed
2 kb promoter length (-1931 nt), far from the TSS and the second binding site is
located at (-254 nt). To date there has been no evidence of FoxD3 in the role of PSG
regulation. Reporter construct assays are needed to elucidate if this transcription
factor is involved in the suppression or activation of Psg22 transcription. These stand-
alone putative Psg22 promoter FoxD3 binding sites are intriguing, especially as there
are no other FoxD3 binding sites in a 2 kb region spanning all 16 other murine Psgs.
Lopez-Diaz et al, 2007, reported that the minimal promoter region of all
PSG genes contains a putative Retinoic Acid Responsive Element (RARE) and
that mutations at specific nucleotides within the RARE motif inhibits both RXRα-
DNA interactions and RXRα transcriptional activation of PSG5 promoter [200]. I
investigated whether murine Psgs possessed this overlapping regulatory SP1-RARE
site, using MatInspector transcription factor binding analysis software. 15 of the
murine Psg possess a putatuive SP1 binding site, but only four out of 17 murine Psgs
possess this overlapping SP1-RARE site in the CPE region. Psg17, Psg19, Psg20 and
Psg26 all possess overlapping SP1-RXRα sites. Interestingly Psg22 does not possess
this overlapping dual transcription factor site, but only contains an SP1 site. Also of
note, if the Guanine (G) base located at -35 on the Psg22 2 kb TSS upstream region,
is mutated to a Cytosine (C), the RXRα site is reintroduced when analysed using the
Transcription factor Binding Site software. I found that there are 4 other putative RxR
binding sites along this 2 kb TSS upstream region of Psg22, and all 17 murine Psgs
possess at least two RxR binding sites.
The AP-2 γ or Tfap2c transcription factor, which is involved in TGC
differentiation [78, 8], was found only to have one putative binding site on only one
murine Psg, Psg20, suggesting that it does not have a role in Psg22 transcriptional
regulation. The Kruppel-like factor 4 (KLF4) which is implicated in the regulation of
human PSG5 transcription has no putative binding sites on any murine Psg promoter,
indicating that it in not involved in directly binding to murine Psg DNA regulatory
sequences. Its family member, KLF6, which also plays a role in PSG5 regulation,
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has binding sites on only six of 17 murine Psg promoters, being Psg16, Psg17, Psg19,
Psg22, Psg24 and Psg29. The Psg22 promoter has two bHLH Hand1 transcription factor
binding sites, which is comparable to the frequency of Hand1 sites on the other 7 Psg
promoters which were found to posses this transcription factor. Also Psg22 has two
NeuroD1 binding sites, which is comparable to the number of NeuroD1 sites present
on the 9 other Psg that contain these putative binding sites. Stat3 has two putative
binding sites on Psg22 promoter, in contrast Psg16 has four sites, which is the most
putative binding sites in the 15 Psg with Stat3 sites. Tead4 sites can be found on all
murine Psg, with the exception of Psg24. There are three Ik3 binding sites on the Psg22
promoter, which is the most sites presents on all murine Psg promoters except Psg16.
The Gata2/3 transcription factor is also present on all murine Psg promoters, with the
exception of Psg21. There are two Gata2/3 sites on the Psg22 regulatory region. Cdx2
is present on all murine Psg, except Psg19. The Cdx2 transcription factor has 3 sites on
the Psg22 promoter, although, Psg26 has 5 putative sites.
The only transcription factor, which is involved in TGC differentiation and
is well represented in all mouse Psg promoters is Gcm1. Psg22 only has two Gcm1
binding sites, with Psg24 and Psg31 both containing 8 Gcm1 regulatory regions. It is
interesting that Psg24 and Psg31 share a common number of these regulatory sites,
as they share the domain expansion of internal N domains, although their regulatory
regions do not branch together on the phylogenetic tree. This suggests that Gcm1
has a potential role in regulating all murine Psg, as there is a conservation of these
sites amongst murine Psg. Further in vitro reporter construct analysis involving
these individual transcription factors need to be employed to discern whether this
in silico analysis has yielded transcription factor candidates that regulate murine Psg
transcription.
Murine Psg 2 kb regulatory regions (Fig:3.23.A), do not follow the
phlyogenetic relationships that is evident between the coding sequences of the Psg
genes in (Fig:3.2.A). Psg21 and Psg23 2 kb regulatory regions are highly related, as
are Psg30 and Psg31 regulatory regions. Psg26 and Psg28 are also highly related.
This phylogenetic tree reveals that the Psg22 2 kb regulatory region is located on
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
125 John Michael Williams
3. RESULTS 3.2 Function and Regulation of murine Psg22
A
C
B
Figure 3.23: Investigating and quantifying Psg promoter activity. Promoter
activity was quantified by induction of β-Galactosidase using Pierce Mammalian β-
Galactosidase Assay Kit in Human choriocarcinoma JAR cell line. (A) Psg 2 kb
upstream region neighbour-joined phylogenetic tree. (B) Schematic of Psg 2 kb
upstream region inserted into NotI sites in LacZ expression vector. (C) β-Galactosidase
quantification of promoter constructs in JAR cell line (n=3).
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subbranch of it own, and its closest relatives are Psg27, Psg20, Psg21 and Psg23. It is
interesting to note that Psg19 and Psg22 2 kb regions are quite different, even though
these two genes’ coding sequences cluster together on the same phylogenetic branch.
This difference in 2 kb regulatory region similarity may be the reason why Psg22 has a
higher expression level than Psg19 which is the closest relative of Psg22. Also of note
is the location of the Psg16 upstream region on this phylogenetic tree, which does not
branch with any other Psg family member.
To investigate the promoter activity of murine Psgs, a quantitative LacZ
expression assay was undertaken to assess the activity of Psg20, Psg22 and Psg23 2
kb regulatory regions. Psg20, Psg22 and Psg23 2 kb upstream regions were cloned
individually into LacZ expression vectors. Cloned Psg 2kb upstream regions were
sequence verified (GATC, Germany) and correctly engineered LacZ constructs were
transfected into the human choriocarcinoma Jar cell line. Jar cells were maintained for
48 hours post transfection, and the resulting LacZ expression was measured using the
Pierce ThermoScientific Mammalian β-Galactosidase Assay Kit as per manufacturers
instructions. The schematic of the LacZ vector used and restriction sites employed
in the cloning of the 2 kb Psg regulatory regions are shown (Fig:3.23.B). This LacZ
expression vector contains a partial human β-globulin promoter linked to a LacZ gene
coding region, and LacZ expression is driven by the region of DNA that is cloned
between the two NotI restriction sites. β-Galactosidase activity is measured simply by
colourimetric quantification.
The quantified LacZ activity associated with each Psg regulatory region
tested is shown (Fig:3.23.C). An empty LacZ vector was used as a negative control,
and as can be seen, confers no promoter activity. A pCMV-SPORT-βgal LacZ construct
was used as a positive control and gives the highest induction of LacZ in transfected
Jar cells. This is due to the presence of the strong CMV promoter driving LacZ
expression in this cell line. The Sprouty3 promoter positive control induced LacZ
expression at slightly higher levels than the Psg 2 kb regulatory regions. The Psg22 2 kb
region induced the highest level of LacZ expression of the three Psg regions analysed,
although the difference in promoter activity between these three Psg 2 kb regions was
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marginal. Psg23 induced LacZ at a slightly lower level, and Psg20 was found to induce
the lowest levels of LacZ of the Psg 2 kb upstream regions tested. This result shows
that the three Psgs upstream regulatory regions tested, have a low level of promoter
activity in JAR cells.
3.2.6 Investigation of chromatin structure and accessibility in Psg
promoters
I investigated whether the 2 kb upstream region of Psg22 possess an open
chromatin conformation associated with Psg22 transcription in TGC. I employed
the EpiQ chromatin analysis kit (Bio-Rad) to assess the conformation of chromatin
in cultured cells. The EpiQ kit quantifies the impact of epigenetic events, such as
DNA methylation and histone modification, on gene expression regulation through
chromatin state changes. This assay is based on the principle of in situ chromatin
digestion, genomic DNA purification, and qRT-PCR to determine the chromatin
environment of targeted regions of the genome. It can discriminate open, actively
transcribed chromatin regions from closed, transcriptionally silent regions. Two TSC
lines (TS-R26 and TS-GFP), their differentiated TGCs (GC-R26 and GC-GFP), MEFs
and 3T3 cell lines were used. Psg specific primers were designed as per manufacturers
instructions, spanning a region 300 bp in the TSS upstream regions of Psg22 and Psg23.
Psg22 primers were located at -151 bp from the Transcriptional Start site, and the
Psg23 primers were located -125 bp from the Transcriptional Start site. Primers used
are described (Table 2.1.). Cultured cells were exposed to in situ chromatin nuclease
digestion, genomic DNA was purified and qRT-PCR analysis was performed as per
protocol. Three biological replicates and three technical replicates for each cell line
was evaluated using the online EpiQ Chromatin Kit Data Analysis Tool, provided
with the kit. A lower than 65% accessibility result, deems the conformation of the
region inaccessible and thus moderately silenced. A 65% or above accessibility result,
deems the chromatin state accessible and active, meaning this region is minimally
silenced, or not silenced at all. The percentage of chromatin accessibility for the
Psg22 300 bp TSS upstream region, in a variety of cell lines are shown (Fig:3.24.A).
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A
B
Accessibility Chromatin Structure Potential of Epigenetic Silencing
95-100% Fully accessible Not silenced
65-95% Mostly accessible Low level of silencing
20-65% Low  accessibility Moderately silenced
0-20% Highly inaccessible Completely silenced
Figure 3.24: Quantification of chromatin accessibility in Psg22 and Psg23 promoter
regions in TSCs (TS-GFP and TS-R26), differentiated TGCs (GC-GFP and GC-R26),
MEFs and 3T3 Cells. Biorad EpiQ Chromatin Accessibility Assay was used to
determine percentage accessibility of chromatin using Psg specific promoter primers
with 300 bp amplicons. Unlike the Psg23 promoter, the Psg22 promoter region is in the
active chromatin conformation in differentiated TGCs. (n=3).
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Fibroblast derived MEF and 3T3 cell lines were used as controls, as there is no Psg22 or
Psg23 expression found in these cell lines and the chromatin in these upstream regions
should not be in an active conformation in these cell lines. The chromatin accessibility
of the Psg22 upstream region is found to be 49% in MEFs, and 55% in 3T3 cells, and is
in the inactive conformation which was expected. Chromatin accessibility was found
to be 36% in the TS-R26 cell line and 54% in the TS-GFP cell line. The conformation in
both these TSC lines is the inactive state, which is consistent with low Psg expression
levels in these cell lines. Analysis of differentiated TGC chromatin conformation has
revealed that the Psg22 300 bp TSS upstream region is in the active conformation in
these cells. The Psg22 300 bp TSS upstream region had a 67% accessible chromatin
structure in GC-R26 cells, and a 71% chromatin accessible chromatin structure in GC-
GFP cells. This demonstrates that the Psg22 promoter is mostly accessiblenin these
TGC populations which is unsurprising as these cells are the primary source of Psg22
expression, and an open chromatin conformation is expected due to the high levels of
Psg22 transcription.
As a Psg 300 bp TSS upstream region control, the Psg23 300 bp TSS upstream
region chromatin conformation was also investigated. As per the Psg22 region, the
chromatin accessibility of the Psg23 300 bp TSS upstream region was found to be
inaccessible in MEFs, 3T3 cells, and in both TS cell lines (Fig:3.24.B). Psg23 chromatin
accessibility was 30% in MEF cells, 35% in 3T3 cells, 31% in TS-R26 cells, and 39%
in TS-GFP cells. All of these cell lines demonstrated that the Psg23 promoter was
poorly accessible due to an inactive chromatin conformation. In contrast to the Psg22
promoter region, the Psg23 promoter chromatin conformation was found to be in the
inactive state in differentiated TGCs, giving an accessibility result of 53% in GC-R26
cells, and 57% in GC-GFP cells, just short of the 65% cutoff percentage. These results
indicate that the Psg23 300 bp TSS upstream region does not undergo a chromatin
conformational change as a consequence of TSC differentiating into TGCs, as occurs
with the Psg22 300 bp TSS upstream region. There is only a slight difference in
promoter activity between these two regions in the LacZ-reporter assay, which is
surprising given the stark differences in chromatin conformation demonstrated in
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TGCs for these regions (Fig:3.24.C). I have found, using the Chromatin Accessibility
assay, that the murine Psg22 upstream region undergoes substantial changes in
chromatin accessibility upon TGC differentiation that is not seen in the corresponding
region of Psg23.
3.2.7 Identification of Psg22 antisense transcript
I found only slight differences in promoter activity between the Psg20, Psg22 and
Psg23 regulatory regions which suggests that an alternative mechanism is responsible
for the increased Psg22 expression in TGC. Transcription factor binding analysis of
murine Psg upstream regions did not suggest an explanation. To address this issue, I
investigated a putative enhancer element located upstream of Psg22 that is not present
in the rest of the murine Psg family which may be responsible for these high levels of
Psg22 expression. From an extensive search using the available genome browsers, I
located an Expressed Sequence Tag (EST) located approximately 5738 bp upstream of
the Psg22 Transcriptional Start Site. This EST was found using the EST track on the
UCSC genome browser. Annotated as BY564540, this EST is 417 bp in length and is
located on the negative strand. A screen capture from the UCSC browser (Fig:3.25.A),
illustrates the location of BY564540 in relation to Psg22. Using the BY564540 sequence
and the online BLAST programme, I examined whether there were any other regions
in the murine Psg family locus that possessed a similar EST or region of similarity.
The BLAST results indicated that there are three other regions within the Psg locus,
that had very similar sequence to the BY564540 EST. I named these regions BLAST
1-3. The closest match to the BY564540 sequence was located approximately 9264 bp
downstream of Psg22 stop codon (TGA). This sequence (BLAST 1) was 90% similar to
the original EST sequence. Two other BLAST hits, (BLAST 2 and BLAST 3) revealed
sequences that were 86% and 81% similar respectively. BLAST 2 sequence was located
upstream of Psg19 and the third BLAST hit, BLAST 3 was located upstream of Psg25.
Locations of these three BLAST hits, along with the original EST BY564540, and
their relative orientations on the mouse Psg locus are shown (Fig:3.25.B). All BLAST
sequences were found to be in the opposite orientation to the Psg genes that they
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reside next to. It was found that the BLAST 1 hit, downstream of Psg22 is in the same
orientation as BY564540, whereas the other two BLAST hits, BLAST 2 and 3 are in the
opposite orientation. I investigated if BY564540 and transcripts arising from the
regions identified by the BLAST analysis are expressed in trophoblast lineages. Using
RT-PCR, BY564540 specific primers were designed (Table 2.4.), and the expression of
this EST was determined. This BY564540 EST is expressed in trophoblast lineages,
but more interestingly, is expressed in a TGC specific manner (Fig:3.25.C). Two TSC
lines were tested, and expression of BY564540 was not found in these TSC lines,
but when these TSC undergo differentiation, BY564540 EST expression is detected.
I have shown its expression in two differentiated TGC lines, EPC tissue, and three
stages of placental development (E13, E15, and E17). No expression of this EST
can be found in ES cells. I investigated the expression of the three BLAST result
regions in trophoblast lineages. BLAST 1-3 region specific primers were designed
using the Primer-Blast programme and I examined their expression in the TSC and
differentiated TGC. As with the original BY564540 EST, these sequences were also
expressed in a TGC specific manner, with no expression found in undifferentiated
TSC. RT-PCR products were cloned and sequence verified (GATC, Germany). All
RT-PCR amplicon sequences returned were BLASTed against the mouse genome,
and sequences corresponded to the exact sequences predicted by the BY564540 EST
BLAST results (Fig:3.25.D). The BY564540 EST is expressed, as are the three BLAST
regions that are similar to this EST. The 417 bp sequence that is present on the UCSC
genome browser was analysed using the online ORF finder software programme,
(http://www.ncbi.nlm.nih.gov/projects/gorf/gorf.html), and no coding ORFs were
found in any of the three frames tested. This result establishes that this BY564540
EST, is expressed in a TGC-specific manner, has no protein-coding potential, and that
this BY564540 antisense transcript is a noncoding RNA transcript. The fact that Psg22
is flanked by these two antisense transcripts, may have a role in the upregulation of
Psg22 expression in TGCs in the first half of pregnancy. The next step was to map
these non-coding RNA antisense transcripts and to test if these antisense transcripts
have a regulatory function in TGC.
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Figure 3.25: Identification of BY564540 EST transcript. (A) BY564540 EST located
upstream of Psg22 exon 1 on UCSC genome browser. (B) BLAST results of BY564540
EST. Three regions highlighted by green boxes contain homologous sequences to
BY564540 EST (yellow box). Named BLAST result 1-3, the relative orientations of
these BLAST results are shown. (C) BY564540 EST transcript is expressed in TGC but
not in TSC. The expression of BLAST 1- 3 (B1-B3) regions is also found in TGC but
not in TSC. (D) RT-PCR amplicons were cloned and sequenced, all four transcripts are
expressed.
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3.2.8 Mapping of the BY564540 and BLAST 1 antisense transcripts using
primer walking
Following on from the detection of expression of this EST and similar regions, it
was necessary to map the structure of these antisense transcripts. I employed a
primer walking approach to map the BY564540 transcript, as an initial attempt at
5’RACE (Rapid Amplification of cDNA Ends), to map the 5’ end of this transcript
was unsuccessful (data not shown). Antisense transcript specific primers were
designed, and used to RT-PCR this transcript in an overlapping manner, to find the
transcribed boundaries. Specific RT-PCR primers used for the Primer walking of
Antisense transcripts are shown (Tables 2.5. & 2.6.). Transcript specific primer walking
primer locations, and the locations and distances of the BY564540 EST and its similar
BLAST 1 antisense transcript in relation to the Psg22 locus is illustrated (Fig:3.26.).
Using the primer walking method I mapped the BY564540 and BLAST 1 antisense
transcripts. Amplifying E10 dissected TGC cDNA using specified RT-PCR primer
combinations gave an approximate size of BY564540 antisense transcript as 6148 bp
and the approximate size of BLAST 1 antisense transcript is 6370 bp. Using RT-PCR
primer walking, I was able to detect transcription of the BY564540 antisense transcript
to the TSS of Psg22. The length and position of the 5’ end of this transcript implicates
this BY564540 antisense transcript, as a divergent or bidirectional lncRNA, as its
transcription initiates within 1000 bp of the TSS of Psg22, the fact that this transcript
is over 6 kb in length, and contains no ORFs in any of the three frames analysed.
The presence of the second lncRNA antisense transcript, BLAST 1 lncRNA antisense
transcript, downstream of Psg22, may have occurred as a result of a duplication event
of the BY564540 lncRNA, when the Psg22 gene locus was subjected to the inversion
event (Fig:3.1.). I hypothesise that the expression of these lncRNA transcripts function
in maintaining an open local chromatin conformation, resulting in ease of access of
the Psg22 transcriptional machinery to Psg22 promoter regulatory regions.
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3.2.9 Investigation of BY564540 antisense transcript expression relative to
Psg22 expression
As the primer walking experiment has demonstrated, the BY564540 EST antisense
transcript is approximately 6 kb in length, and is expressed in differentiated TGCs,
as is Psg22, suggesting that there is a possibility of this antisense transcript being
involved in the regulation of Psg22 expression. I investigated the relative abundance
of the BY564540 lncRNA antisense transcript relative to the expression of the primary
Psg22 transcript and expression patterns in trophoblast cells and tissues. Employing
the same technique used to quantify the expression of the Psg22 splice variants as
described in materials and methods, a specific region of each transcript was dual
cloned into a single construct, which was used to construct a standard curve for qRT-
PCR analysis. Once both inserts had been correctly cloned and sequence verified,
a standard curve was constructed using serial dilutions of the template plasmid as
described [251, 252]. Primers used in cloning of the dual transcript vector, and qRT-
PCR primers used are described (Table 2.10.). A variety of trophoblast derived cell
lines and tissues were used as templates for the qRT-PCR reactions, including two
TSC lines (TS-EXE and TS-GFP), their differentiated TGCs, dissected TGCs (E10 and
E11), dissected EPC (E10 and E11), and three embryonic stages of placenta (E13, E15
and E17).
The relative quantification of Psg22 and BY564540 antisense transcripts
can be seen (Fig:3.27.). These results show that this antisense transcript follows
the same expression patterns that were found for both Psg22 transcripts, having
higher expression in earlier embryonic time points and expression levels lowering as
embryonic development progresses (Fig:3.27.A&B). Reproducing my previous results,
the expression pattern of the Psg22 transcript is the same as in (Fig:3.13.C & Fig:3.14.C).
This data shows that there are low levels of expression of both the Psg22 transcript and
the BY564540 antisense transcript in both TSC lines. This is due to a mixed population
of cell types found therein, which was shown by expression of Eomes, Pl2 and
Tpbpa. Psg22 transcript expression increases upon differentiation to TGCs, as does the
BY564540 antisense transcript. The increase of expression of the BY564540 transcript
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Figure 3.27: Relative quantification of Psg22 compared to BY564540 antisense
transcript expression. (A) Relative quantification in TSC and differentiated TGC. (B)
Relative quantification in trophoblastic tissues. Psg22 expression is remarkably higher
than the antisense transcript in all cell lines tested, with the closest expression found
in TSC. (n=3)
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in differentiated TGCs, and the mirroring of Psg22 expression patterns suggests that
these two transcripts are co-expressed and this BY564540 antisense transcript may be
regulating the expression of Psg22 or vice versa, in a tissue specific manner. These
similar expression patterns are also observed in the trophoblastic tissues tested. The
differences in expression levels are quite stark in these tissues, with a nearly 1000 fold
difference in expression levels between the two transcripts in E10 dissected TGCs.
Expression of BY564540 decreases from E10 to E11 in dissected TGCs, and in the three
embryonic stages of placenta, decreasing as the placenta develops from E13 to E17.
These results demonstrate that the BY564540 antisense transcript is expressed
at low levels in trophoblastic cell lines and tissues, with the highest levels of
expression found in dissected TGCs and E13 placental samples, demonstrating a
concordant expression pattern with its neighbouring gene, Psg22. These concordant
expression patterns are further evidence that these lncRNAs may be responsible for
the upregulation of Psg22 expression through an possible epigenetic mechanism of
transcriptional regulation. This low level of expression could possibly maintain an
open chromatin structure surrounding the Psg22 locus, which in turn may facilitate in
the increased expression of Psg22, as the transcriptional machinery involved in Psg22
expression encounters an open chromatin conformation, and the Psg22 promoter is
easily accessible for the initiation of transcription. The opposite is also possible
whereby, the expression of Psg22 may modulate local chromatin conformatin and
regulate the expression of these lncRNAs. Whether these lncRNA transcripts are
involved in modulation of local chromatin, is addressed in the next section.
3.2.10 Investigation of chromatin structure and accessibility in BY564540
and BLAST 1 antisense transcript regions
Continuing the investigation concerning the chromatin conformation associated with
the Psg22 upstream region, which supported the hypothesis for the role of the
BY564540 antisense transcript in the regulation of Psg22 expression in TGCs, I
investigated the conformational states of chromatin of the original BY564540 EST
and its Blast 1 result regions. The EpiQ chromatin analysis kit was used for
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this investigation. Region specific primers were designed as per protocol and are
described (Table 2.1.) Primers were designed spanning 300 bp within the original
BY564540 EST sequence, also primers were designed in a region 2 kb upstream and
2 kb downstream of the BY564540 EST. Similar primer sets were designed using the
BLAST 1 result and surrounding regions as a template for primer design. Primers
were designed within the corresponding BLAST 1 result sequence, and also 2 kb
upstream and 2 kb downstream of this region. Locations of primers on the Psg22 locus
that were used in this experiment are shown (Fig:3.28.A). These downstream flanking
primer sets were used to distinguish between regions that are actively transcribed,
in contrast to regions lacking active transcription. The previous primer walking
experiment has mapped the regions that are transcribed on both these antisense
transcripts (Fig:3.25.).
As before, TS-R26 and TS-GFP, differentiated TGC (GC-R26 and GC-GFP)
were used as templates. The percentage accessibility of the BY564540 EST region in
TSC and differentiated TGCs is shown (Fig:3.28.B). The chromatin conformation of
this region was found to be in an inactive state in both TSC lines tested, returning
chromatin accessibility of 31% in TS-R26 cells, and 51% in TS-GFP cells. This
result is consistent with the extremely low levels of expression of BY564540 found
in TSC lines, which would therefore have an inactive chromatin conformation as a
result of this low expression. Congruous with the results obtained from the Psg22
promoter investigation in TGCs, the region of chromatin associated with the BY564540
EST antisense transcript was shown to be in an open, active conformation, upon
differentiation to a TGC fate. Chromatin accessibility in this region was found to be
74% in GC-R26 cells, and 81% in GC-GFP cells. The open conformation of chromatin in
this region in TGCs may be due to the expression to the of these antisense transcripts,
or conversely, the expression of these antisense transcripts may facilitate in opening
the local chromatin conformation.
Similar results found in the conformation of chromatin within the BLAST 1
antisense transcript are shown (Fig:3.28.C). As with the BY564540 antisense transcript,
this BLAST 1 region has a closed chromatin conformation in TSC, with a chromatin
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accessibility of 41% in TS-R26 cells, and 52% in TS-GFP cells. As before, we can see
a conformational change of chromatin, once TSC undergo differentiated into TGC.
Chromatin accessibility of 71% in GC-R26 cells and 69% in GC-GFP cells was observed
for this BLAST 1 antisense transcript, mirroring the results obtained with the BY564540
EST antisense transcript. These two antisense transcripts, have demonstrated
concordant expression patterns, and are associated with TGC-specific open chromatin
states. These data support the hypothesis of the divergent/bidirectional BY564540
antisense transcript and its related and BLAST 1 antisense transcript playing a pivotal
role in the upregulation of Psg22 expression or are correlated with it.
To confirm that this active local chromatin conformation is correlated with the
expression of these antisense transcripts, I performed the chromatin accessibility assay
using primer sets located 2 kb upstream and 2 kb downstream of the BY564540 and
BLAST 1 antisense transcripts. The upstream primer sets for both antisense transcripts
are located within these transcripts and are located in regions where transcription
is active. Using the upstream BY564540 primers, two TSC lines demonstrated a
closed chromatin conformation, having chromatin accessibility of 40% in TS-R26 cells,
51% in TS-GFP cells. I found that there is a TGC-specific opening of chromatin
conformation in the region 2 kb upstream of the original BY564540 EST (Fig:3.29.A).
A chromatin accessibility of 72% was found in GC-R26 cells and the GC-GFP cell line
demonstrated a chromatin accessibility of 83%. Similar results were found in the 2
kb upstream region of the BLAST 1 antisense transcript (Fig:3.29.B), as there is the
same chromatin conformational change in this region upon TGC differentiation. In
TSC, there is a chromatin accessibility of 43% (TS-R26) and 50% (TS-GFP) respectively,
whereas the local chromatin opens considerably in TGC, with chromatin accessibility
of 77% in GC-R26 and 74% in GC-GFP cell lines in this upstream BLAST 1 region.
Taking into account that these upstream regions are located within the BY564540 and
BLAST 1 transcripts, it is not surprising that there is a similar chromatin conformation
within these upstream regions. These results demonstrate that regions which are
actively transcribed and contain these antisense transcripts are associated with an
open conformation of the surrounding chromatin, rather than it being a feature of
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Figure 3.28: Quantification of chromatin accessibility in BY564540 and BLAST 1
antisense transcripts in TSC, and differentiated TGC. (A) Locations of primers used
in chromatin accessibility assay on Psg22 locus. (B) Quantification of chromatin
accessibility in BY564540 antisense transcript. (C) Quantification of chromatin
accessibility in BLAST 1 antisense transcript. Biorad EpiQ Chromatin Accessibility
Assay was used to determine percentage accessibility of chromatin using antisense
specific specific promoter primers with 300 bp amplicons. (n=3)
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local chromatin. These results confirm that the chromatin accessibility in these regions
is correlated with the expression of two novel antisense transcripts, in a TGC-specific
dependent manner.
I investigated whether chromatin conformational state in these regions
is dependent on expression of these antisense transcripts and is not just a local
chromatin feature that spans several kb. I investigated, whether there is chromatin
conformational change in TGC, in a region that is not associated with transcription.
I used regions 2 kb downstream of these antisense transcripts and designed region
specific primers as per protocol. The conformation of the chromatin in a region 2
kb downstream of BY564540 antisense transcript that does not have an associated
transcript is shown (Fig:3.29.C). Both TSC lines have an inactive or closed chromatin
conformation, with chromatin accessibility at 37% (TS-R26) and 50% (TS-GFP). Upon
differentiation to TGC, we see a slight increase in the chromatin accessibility, 45%
(GC-R26) and 61% (GC-GFP), but this increase in accessibility, is not enough to deem
the chromatin in an accessible state (below 65%). The same pattern was found in the
region 2 kb downstream of the BLAST 1 antisense transcript, that upon differentiation
to a TGC fate, there is no change to the overall conformation of chromatin in this
region. The chromatin accessibility observed in both TSC lines was 34% (TS-R26) and
53% (TS-GFP), while the accessibility of chromatin of 56% (GC-R26) and 59% (GC-
GFP) was observed in both TGC lines for this downstream region (Fig:3.29.D). This
demonstrates that regions which are not actively transcribed are not associated with
an open chromatin conformation.
This difference between TSC and TGC chromatin conformation in these
regions is correlated to low level expression of the BY564540 and Blast1 lncRNA
antisense transcripts, and is associated an active open chromatin conformation in the
Psg22 promoter region. This association is not present in the Psg23 promoter, which
demonstrates that this is Psg22-specific rather than promoter associated chromatin
opening. This maintenance of an active chromatin state in the promoter region of
Psg22 by low level expression of the BY564540 antisense transcript, further supports
the hypothesis that the BY564540 antisense transcript is a bidirectional lncRNA, with
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Figure 3.29: Quantification of chromatin accessibility in a region 2 kb upstream
and 2 kb downstream of BY564540 and BLAST 1 antisense transcripts in TSC, and
differentiated TGC. Quantification of chromatin accessibility in (A&B) 2 kb upstream
of BY564540 and BLAST 1 antisense transcripts; and (C&D) 2 kb downstream of
BY564540 and BLAST 1 antisense transcripts. Biorad EpiQ Chromatin Accessibility
Assay was used to determine percentage accessibility of chromatin using specific
primers with 300 bp amplicons. (n=3)
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a role in the enhancement of Psg22 expression in a cell-specific manner. The exact
mechanism of how this enhancer RNA (eRNA) functions is yet to be determined, and
future work is needed to elucide the exact mechanisms. I hypothesise a mechanism
that is similar to the the enhancer mechanism proposed by Rinn et al, [221], (Fig:1.9.D),
in which chromosome looping of these antisense transcripts, maintains an active local
chromatin state, enabling the Psg22 transcriptional machinery access to the Psg22
promoter. This epigenetic transcriptional regulation of Psg22 is a novel mechanism
that has to date not been described in the PSG or CEACAM families.
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Discussion and future directions
4.1 A review of human and rodent PSG loci
The multigene PSG family, is a rapidly evolving subset of placenta-specific hormones
that has been shown to be undergoing positive selection [111]. To fully understand
the expansion and evolution of this family, correct gene sequences and their locations
at the Psg locus are needed. Using new mouse genome assemblies available on the
publically accessible genome databases, I compiled an up-to-date accession table of
all known human, rat and murine PSGs. Using the correctly annotated murine Psg
sequences, I was able to discern the genomic length, exon structure, gene orientation,
TSS, CDS and locus coordinates for all murine Psg genes. I determined ORF length
and domain structure of each corresponding Psg protein. From these data, I produced
an updated map of the previously predicted Psg locus [146]. The discovery of a recent
gene inversion event of Psg22 within the Psg locus is interesting as it may explain
the high levels of Psg22 expression relative to the murine Psg multigene family and
provides new information concerning the evolution of the murine Psg genomic locus
structure and organisation. It is unknown when this inversion event occured but it is
common to at least two murine strains. These correct gene loci maps and accession
table have produced a detailed description of the entire rodent PSG family and will
aid in further studies of PSG expression and function.
4. DISCUSSION AND FUTURE DIRECTIONS 4.1 A review of human and rodent PSG loci
Within both mouse and rat PSG families, there is a cluster of members that
are flanked by the Mill1 and Mill2 genes. In the murine Psg family, 11 of 17 Psgs
are located within this cluster. In contrast, only two of eight rat PSGs are located
within this region. This suggests that there was either an expansion of the murine
Psg family within the major Psg cluster relative to the rat PSG family, or that the
rat PSG family experienced a contraction within this cluster. It is hypothesisd that
expansion of the murine Psg gene family suggests that this multigene family is under
selection both for increased gene dosage and diversification of function [146]. To
gain a better insight into the evolution of rodent PSGs, a neighbour-joined pairwise-
comparison phylogenetic tree of murine and rat PSG CDS were constructed. Co-
branching of certain murine and rat PSGs, upstream of the Mill1/2 flanked rodent
PSG cluster, in the multi-species phylogenetic analysis suggests that these regions
are syntenic, and that there are orthologous relationships between members of these
species. The identification of 5 rodent PSG orthologous relationships that are common
to this region in both species is important for the reliable prediction/extrapolation
of gene function. To date there has been no human PSG orthologues found. The
orthologous relationship between PSG36 and Psg24 is also supported as both contain
five N domains [146].
I employed a Psg specific probe and southern hybridisation, to screen a
mouse 129/Sv PAC library and obtained a number of Psg containing PAC clones. The
PAC3 clone (647-D4) contains a region of the Psg locus (Psg26 - Psg22), which was
confirmed by PCR characterisation. End sequencing of the PAC3 clone, has revealed
that the Psg22 inversion event is also common to the 129/Sv mouse strain, and is
not a strain specific evolutionary event. This PAC3 clone was used to clone the 2 kb
regulatory regions of Psg20, Psg22, and Psg23, that were used in LacZ-reporter assays
in this thesis. These Psg containing clones can be used in future research as sources of
isogenic homology arms used to construct individual Psg KO vectors or a locus KO
vector.
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To facilitate the investigation of Psg expression in trophoblast lineages, an in vitro
cell culture model that expresses endogenous Psg was needed. I employed a
6 day FCM withdrawal method to differentiate two TSC lines (TS-EXE and TS-
GFP) into predominantly TGC populations and surveyed Psg22 expression in both
undifferentiated and differentiated states. I found that there was a clear upregulation
of Psg22 expression upon differentiation towards a TGC fate. This Psg22 expression
was comparable to the expression levels found in E15 placenta. It has been previously
shown that RA induces differentiation towards a TGC fate [101], although RA treated
TSCs failed to produce a high level of endogenous Psg22 expression in comparison
to the 6 day FCM withdrawal protocol, but may be used in conjunction with FCM
withdrawal, to enhance TGC-specfic differentiation. This cell culture model of
endogenous Psg22 expression with expression levels comparable to that of placental
tissue can be used to further elucidate the expression, regulation and functions of Psgs
in vitro. This model can be utilised to determine the exact role of Psgs in trophoblast
development and in TGC differentiation.
To support previous data concerning murine Psgs expression in the placenta,
I have shown that two previously uncharacterised Psgs, (Psg31 and Psg32), were
expressed in E15 placental tissues. Using overlapping primers, and sequence analysis
of cloned RT-PCR amplicons, I was able to map both Psg31 and Psg32 transcripts.
These cloned sequences were aligned against the Psg locus and I determined the
correct exon and domain structure of both these genes. I found that Psg31 has
10 exons and is composed of an N1-N1*-N2-N3-N4-N5-N6-N7-A domain structure,
which supports previously predictions that Psg31 has evolved from a duplication
of the entire Psg30 gene and a subsequent duplication of the N1 domain [148].
Sequencing analysis revealed that Psg32 contains 5 exons, and has a N1-N2-N3-A
domain structure. I have shown that Psg32, (previously Cea6 or Psg-ps1) [106], is not a
pseudogene, and is expressed in murine placenta. The expression of Psg31 and Psg32
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adds these genes to the list of placentally expressed Psgs.
Previous studies of Psg gene expression in mouse pregnancy indicated that
different family members exhibit different expression levels between E11 and E18,
suggesting the possibility of divergent functions [146]. Using comprehensive semi-
quantitative expression studies I have generated an expression profile of murine
Psgs in a variety of trophoblast lineages and cell lines. RT-PCR expression surveys
revealed that there are a number of Psgs expressed in two TSC lines, but that upon
differentiation to TGC, Psg22 is the most abundant transcript. I found similar Psgs
expressed in E5 blastocysts, with Psg22 being the most abundant transcript in E11
blastocyst outgrowths, which have high levels of TGCs. This supports data that has
shown that Psg22 is expressed from E5.5 in the developing embryo to the remainder of
the gestational period in the murine placenta, with highest levels of expression been
found in TGC [49, 165].
These results point to a differentiation-led shift in Psg expression between
undifferentiated TSC and differentiated TGCs in two cell lines and primary blastocyst
cultures. Quantitative expression analysis by qRT-PCR confirmed this high expression
of Psg22 in TGCs relative to expression found in TSCs. The expression of Psg19,
Psg21, Psg22 and Psg23 was quantified in TSC, TGC, dissected TGC, dissected EPC,
and placental samples. Psg19 and Psg22 are closely related, and have shown similar
expression patterns in these tissues. Psg21 and Psg23 are also closely related and also
share similar expression patterns. It was found that Psg22 has the highest expression
levels in TGC and dissected trophoblastic tissues, when compared to Psg19, Psg21,
and Psg23. These data support previous studies which have shown that Psg21 and
Psg23 gene transcripts together constitute the bulk of Psg gene expression in the SpT,
and that Psg22 constitutes the majority of Psg expression in the first half of pregnancy
[191].
Furthermore, these data demonstrate that Psgs have the same expression
patterns in vitro as in vivo and Psg genes display developmentally regulated tissue-
specific and cell-specific expression patterns. The importance of describing individual
Psg family member expression is also confirmed in the predominant Psg22 expression
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in these TGC populations, leading us to believe that Psg22 may have a specific
individual alternative function in early placental development that differs from the
remaining Psg genes in TGC and time-points in development. These differences in
the level and developmental timing of expression of different mouse Psgs implicate
a divergence of PSG function, although this cannot be confirmed as only four of 17
murine Psg were investigated [148, 191]. In summary, expression levels of Psg genes
in placental tissues of different developmental stages revealed dramatic differences in
the developmental expression profile of individual Psg family members. Overall the
expression data in this study matches well with previous analyses of the distribution
of Psg transcripts in placental tissues and exhibit further the important role of Psg22
in early placental development. This expression data will aid in functional studies of
this complex gene family.
Non-placental cell expression of certain Psgs was found previously in FAE in
the GIT, and in the brain [192, 193]. Non-placental PSG expression was confirmed in
human and mouse GIT tissues by RT-PCR and qRT-PCR, implying a wider role of PSG
functionality, than one restricted to the placenta. Various Psg transcripts were found
to be expressed in the GIT of the mouse from the oral cavity to rectum. These results
were supported by qRT-PCR which confirmed murine Psg expression in esophagus
and ascending colon, although this GIT expression was not as high as placental Psg
expression. This lower level of expression could be due to the fact that to induce a Th2
response in the placenta, a higher dosage of Psg is needed than in the GIT, and may
be similar in humans although to date there is no evidence for this. Using RT-PCR
cloning screens, human PSG expression was also detected in esophageal tissue. The
expression of PSGs in the human and murine GIT furthers supports the hypothesis
of PSGs involvement in oral tolerance, and mucosal immune modulation [192]. The
expression of human PSG in GIT tissues, and comparative mouse Psg GIT expression,
suggests that these PSGs have a conservation of function in both mice and human
GIT. The esophagous is a novel site of PSG expression, showing that PSG expression
is not placenta-specific in mice or humans. The function of PSG in the GIT needs to
be elucidated, and will give a new direction to PSG functional research, concerning
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regulation of immune and inflammatory mediators in the GIT which would promote
a tolerogenic response to commensal bacteria.
The highly expressed Psg22 was found to have an alternative splice variant,
by RT-PCR. These transcripts share concordant expression patterns and are expressed
in TGCs. This truncated alternative splice variant has the N1 domain spliced out.
Using qRT-PCR, the relative expression of these splice variants was quantified. It
was found that the alternative splice variant is expressed at much lower levels than
the primary transcript in trophoblast tissues and cell lines. This expression profile
suggests that this truncated Psg22 variant may have a functional relevance to TGCs
due to the upregulation of its expression in these cell lines. With the discovery of this
high rate of Psg22 transcription, the levels of translation of the Psg22 protein needed to
be established. Since there is a lack of mAbs that specifically detect endogenous Psg22
protein, the ribosome loading of Psg22 transcripts was investigated, as ribosomal
loading of transcripts is a good indicator of protein translation. Utilising sucrose
gradients and polysome fractionation techniques [253], it was clearly shown that
Psg22 transcripts were indeed heavily loaded with ribosomes, as the majority of Psg22
transcripts were found in the fractions containing the Polysome bound mRNAs. This
is indicative that these transcripts are translated. It is necessary to generate a specific
anti-Psg22 antibody to determine the levels of endogenous Psg22 protein in vivo.
4.3 Psg22 induces TGFβ1 in monocytes and macrophages
Protein was generated from the two Psg22 splice variants to investigate whether
deletion of the N1 domain affects Psg22 function, as Psg22N1A has been shown
to induce TGFβ1from peritoneal macrophages [165]. It was found that both of
these proteins induce the release of TGFβ1 from monocytes and macrophages, and
encode for proteins with similar function. Generation of recombinant individual
domain mutant proteins would be required to discern which region of the Psg22
protein is responsible for this TGFβ1 upregulation. Previous reports have shown
that Psg23N1A, and Psg19 up-regulate TGFβ1 in these cells [170, 265]. It is not
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surprising that Psg22 induces TGFβ1, as Psg22 and Psg19 are very similar proteins
(Fig:3.2.A). I have shown that Psg22 treatments have upregulated TGFβ1 at the protein
level, although I have not investigated whether there is an upregulation of TGFβ1 at
the transcriptional level. These data suggests a role for Psg22 in angiogenesis and
immunomodulation as TGFβ1 is an pro-angiogenic, anti-inflammatory cytokine and
follows the hypothesis that Psgs function as immunoregulators during pregnancy [12].
The treatment of monocytes/macrophages with recombinant murine Psg22 leads to
upregulation of the anti-inflammatory cytokine TGFβ1, which has been implicated
in the enhancement of Th2-type immune responses [12]. It is hypothesised that
Psg22 expression in early pregnancy may be important for the development of the
trophoblast not only by stimulating maternal immune cells to produce angiogenic
growth factors but also by direct effects on endothelial cells to promote vascular
expansion and development [165].
To asses this function of Psg22, a knock-down of Psg22 expression in vitro
was attempted, using two Psg22 shRNA constructs. These shRNAs were tested
in two TGC lines and have shown to generate knockdown of Psg22 expression in
vitro. Following on from this, packaging these Psg22 shRNA vectors into a lentiviral
delivery system, and transfect post-fertilisation embryos or ES cells with these vectors,
and implant these transfected embryos/cells into pseudo-pregnant female recipient
mice to produce chimeric or transgenic neonates which posses a Psg22 knockdown
in vivo [249]. This will enable us to utilise these Psg22 shRNA constructs in future
research to produce a knockdown Psg22 phenotype in vivo and investigate the
implications of reduced levels of Psg22 protein on pregnancy outcomes. Due to time
and financial constraints it was not possible to test these shRNA vectors in vivo. The
fact that there are 17 murine Psgs, which are very similar to each other, and the high
probability that murine Psg share a common function, may make a single knockdown
of an individual Psg undetectable in regards to a loss of function phenotype. A
complimentary targeted deletion of the major Psg cluster flanked by Mill1 and Mill2,
may be needed to obtain a knockdown phenotype that is severe enough and not
counteracted by the functions of the remaining untargeted Psg members. Due to time
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constraints I was unable to pursue this experiment.
4.4 Psg22 regulatory regions exhibit low levels of promoter
activity in vitro
To elucidate the mechanisms responsible for the regulation of Psg22, a 2 kb region
containing the predicted regulatory region was analysed to detect transcription factor
binding sites that could explain this high level of expression of just one of 17 mouse
Psgs in the first half of pregnancy. Using transcription factor binding site analysis
software, the frequencies of putative transcription factor binding sites of 15 TGC
associated transcription factors on the 17 murine Psg 2 kb upstream regions were
analysed. It has been previously reported that the minimal promoter region of all
human PSG genes contains a putative Retinoic Acid Responsive Element (RARE)
which has been shown to facilitate RXRα transcriptional activation of PSG5 promoter
[200]. There is conservation of this SP1-RXRα (RARE) site in murine Psgs: Psg17,
Psg19, Psg20 and Psg26. The fact that Psg22 does not possess this canonical regulatory
region due to a SNP within this region, implies that this mutation in the Psg22
promoter region has possibly selected against this RXRα site, which implicates the
involvement of a different regulatory mechanism that works independently of the
SP1/RXR signalling mechanism that is present in all human PSG and four of the
murine Psgs.
From the transcription factor binding analysis (Table 3.1.), it was found
that there are 4 other RXR sites present along this 2 kb region Psg22 promoter
region, and it was also shown that RA treatment does induce Psg22 expression in
TSC, demonstrating that RXR signalling regulates Psg22 expression (Fig:3.7.). There
are putative transcription factor binding sites for RxRα in every murine Psg 2 kb
regulatory region, indicating that this regulatory mechanism is conserved in the
mouse as in the human.
Transcription factor binding site analysis did not reveal specific transcription
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factor binding sites that would distinguish the Psg22 promoter from the 16 other
Psgs promoters. LacZ-promoter-reporter assays also demonstrated that the Psg22
promoter possessed promoter activity levels similar to Psg20, Psg21 and Psg23 in
JAR cells. These results suggest that there is a low level of promoter activity
associated with Psg promoter regions in vitro. Although this low level of promoter
activity does not properly address the differences in the individual levels of Psg
expression. It was hypothesised that a differential regulatory method of inducing
Psg22 expression that enhances basal Psg22 induction by promoter regions may exist.
This alternative mechanism could effect individual Psg expression levels as there only
a slight difference in LacZ expression induced between the Psg regulatory regions
tested, although there is a difference in expression levels between these Psg, both
spatially and temporally. Analysis of the conformation of chromatin surrounding
the Psg22 and Psg23 promoters led to the discovery that the Psg22 promoter possess
heterochromatin in TGC but not TSC, whereas the Psg23 promoter had its chromatin
in a closed state in both TSC and TGC. This led to the hypothesis that there was an
alternative unknown mechanism that is responsible for the upregulation of Psg22.
Human PSG regulation is not only controlled at the transcriptional level
via DNA binding factors, it has been shown that cis and trans acting negative
elements repress PSG5 transcription, irrespective of the cell type [205]. The same
kind of mechanisms could control mouse Psg regulation. These findings are
consistent with the hypothesis that the differences between TATA-containing and
TATA-less promoters might allow them to respond to a different subset of activators
and or repressors [269]. It is necessary to investigate the role of cis/trans acting
regulatory sequences, epigenetic modulation in the upregulation of PSG genes during
trophoblast development [181] to provide a better understanding of the regulation of
these genes.
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Upon further investigation of the Psg22 locus, an EST sequence was found upstream
of the Psg22 TSS which is transcribed in an antisense direction. Using bioinformatical,
RT-PCR and sequencing approaches, it was found that this BY564540 EST is expressed
in a cell specfic manner with expression detected in TGC but not TSC. Three other
regions that are similar to the EST sequence were found on the Psg locus. Blast
results revealed the sequence with the closest similarity to BY564540 was found to
be downstream of the 3’ end of Psg22. The length of these two antisense transcripts
was discovered to be approximately 6 kb, with transcription of the BY564540 antisense
transcript starting within a few hundred base pairs of the Psg22 TSS. Neither of these
antisense transcript possess an ORF in any three frames analysed, indicating that these
antisense transcripts are lncRNAs. The presence of this second antisense transcript,
BLAST 1 lncRNA antisense transcript, downstream of Psg22, may have occurred as a
result of a duplication event of the BY564540 lncRNA, when the Psg22 gene locus was
subjected to the inversion event.
Relative quantitative expression analysis revealed that this BY564540 lncRNA
antistranscript is expressed in low levels compared to the Psg22 transcript in a variety
of TGC lineage tissues. This qRT-PCR analysis also revealed that the BY564540
transcript is expressed in a concordant expression pattern to Psg22. The expression
of BY564540 lncRNA antisense transcript is ten fold higher in TGC than in TSC, and
it is hypothesised that this TGC-specific antisense transcription is correlated with the
chromatin conformational change in this region and to the region surrounding the
Psg22 2 kb regulatory regions. These results show that upon differentiation of TSC
to TGC, this region of chromatin undergoes a conformational change from a closed
inactive state into a open accessible state that would facilitate the upregulation in
expression of neighbouring genes due to the ease of accessibility of transcriptional
machinery within this region. Further chromatin analysis of these regions revealed
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that in regions where the BY564540 and BLAST1 lncRNA antisense trancripts are
transcribed, they are associated with an open or active chromatin conformation,
and downstream regions, which were non-transcriptionally active, are in the closed
conformation. This demonstrates that expression of BY564540 and BLAST1 lncRNA
antisense transcripts is dependent on TGC differentiation and is associated with open
local chromatin conformation. I hypothesise that the high levels of Psg22 found in
TGC, are correlated with the transcription of these BY564540 and BLAST1 lncRNA
antisense trancripts and the open conformation of local chromatin in the Psg22 locus.
Due to the fact that these transcripts are non-coding, show concordant
expression patterns with neighbouring genes, and are transcribed in a bidirectional
antisense manner, it is concluded that these lncRNA antisense transcripts are
enhancer RNAs (eRNAs). The open chromatin conformation that is associated
with the expression of these antisense transcripts may facilitate the easy access
of regulatory machinery to the Psg22 promoter, and suggests a novel epigenetic
regulatory mechanism that to date has not been described in relation to murine Psg
transcriptional regulation. The exact mechanism in which these eRNAs function is yet
to be determined, and future research is needed to elucidate this.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
155 John Michael Williams
Chapter 5
Bibliography
Bibliography
[1] Springer MS, Murphy WJ, Eizirik E, O’Brien SJ. Placental mammal
diversification and the Cretaceous-Tertiary boundary. Proceedings of the
National Academy of Sciences of the United States of America. 2003
Feb;100(3):1056–61. Available from: http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=298725&tool=pmcentrez&rendertype=abstract.
[2] Rawn SM, Cross JC. The evolution, regulation, and function of
placenta-specific genes. Annual review of cell and developmental biology. 2008
Jan;24(June):159–81. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18616428 http://www.
annualreviews.org/doi/abs/10.1146/annurev.cellbio.24.110707.175418.
[3] Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental
anatomy of the murine and human definitive placentae. Placenta. 2002
Jan;23(1):3–19. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11869088.
[4] Aubuchon M, Schulz LC, Schust DJ. Preeclampsia: animal models for a human
cure. Proceedings of the National Academy of Sciences of the United States of
America. 2011 Jan;108(4):1197–8. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3029729&tool=pmcentrez&rendertype=abstract.
[5] Hemberger M, Cross JC. Genes governing placental development. Trends in
endocrinology and metabolism. 2001;12(4):162–8. Available from:
BIBLIOGRAPHY
http://www.ncbi.nlm.nih.gov/pubmed/11295572.
[6] Carter aM. Animal models of human placentation–a review. Placenta. 2007
Apr;28 Suppl A:S41–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17196252.
[7] Watson ED, Cross JC. Development of structures and transport functions in the
mouse placenta. Physiology (Bethesda, Md). 2005 Jul;20:180–93. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/15888575.
[8] El-Hashash AHK, Warburton D, Kimber SJ. Genes and signals regulating
murine trophoblast cell development. Mechanisms of development.
2009;127(1-2):1–20. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2865247&tool=pmcentrez&rendertype=abstract.
[9] Rossant J, Cross JC. Placental development: lessons from mouse mutants.
Nature reviews. 2001 Jul;2(7):538–48. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11433360.
[10] Soares MJ. The prolactin and growth hormone families: pregnancy-specific
hormones/cytokines at the maternal-fetal interface. Reproductive biology and
endocrinology. 2004 Jul;2:51. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
471570&tool=pmcentrez&rendertype=abstract.
[11] Trowsdale J, Betz AG. Mother’s little helpers: mechanisms of maternal-fetal
tolerance. Nature immunology. 2006 Mar;7(3):241–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16482172.
[12] Motrán CC, Diaz FL, Montes CL, Bocco JL, Gruppi A. In vivo expression of
recombinant pregnancy-specific glycoprotein 1a induces alternative activation
of monocytes and enhances Th2-type immune response. European journal of
immunology. 2003 Nov;33(11):3007–16. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/14579269.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
158 John Michael Williams
BIBLIOGRAPHY
[13] Ha CT, Wu J, Irmak S, Lisboa FA, Dizon AM, Warren J, et al. Human pregnancy
specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular
morphogenesis. Biology of reproduction. 2010 Jul;83(1):27–35. Available from:
http://www.biolreprod.org/content/83/1/27.short http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2888962&tool=
pmcentrez&rendertype=abstract.
[14] Chaouat G, Ledée-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J.
TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in
pregnancy/early abortion: reexamining the TH1/TH2 paradigm. International
archives of allergy and immunology. 2004 Jun;134(2):93–119. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15153791.
[15] Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I
antigen, HLA-G, expressed in human trophoblasts. Science (New York, NY).
1990 Apr;248(4952):220–3. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/2326636.
[16] Simmons DG, Cross JC. Determinants of trophoblast lineage and cell subtype
specification in the mouse placenta. Developmental biology. 2005
Aug;284(1):12–24. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15963972.
[17] Red-Horse K, Zhou Y. Trophoblast differentiation during embryo implantation
and formation of the maternal-fetal interface. Journal of Clinical Investigation.
2004;114(6). Available from:
http://www.jci.org/cgi/content/abstract/114/6/744.
[18] Aplin JD, Kimber SJ. Trophoblast-uterine interactions at implantation.
Reproductive biology and endocrinology. 2004 Jul;2:48. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
471567&tool=pmcentrez&rendertype=abstract.
[19] Aplin JD. Embryo implantation: the molecular mechanism remains elusive.
Reproductive biomedicine online. 2007 Jan;14 Spec No:49–55. Available from:
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
159 John Michael Williams
BIBLIOGRAPHY
http://www.ncbi.nlm.nih.gov/pubmed/20483399.
[20] Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the
development puzzle. Science (New York, NY). 1994 Dec;266(5190):1508–18.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/7985020.
[21] Tanaka S. Promotion of Trophoblast Stem Cell Proliferation by FGF4. Science.
1998 Dec;282(5396):2072–2075. Available from:
http://www.sciencemag.org/cgi/doi/10.1126/science.282.5396.2072.
[22] Roberts RM, Fisher SJ. Trophoblast stem cells. Biology of reproduction. 2011
Mar;84(3):412–21. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3043125&tool=pmcentrez&rendertype=abstract.
[23] Gardner RL. Origin and differentiation of extraembryonic tissues in the mouse.
International review of experimental pathology. 1983 Jan;24:63–133. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/6302028.
[24] Rossant J, Vijh KM. Ability of outside cells from preimplantation mouse
embryos to form inner cell mass derivatives. Developmental biology. 1980
May;76(2):475–82. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/6893035.
[25] Handyside AH. Time of commitment of inside cells isolated from
preimplantation mouse embryos. Journal of embryology and experimental
morphology. 1978 Jun;45:37–53. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/353216.
[26] Kunath T, Strumpf D, Rossant J. Early trophoblast determination and stem cell
maintenance in the mouse–a review. Placenta. 2004 Apr;25 Suppl A:S32–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15033304.
[27] Gardner RL, Papaioannou VE, Barton SC. Origin of the ectoplacental cone and
secondary giant cells in mouse blastocysts reconstituted from isolated
trophoblast and inner cell mass. Journal of embryology and experimental
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
160 John Michael Williams
BIBLIOGRAPHY
morphology. 1973 Dec;30(3):561–72. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/4772385.
[28] Roberts RM, Ezashi T, Das P. Trophoblast gene expression: transcription factors
in the specification of early trophoblast. Reproductive biology and
endocrinology : RB&E. 2004 Jul;2:47. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
471566&tool=pmcentrez&rendertype=abstract.
[29] Hu D, Cross JC. Development and function of trophoblast giant cells in the
rodent placenta. The International journal of developmental biology. 2010
Jan;54(2-3):341–54. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19876834.
[30] James JL, Carter aM, Chamley LW. Human placentation from nidation to 5
weeks of gestation. Part I: What do we know about formative placental
development following implantation? Placenta. 2012 May;33(5):327–34.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22374510.
[31] Cross JC, Simmons DG, Watson ED. Chorioallantoic morphogenesis and
formation of the placental villous tree. Annals of the New York Academy of
Sciences. 2003 May;995:84–93. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12814941.
[32] Sapin V, Dollé P, Hindelang C, Kastner P, Chambon P. Defects of the
chorioallantoic placenta in mouse RXRalpha null fetuses. Developmental
biology. 1997 Nov;191(1):29–41. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9356169.
[33] Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, et al.
Interactions between Trophoblast Cells and the Maternal and Fetal Circulation
in the Mouse Placenta. Developmental Biology. 2002 Oct;250(2):358–373.
Available from:
http://linkinghub.elsevier.com/retrieve/pii/S0012160602907736.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
161 John Michael Williams
BIBLIOGRAPHY
[34] Orwig K, Wolfe MW, Cohick C, Dai G. Trophoblast-specific regulation of
endocrine-related genes. Placenta. 1998;p. 65–85. Available from:
http://www.sciencedirect.com/science/article/pii/S0143400498800076.
[35] Simmons DG, Fortier AL, Cross JC. Diverse subtypes and developmental
origins of trophoblast giant cells in the mouse placenta. Developmental
biology. 2007 Apr;304(2):567–78. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17289015.
[36] Zybina EV, Zybina TG. Polytene chromosomes in mammalian cells.
International review of cytology. 1996 Jan;165:53–119. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8900957.
[37] Gardner RL, Davies TJ. Lack of coupling between onset of giant transformation
and genome endoreduplication in the mural trophectoderm of the mouse
blastocyst. The journal of experimental zoology. 1993 Jan;265(1):54–60.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8459230.
[38] Soloveva V, Linzer DIH. Differentiation of placental trophoblast giant cells
requires downregulation of p53 and Rb. Placenta. 2004 Jan;25(1):29–36.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15013636.
[39] Bevilacqua EM, Abrahamsohn PA. Ultrastructure of trophoblast giant cell
transformation during the invasive stage of implantation of the mouse embryo.
Journal of morphology. 1988 Dec;198(3):341–51. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/3221406.
[40] Carney EW, Prideaux V, Lye SJ, Rossant J. Progressive expression of
trophoblast-specific genes during formation of mouse trophoblast giant cells in
vitro. Molecular reproduction and development. 1993 Apr;34(4):357–68.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8471259.
[41] Zybina EV, Zybina TG, Stein GI. Trophoblast cell invasiveness and capability
for the cell and genome reproduction in rat placenta. Early pregnancy (Online).
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
162 John Michael Williams
BIBLIOGRAPHY
2000 Jan;4(1):39–57. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11719821.
[42] Enders AC, Welsh AO. Structural interactions of trophoblast and uterus during
hemochorial placenta formation. The journal of experimental zoology. 1993
Sep;266(6):578–87. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8371099.
[43] Pijnenborg R, Robertson WB, Brosens I, Dixon G. Review article: trophoblast
invasion and the establishment of haemochorial placentation in man and
laboratory animals. Placenta. 1981;2(1):71–91. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7010344.
[44] Hemberger M, Hughes M, Cross JC. Trophoblast stem cells differentiate in
vitro into invasive trophoblast giant cells. Developmental biology. 2004
Jul;271(2):362–71. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15223340.
[45] Zechner U, Hemberger M, Constância M, Orth A, Dragatsis I, Lüttges A, et al.
Proliferation and growth factor expression in abnormally enlarged placentas of
mouse interspecific hybrids. Developmental dynamics : an official publication
of the American Association of Anatomists. 2002 Jun;224(2):125–34. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/12112466.
[46] Talamantes F. Structure and regulation of secretion of mouse placental
lactogens. Progress in clinical and biological research. 1990 Jan;342:81–5.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2200057.
[47] Cross JC, Anson-Cartwright L, Scott IC. Transcription factors underlying the
development and endocrine functions of the placenta. Recent progress in
hormone research. 2002 Jan;57:221–34. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12017545.
[48] Iwatsuki K, Shinozaki M, Sun W, Yagi S, Tanaka S, Shiota K. A novel secretory
protein produced by rat spongiotrophoblast. Biology of reproduction. 2000
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
163 John Michael Williams
BIBLIOGRAPHY
May;62(5):1352–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10775187.
[49] Wynne F, Ball M, McLellan AS. Mouse pregnancy-specific glycoproteins:
tissue-specific expression and evidence of association with maternal
vasculature. Reproduction. 2006;Available from:
http://www.reproduction-online.org/content/131/4/721.short.
[50] Guzman-Ayala M, Ben-Haim N, Beck S, Constam DB. Nodal protein
processing and fibroblast growth factor 4 synergize to maintain a trophoblast
stem cell microenvironment. Proceedings of the National Academy of Sciences
of the United States of America. 2004 Nov;101(44):15656–60. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
524845&tool=pmcentrez&rendertype=abstract.
[51] Hemberger M, Dean W, Reik W. Epigenetic dynamics of stem cells and cell
lineage commitment: digging Waddington’s canal. Nature reviews Molecular
cell biology. 2009 Aug;10(8):526–37. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19603040.
[52] Ralston A, Rossant J. How signaling promotes stem cell survival: trophoblast
stem cells and Shp2. Developmental cell. 2006 Mar;10(3):275–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16516829.
[53] Uy GD, Downs KM, Gardner RL. Inhibition of trophoblast stem cell potential
in chorionic ectoderm coincides with occlusion of the ectoplacental cavity in
the mouse. Development (Cambridge, England). 2002 Aug;129(16):3913–24.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12135928.
[54] Hunt CV, Avery GB. The development and proliferation of the trophoblast
from ectopic mouse embryo allografts of increasing gestational age. Journal of
reproduction and fertility. 1976 Mar;46(2):305–11. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1255559.
[55] Senner CE, Hemberger M. Regulation of early trophoblast differentiation -
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
164 John Michael Williams
BIBLIOGRAPHY
lessons from the mouse. Placenta. 2010 Nov;31(11):944–50. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20797785.
[56] Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M.
Requirement of FGF-4 for postimplantation mouse development. Science (New
York, NY). 1995 Jan;267(5195):246–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7809630.
[57] Niswander L, Martin GR. Fgf-4 expression during gastrulation, myogenesis,
limb and tooth development in the mouse. Development (Cambridge,
England). 1992 Mar;114(3):755–68. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1618140.
[58] Rappolee DA, Basilico C, Patel Y, Werb Z. Expression and function of FGF-4 in
peri-implantation development in mouse embryos. Development (Cambridge,
England). 1994 Aug;120(8):2259–69. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7925026.
[59] Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. Targeted disruption of
fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in
pregastrulation mammalian development. Proceedings of the National
Academy of Sciences of the United States of America. 1998 Apr;95(9):5082–7.
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=20217&tool=pmcentrez&rendertype=abstract.
[60] Ma GT, Soloveva V, Tzeng SJ, Lowe La, Pfendler KC, Iannaccone PM, et al.
Nodal regulates trophoblast differentiation and placental development.
Developmental biology. 2001 Aug;236(1):124–35. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11456449.
[61] Erlebacher A, Price Ka, Glimcher LH. Maintenance of mouse trophoblast stem
cell proliferation by TGF-beta/activin. Developmental biology. 2004
Nov;275(1):158–69. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15464579.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
165 John Michael Williams
BIBLIOGRAPHY
[62] Guillemot F, Nagy A, Auerbach A, Rossant J, Joyner AL. Essential role of
Mash-2 in extraembryonic development. Nature. 1994 Sep;371(6495):333–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8090202.
[63] Scott IC, Anson-Cartwright L, Riley P, Reda D, Cross JC. The HAND1 basic
helix-loop-helix transcription factor regulates trophoblast differentiation via
multiple mechanisms. Molecular and cellular biology. 2000 Jan;20(2):530–41.
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=85124&tool=pmcentrez&rendertype=abstract.
[64] Hattori N, Nishino K, Ko YG, Hattori N, Ohgane J, Tanaka S, et al. Epigenetic
control of mouse Oct-4 gene expression in embryonic stem cells and
trophoblast stem cells. The journal of biological chemistry. 2004
Apr;279(17):17063–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/14761969.
[65] Liu L, Roberts RM. Silencing of the gene for the beta subunit of human
chorionic gonadotropin by the embryonic transcription factor Oct-3/4. The
Journal of biological chemistry. 1996 Jul;271(28):16683–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8663260.
[66] Liu L, Leaman D, Villalta M, Roberts RM. Silencing of the gene for the
alpha-subunit of human chorionic gonadotropin by the embryonic
transcription factor Oct-3/4. Molecular endocrinology (Baltimore, Md). 1997
Oct;11(11):1651–8. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9328347.
[67] Ezashi T, Ghosh D, Roberts RM. Repression of Ets-2-induced transactivation of
the tau interferon promoter by Oct-4. Molecular and cellular biology. 2001
Dec;21(23):7883–91. Available from: http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=99954&tool=pmcentrez&rendertype=abstract.
[68] Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R.
Multipotent cell lineages in early mouse development depend on SOX2
function. Genes & development. 2003 Jan;17(1):126–40. Available from:
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
166 John Michael Williams
BIBLIOGRAPHY
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
195970&tool=pmcentrez&rendertype=abstract.
[69] Okuda A, Fukushima A, Nishimoto M, Orimo A, Yamagishi T, Nabeshima Y,
et al. UTF1, a novel transcriptional coactivator expressed in pluripotent
embryonic stem cells and extra-embryonic cells. The EMBO journal. 1998
Apr;17(7):2019–32. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1170547&tool=pmcentrez&rendertype=abstract.
[70] Kopp JL, Ormsbee BD, Desler M, Rizzino A. Small increases in the level of
Sox2 trigger the differentiation of mouse embryonic stem cells. Stem cells
(Dayton, Ohio). 2008 Apr;26(4):903–11. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18238855.
[71] Donnison M, Beaton A, Davey HW, Broadhurst R, L’Huillier P, Pfeffer PL. Loss
of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic
patterning. Development (Cambridge, England). 2005 May;132(10):2299–308.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15829518.
[72] Ng RKR, Dean W, Dawson C, Lucifero D, Madeja Z, Reik W, et al. Epigenetic
restriction of embryonic cell lineage fate by methylation of Elf5. Nature cell
biology. 2008 Nov;10(11):1280–90. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2635539&tool=pmcentrez&rendertype=abstract http:
//www.nature.com/ncb/journal/vaop/ncurrent/full/ncb1786.html http:
//www.ncbi.nlm.nih.gov/pubmed/18836439.
[73] Murre C, Voronova A, Baltimore D. B-cell- and myocyte-specific
E2-box-binding factors contain E12/E47-like subunits. Molecular and cellular
biology. 1991 Feb;11(2):1156–60. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
359799&tool=pmcentrez&rendertype=abstract.
[74] Riley P, Anson-Cartwright L, Cross JC. The Hand1 bHLH transcription factor
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
167 John Michael Williams
BIBLIOGRAPHY
is essential for placentation and cardiac morphogenesis. Nature genetics. 1998
Mar;18(3):271–5. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9500551.
[75] Hughes M, Dobric N, Scott IC, Su L, Starovic M, St-Pierre B, et al. The Hand1,
Stra13 and Gcm1 transcription factors override FGF signaling to promote
terminal differentiation of trophoblast stem cells. Developmental biology. 2004
Jul;271(1):26–37. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15196947.
[76] Boudjelal M, Taneja R, Matsubara S, Bouillet P, Dolle P, Chambon P.
Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic
helix-loop-helix family, inhibits mesodermal and promotes neuronal
differentiation of P19 cells. Genes & Development. 1997 Aug;11(16):2052–2065.
Available from:
http://www.genesdev.org/cgi/doi/10.1101/gad.11.16.2052.
[77] Kraut N, Snider L, Chen CM, Tapscott SJ, Groudine M. Requirement of the
mouse I-mfa gene for placental development and skeletal patterning. The
EMBO journal. 1998 Nov;17(21):6276–88. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1170953&tool=pmcentrez&rendertype=abstract.
[78] Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, Williams T.
Transcription factor AP-2gamma is essential in the extra-embryonic lineages
for early postimplantation development. Development (Cambridge, England).
2002 Jun;129(11):2733–47. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12015300.
[79] Yagi R, Kohn MJ, Karavanova I, Kaneko KJ, Vullhorst D, DePamphilis ML,
et al. Transcription factor TEAD4 specifies the trophectoderm lineage at the
beginning of mammalian development. Development (Cambridge, England).
2007 Nov;134(21):3827–36. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17913785.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
168 John Michael Williams
BIBLIOGRAPHY
[80] Strumpf D, Mao CA, Yamanaka Y, Ralston A, Chawengsaksophak K, Beck F,
et al. Cdx2 is required for correct cell fate specification and differentiation of
trophectoderm in the mouse blastocyst. Development (Cambridge, England).
2005 May;132(9):2093–102. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15788452.
[81] Ma GT, Roth ME, Groskopf JC, Tsai FY, Orkin SH, Grosveld F, et al. GATA-2
and GATA-3 regulate trophoblast-specific gene expression in vivo.
Development (Cambridge, England). 1997 Feb;124(4):907–14. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9043071.
[82] Ray S, Dutta D, Rumi MaK, Kent LN, Soares MJ, Paul S. Context-dependent
function of regulatory elements and a switch in chromatin occupancy between
GATA3 and GATA2 regulate Gata2 transcription during trophoblast
differentiation. The Journal of biological chemistry. 2009 Feb;284(8):4978–88.
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=2643515&tool=pmcentrez&rendertype=abstract.
[83] Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, et al.
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.
Proceedings of the National Academy of Sciences of the United States of
America. 1997 Apr;94(8):3801–4. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
20521&tool=pmcentrez&rendertype=abstract.
[84] Knöfler M. Critical growth factors and signalling pathways controlling human
trophoblast invasion. The International journal of developmental biology.
2010;54:269–280. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2974212/.
[85] White LJ, Declercq W, Arfuso F, Charles AK, Dharmarajan AM. Function of
caspase-14 in trophoblast differentiation. Reproductive biology and
endocrinology : RB&E. 2009 Jan;7:98. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
169 John Michael Williams
BIBLIOGRAPHY
2753366&tool=pmcentrez&rendertype=abstract.
[86] Blanchon L, Bocco JL, Gallot D, Gachon aM, Lémery D, Déchelotte P, et al.
Co-localization of KLF6 and KLF4 with pregnancy-specific glycoproteins
during human placenta development. Mechanisms of development. 2001
Jul;105(1-2):185–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11429296.
[87] Tompers DM, Foreman RK, Wang Q, Kumanova M, Labosky Pa. Foxd3 is
required in the trophoblast progenitor cell lineage of the mouse embryo.
Developmental biology. 2005 Sep;285(1):126–37. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16039639.
[88] Liu Y, Labosky Pa. Regulation of embryonic stem cell self-renewal and
pluripotency by Foxd3. Stem cells (Dayton, Ohio). 2008 Oct;26(10):2475–84.
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=2658636&tool=pmcentrez&rendertype=abstract.
[89] Douglas GC, VandeVoort Ca, Kumar P, Chang TC, Golos TG. Trophoblast stem
cells: models for investigating trophectoderm differentiation and placental
development. Endocrine reviews. 2009 May;30(3):228–40. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2726840&tool=pmcentrez&rendertype=abstract.
[90] Westerman BA, Chhatta A, Poutsma A, van Vegchel T, Oudejans CBM.
NEUROD1 acts in vitro as an upstream regulator of NEUROD2 in trophoblast
cells. Biochimica et biophysica acta. 2004 Jan;1676(1):96–103. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/14732494.
[91] Basyuk E, Cross JC, Corbin J, Nakayama H, Hunter P, Nait-Oumesmar B, et al.
Murine Gcm1 gene is expressed in a subset of placental trophoblast cells.
Developmental dynamics : an official publication of the American Association
of Anatomists. 1999 Apr;214(4):303–11. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10213386.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
170 John Michael Williams
BIBLIOGRAPHY
[92] Schreiber J, Riethmacher-Sonnenberg E, Riethmacher D, Tuerk EE, Enderich J,
Bösl MR, et al. Placental failure in mice lacking the mammalian homolog of
glial cells missing, GCMa. Molecular and cellular biology. 2000
Apr;20(7):2466–74. Available from:
http://mcb.asm.org/content/20/7/2466.short http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=85439&tool=
pmcentrez&rendertype=abstract.
[93] Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R, et al.
Interaction between Oct3/4 and Cdx2 determines trophectoderm
differentiation. Cell. 2005 Dec;123(5):917–29. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16325584.
[94] Kuijk EW, Du Puy L, Van Tol HTA, Oei CHY, Haagsman HP, Colenbrander B,
et al. Differences in early lineage segregation between mammals.
Developmental dynamics : an official publication of the American Association
of Anatomists. 2008 Apr;237(4):918–27. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18330925.
[95] Nishioka N, Yamamoto S, Kiyonari H, Sato H, Sawada A, Ota M, et al. Tead4 is
required for specification of trophectoderm in pre-implantation mouse
embryos. Mechanisms of development. 2008;125(3-4):270–83. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18083014.
[96] Russ AP, Wattler S, Colledge WH, Aparicio Sa, Carlton MB, Pearce JJ, et al.
Eomesodermin is required for mouse trophoblast development and mesoderm
formation. Nature. 2000 Mar;404(6773):95–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10716450.
[97] Cheng YH, Aronow BJ, Hossain S, Trapnell B, Kong S, Handwerger S. Critical
role for transcription factor AP-2alpha in human trophoblast differentiation.
Physiological genomics. 2004 Jun;18(1):99–107. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15039486.
[98] Richardson BD, Langland RA, Bachurski CJ, Richards RG, Kessler CA, Cheng
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
171 John Michael Williams
BIBLIOGRAPHY
YH, et al. Activator protein-2 regulates human placental lactogen gene
expression. Molecular and cellular endocrinology. 2000 Feb;160(1-2):183–92.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10715552.
[99] Kuckenberg P, Buhl S, Woynecki T, van Fürden B, Tolkunova E, Seiffe F, et al.
The transcription factor TCFAP2C/AP-2gamma cooperates with CDX2 to
maintain trophectoderm formation. Molecular and cellular biology. 2010
Jul;30(13):3310–20. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2897582&tool=pmcentrez&rendertype=abstract.
[100] Ralston A, Cox BJ, Nishioka N, Sasaki H, Chea E, Rugg-Gunn P, et al. Gata3
regulates trophoblast development downstream of Tead4 and in parallel to
Cdx2. Development (Cambridge, England). 2010 Feb;137(3):395–403. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/20081188.
[101] Yan J, Tanaka S, Oda M, Makino T, Ohgane J, Shiota K. Retinoic acid promotes
differentiation of trophoblast stem cells to a giant cell fate. Developmental
biology. 2001 Jul;235(2):422–32. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11437448.
[102] Loregger T. Regulatory Transcription Factors Controlling Function and
Differentiation of Human Trophoblast - A Review. Placenta. 2003
Apr;24:S104–S110. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S014340040290929X.
[103] Fitzgerald JS, Busch S, Wengenmayer T, Foerster K, de la Motte T, Poehlmann
TG, et al. Signal transduction in trophoblast invasion. Chemical immunology
and allergy. 2005 Jan;88:181–99. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16129946.
[104] Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the
pathogenesis of preeclampsia. Obstetrics and gynecology annual. 1972
Jan;1:177–91. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/4669123.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
172 John Michael Williams
BIBLIOGRAPHY
[105] Brümmendorf T, Rathjen FG. Cell adhesion molecules. 1: immunoglobulin
superfamily. Protein profile. 1994 Jan;1(9):951–1058. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8528906.
[106] Rudert F, Saunders AM, Rebstock S, Thompson JA, Zimmermann W.
Characterization of murine carcinoembryonic antigen gene family members.
Mammalian genome : official journal of the International Mammalian Genome
Society. 1992 Jan;3(5):262–73. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1638085.
[107] Ohta T. Evolution of gene families. Gene. 2000 Dec;259(1-2):45–52. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/11163960.
[108] Louis EJ. Evolutionary genetics: making the most of redundancy. Nature. 2007
Oct;449(7163):673–4. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17928851.
[109] Kammerer R, Zimmermann W. Coevolution of activating and inhibitory
receptors within mammalian carcinoembryonic antigen families. BMC biology.
2010 Jan;8:12. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2832619&tool=pmcentrez&rendertype=abstract.
[110] Haig D. Genetic Conflicts in Human Pregnancy. The Quarterly Review of
Biology. 1993 Dec;68(4):495. Available from:
http://www.journals.uchicago.edu/doi/abs/10.1086/418300.
[111] Chuong EB, Tong W, Hoekstra HE. Maternal-fetal conflict: rapidly evolving
proteins in the rodent placenta. Molecular biology and evolution. 2010
Jun;27(6):1221–5. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20123797.
[112] Hammarström S. The carcinoembryonic antigen (CEA) family: structures,
suggested functions and expression in normal and malignant tissues. Seminars
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
173 John Michael Williams
BIBLIOGRAPHY
in cancer biology. 1999 Apr;9(2):67–81. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10202129.
[113] Kuespert K, Pils S, Hauck CR. CEACAMs: their role in physiology and
pathophysiology. Current opinion in cell biology. 2006 Oct;18(5):565–71.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/16919437.
[114] Beauchemin N, Benchimol S, Cournoyer D, Fuks A, Stanners CP. Isolation and
characterization of full-length functional cDNA clones for human
carcinoembryonic antigen. Molecular and cellular biology. 1987
Sep;7(9):3221–30. Available from: http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=367958&tool=pmcentrez&rendertype=abstract.
[115] Oikawa S, Nakazato H, Kosaki G. Primary structure of human
carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochemical
and biophysical research communications. 1987 Jan;142(2):511–8. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/3814146.
[116] Zheng QX, Tease LA, Shupert WL, Chan WY. Characterization of cDNAs of the
human pregnancy-specific beta 1-glycoprotein family, a new subfamily of the
immunoglobulin gene superfamily. Biochemistry. 1990 Mar;29(11):2845–52.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2346748.
[117] Nagaishi T, Chen Z, Chen L, Iijima H, Nakajima a, Blumberg RS. CEACAM1
and the regulation of mucosal inflammation. Mucosal immunology. 2008
Nov;1 Suppl 1(November):S39–42. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19079227.
[118] Coutelier JP, Godfraind C, Dveksler GS, Wysocka M, Cardellichio CB, Noël H,
et al. B lymphocyte and macrophage expression of carcinoembryonic
antigen-related adhesion molecules that serve as receptors for murine
coronavirus. European journal of immunology. 1994 Jun;24(6):1383–90.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8206098.
[119] Prall F, Nollau P, Neumaier M, Haubeck HD, Drzeniek Z, Helmchen U, et al.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
174 John Michael Williams
BIBLIOGRAPHY
CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is
expressed in epithelium, endothelium, and myeloid cells in a wide range of
normal human tissues. The journal of histochemistry and cytochemistry :
official journal of the Histochemistry Society. 1996 Jan;44(1):35–41. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/8543780.
[120] Kammerer R, Stober D, Singer BB, Obrink B, Reimann J. Carcinoembryonic
antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent
regulator of T cell stimulation. Journal of immunology (Baltimore, Md : 1950).
2001 Jun;166(11):6537–44. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11359805.
[121] Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of
immunity. Nature reviews Immunology. 2006 Jun;6(6):433–46. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16724098.
[122] Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP.
Carcinoembryonic antigen, a human tumor marker, functions as an
intercellular adhesion molecule. Cell. 1989 Apr;57(2):327–34. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/2702691.
[123] Taheri M, Saragovi U, Fuks A, Makkerh J, Mort J, Stanners CP. Self recognition
in the Ig superfamily. Identification of precise subdomains in carcinoembryonic
antigen required for intercellular adhesion. The Journal of biological chemistry.
2000 Sep;275(35):26935–43. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10864933.
[124] Tan K, Zelus BD, Meijers R, Liu Jh, Bergelson JM, Duke N, et al. Crystal
structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA
family. The EMBO journal. 2002 May;21(9):2076–86. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
125375&tool=pmcentrez&rendertype=abstract.
[125] Obrink B. CEA adhesion molecules: multifunctional proteins with
signal-regulatory properties. Current opinion in cell biology. 1997
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
175 John Michael Williams
BIBLIOGRAPHY
Oct;9(5):616–26. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9330864.
[126] Muchová L, Vítek L, Jirsa M. [CEACAM1–a less well-known member of the
family of carcinoembryonic antigens]. Casopís lékar˘u˚ c˘eských. 2003
Jan;142(5):259–63. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12920788.
[127] Lin T, Halbert S, Spellacy W. Measurement of pregnancy-associated plasma
proteins during human gestation. Journal of Clinical Investigation.
1974;54(April):576–582. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC301590/.
[128] Lee JN, Grudzinskas JG, Chard T. Circulating levels of pregnancy proteins in
early and late pregnancy in relation to placental tissue concentration. British
journal of obstetrics and gynaecology. 1979 Nov;86(11):888–90. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/315792.
[129] Kromer B, Finkenzeller D, Wessells J, Dveksler G, Thompson J, Zimmermann
W. Coordinate expression of splice variants of the murine pregnancy-specific
glycoprotein (PSG) gene family during placental development. European
journal of biochemistry / FEBS. 1996 Dec;242(2):280–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8973644.
[130] Rebstock S, Lucas K, Weiss M, Thompson J, Zimmermann W. Spatiotemporal
expression of pregnancy-specific glycoprotein gene rnCGM1 in rat placenta.
Developmental dynamics : an official publication of the American Association
of Anatomists. 1993 Nov;198(3):171–81. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8136522.
[131] Lei KJ, Sartwell aD, Pan CJ, Chou JY. Cloning and expression of genes
encoding human pregnancy-specific glycoproteins. The Journal of biological
chemistry. 1992 Aug;267(23):16371–8. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1644821.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
176 John Michael Williams
BIBLIOGRAPHY
[132] Rettenberger G, Klett C, Zechner U, Kunz J, Vogel W, Hameister H.
Visualization of the conservation of synteny between humans and pigs by
heterologous chromosomal painting. Genomics. 1995 Mar;26(2):372–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/7601464.
[133] Teglund S, Olsen A, Khan WN, Frangsmyr L, Hammarström S. The
pregnancy-specific glycoprotein (PSG) gene cluster on human chromosome 19:
fine structure of the 11 PSG genes and identification of 6 new genes forming a
third subgroup within the carcinoembryonic antigen (CEA) family. Genomics.
1994;23(3):669–684. Available from:
http://www.sciencedirect.com/science/article/pii/S0888754384715564.
[134] Rudert F, Zimmermann W, Thompson JA. Intra- and interspecies analyses of
the carcinoembryonic antigen (CEA) gene family reveal independent evolution
in primates and rodents. Journal of molecular evolution. 1989
Aug;29(2):126–34. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/2509715.
[135] Zhou GQ, Baranov V, Zimmermann W, Grunert F, Erhard B, Mincheva-Nilsson
L, et al. Highly specific monoclonal antibody demonstrates that
pregnancy-specific glycoprotein (PSG) is limited to syncytiotrophoblast in
human early and term placenta. Placenta. 1997 Sep;18(7):491–501. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/9290143.
[136] Bohn H. [Detection and characterization of pregnancy proteins in the human
placenta and their quantitative immunochemical determination in sera from
pregnant women]. Archiv für Gynäkologie. 1971 Oct;210(4):440–57. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/5001318.
[137] Gardner MO, Goldenberg RL, Cliver SP, Boots LR, Hoffman HJ. Maternal
serum concentrations of human placental lactogen, estradiol and pregnancy
specific beta 1-glycoprotein and fetal growth retardation. Acta obstetricia et
gynecologica Scandinavica Supplement. 1997 Jan;165:56–8. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9219458.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
177 John Michael Williams
BIBLIOGRAPHY
[138] Gordon YB, Grudzinskas JG, Lewis JD, Jeffrey D, Letchworth AT. Circulating
levels of pregnancy-specific beta1-glycoprotein and human placental lactogen
in the third trimester of pregnancy: their relationship to parity, birth weight,
and placental weight. British journal of obstetrics and gynaecology. 1977
Sep;84(9):642–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/911715.
[139] Gordon YP, Grudzinskas JG, Jeffrey D, Chard T. Concentrations of
pregnancy-specific beta 1-glycoprotein in maternal blood in normal pregnancy
and in intrauterine growth retardation. Lancet. 1977 Mar;1(8007):331–3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/64859.
[140] Würz H, Geiger W, Künzig HJ, Jabs-Lehmann A, Bohn H, Lüben G.
Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal
blood and in amniotic fluid normal and pathologic pregnancies. Journal of
perinatal medicine. 1981 Jan;9(2):67–78. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/6787188.
[141] Tamsen L. Pregnancy-specific beta 1-glycoprotein (SP1) levels measured by
nephelometry in serum from women with vaginal bleeding in the first half of
pregnancy. Acta obstetricia et gynecologica Scandinavica. 1984 Jan;63(4):311–5.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/6611014.
[142] MacDonald DJ, Scott JM, Gemmell RS, Mack DS. A prospective study of three
biochemical fetoplacental tests: serum human placental lactogen,
pregnancy-specific beta 1-glycoprotein, and urinary estrogens, and their
relationship to placental insufficiency. American journal of obstetrics and
gynecology. 1983 Oct;147(4):430–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/6605089.
[143] Grudzinskas JG, Gordon YB, Menabawey M, Lee JN, Wadsworth J, Chard T.
Identification of high-risk pregnancy by the routine measurement of
pregnancy-specific beta 1-glycoprotein. American journal of obstetrics and
gynecology. 1983 Sep;147(1):10–2. Available from:
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
178 John Michael Williams
BIBLIOGRAPHY
http://www.ncbi.nlm.nih.gov/pubmed/6604456.
[144] Horne CH, Towler CM, Pugh-Humphreys RG, Thomson AW, Bohn H.
Pregnancy specific beta1-glycoprotein–a product of the syncytiotrophoblast.
Experientia. 1976 Sep;32(9):1197. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/971765.
[145] Hau J, Gidley-Baird AA, Westergaard JG, Teisner B. The effect on pregnancy of
intrauterine administration of antibodies against two pregnancy-associated
murine proteins: murine pregnancy-specific beta 1-glycoprotein and murine
pregnancy-associated alpha 2-glycoprotein. Biomedica biochimica acta. 1985
Jan;44(7-8):1255–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/3878707.
[146] McLellan AS, Zimmermann W, Moore T. Conservation of pregnancy-specific
glycoprotein (PSG) N domains following independent expansions of the gene
families in rodents and primates. BMC evolutionary biology. 2005 Jan;5:39.
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=1185527&tool=pmcentrez&rendertype=abstract.
[147] Teglund S, Zhou GQ, Hammarström S. Characterization of cDNA encoding
novel pregnancy-specific glycoprotein variants. Biochemical and biophysical
research communications. 1995 Jun;211(2):656–64. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7794280.
[148] McLellan AS, Fischer B, Dveksler G, Hori T, Wynne F, Ball M, et al. Structure
and evolution of the mouse pregnancy-specific glycoprotein (Psg) gene locus.
BMC genomics. 2005 Jan;6:4. Available from:
http://w25.biomedcentral.com/1471-2164/6/4/ http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=546212&tool=
pmcentrez&rendertype=abstract.
[149] Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and
integrins. Science (New York, NY). 1987 Oct;238(4826):491–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/2821619.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
179 John Michael Williams
BIBLIOGRAPHY
[150] Kim JP, Zhang K, Chen JD, Wynn KC, Kramer RH, Woodley DT. Mechanism of
human keratinocyte migration on fibronectin: unique roles of RGD site and
integrins. Journal of cellular physiology. 1992 Jun;151(3):443–50. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/1295896.
[151] Kim JP, Chen JD, Wilke MS, Schall TJ, Woodley DT. Human keratinocyte
migration on type IV collagen. Roles of heparin-binding site and alpha 2 beta 1
integrin. Laboratory investigation; a journal of technical methods and
pathology. 1994 Sep;71(3):401–8. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7933990.
[152] Kodelja V, Lucas K, Barnert S, von Kleist S, Thompson Ja, Zimmermann W.
Identification of a carcinoembryonic antigen gene family in the rat. Analysis of
the N-terminal domains reveals immunoglobulin-like, hypervariable regions.
The Journal of biological chemistry. 1989 Apr;264(12):6906–12. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7851896 http:
//www.ncbi.nlm.nih.gov/pubmed/2708349 http:
//www.jbc.org/content/264/12/6906.short.
[153] McLane MA, Joerger T, Mahmoud A. Disintegrins in health and disease.
Frontiers in bioscience : a journal and virtual library. 2008 Jan;13:6617–37.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18508683.
[154] Ruoslahti E, Pierschbacher MD. Arg-Gly-Asp: a versatile cell recognition
signal. Cell. 1986 Feb;44(4):517–8. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/2418980.
[155] Rutherfurd KJ, Chou JY, Mansfield BC. A motif in PSG11s mediates binding to
a receptor on the surface of the promonocyte cell line THP-1. Molecular
endocrinology (Baltimore, Md). 1995 Oct;9(10):1297–305. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8544838.
[156] Barbato O, Sousa NM, Klisch K, Clerget E, Debenedetti A, Barile VL, et al.
Isolation of new pregnancy-associated glycoproteins from water buffalo
(Bubalus bubalis) placenta by Vicia villosa affinity chromatography. Research
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
180 John Michael Williams
BIBLIOGRAPHY
in veterinary science. 2008 Dec;85(3):457–66. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18308351.
[157] Szafranska B, Panasiewicz G, Majewska M. Biodiversity of multiple
Pregnancy-Associated Glycoprotein (PAG) family: gene cloning and chorionic
protein purification in domestic and wild eutherians (Placentalia)–a review.
Reproduction, nutrition, development. 2006;46(5):481–502. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17107639.
[158] Motrán CC, Díaz FL, Gruppi A, Slavin D, Chatton B, Bocco JL. Human
pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in
human and mouse monocytes and suppresses the accessory cell-dependent T
cell proliferation. Journal of leukocyte biology. 2002 Sep;72(3):512–21. Available
from: http://www.jleukbio.org/content/72/3/512.short http:
//www.ncbi.nlm.nih.gov/pubmed/12223519.
[159] Wessells J, Wessner DH, Parsells R, White K, Finkenzeller D, Zimmermann W,
et al. Pregnancy specific glycoprotein 18 induces IL-10 expression in murine
macrophages. European journal of immunology. 2000 Jul;30(7):1830–40.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10940872.
[160] Snyder SK, Wessner DH, Wessells J, Waterhouse R, Wahl LM, Zimmermann W,
et al. Pregnancy-specific glycoproteins function as immunomodulators by
inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes.
American journal of reproductive immunology (New York, NY : 1989). 2001
Apr;45(4):205–16. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11327547.
[161] Waterhouse R, Ha CT, Dveksler G. Murine CD9 is the receptor for
pregnancy-specific glycoprotein 17. The Journal of experimental medicine.
2002;195(2):277–282. Available from:
http://jem.rupress.org/content/195/2/277.abstract.
[162] Ellerman DA, Ha CT, Primakoff P, Myles DG, Dveksler GS. Direct binding of
the ligand PSG17 to CD9 requires a CD9 site essential for sperm-egg fusion.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
181 John Michael Williams
BIBLIOGRAPHY
Molecular biology of the cell. 2003;14(12):5098. Available from:
http://www.molbiolcell.org/cgi/content/abstract/14/12/5098.
[163] Ha CT, Waterhouse R, Wessells J, Wu JA, Dveksler GS. Binding of
pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion
of IL-10, IL-6, PGE2, and TGF-beta1. Journal of leukocyte biology. 2005
Jun;77(6):948–57. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15772125.
[164] Ha CT, Waterhouse R, Warren J, Zimmermann W, Dveksler GS.
N-glycosylation is required for binding of murine pregnancy-specific
glycoproteins 17 and 19 to the receptor CD9. American journal of reproductive
immunology (New York, NY : 1989). 2008 Mar;59(3):251–8. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18275518.
[165] Blois SM, Tirado-González I, Wu J, Barrientos G, Johnson B, Warren J, et al.
Early expression of pregnancy-specific glycoprotein 22 (PSG22) by trophoblast
cells modulates angiogenesis in mice. Biology of reproduction. 2012
Jun;86(6):191. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22423048.
[166] Martínez FF, Knubel CP, Sánchez MC, Cervi L, Motrán CC. Pregnancy-specific
glycoprotein 1a activates dendritic cells to provide signals for Th17-, Th2-, and
Treg-cell polarization. European journal of immunology. 2012
Jun;42(6):1573–84. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22678910.
[167] Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, et al.
Characterization of type 1 and type 2 cytokine production profile in
physiologic and pathologic human pregnancy. Clinical and experimental
immunology. 1996 Oct;106(1):127–33. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2200555&tool=pmcentrez&rendertype=abstract.
[168] Hill JA, Polgar K, Anderson DJ. T-helper 1-type immunity to trophoblast in
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
182 John Michael Williams
BIBLIOGRAPHY
women with recurrent spontaneous abortion. JAMA : the journal of the
American Medical Association. 1995 Jun;273(24):1933–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7783303.
[169] Moormann AM, Sullivan AD, Rochford RA, Chensue SW, Bock PJ, Nyirenda T,
et al. Malaria and pregnancy: placental cytokine expression and its relationship
to intrauterine growth retardation. The Journal of infectious diseases. 1999
Dec;180(6):1987–93. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10558956.
[170] Wu J, Johnson BL, Chen Y, Ha CT, Dveksler GS. Murine pregnancy-specific
glycoprotein 23 induces the proangiogenic factors transforming-growth factor
beta 1 and vascular endothelial growth factor a in cell types involved in
vascular remodeling in pregnancy. Biology of reproduction. 2008
Dec;79(6):1054–61. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18753609 http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2613688&tool=
pmcentrez&rendertype=abstract.
[171] Lisboa FA, Warren J, Sulkowski GN, Aparicio M, David G, Zudaire E, et al.
Pregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through
interaction with cell surface proteoglycans. Journal of Biological Chemistry.
2011;286(9):7577. Available from: http://citeseerx.ist.psu.edu/viewdoc/
download?doi=10.1.1.96.5699&amp;rep=rep1&amp;type=pdf http:
//www.jbc.org/content/286/9/7577.short.
[172] Minagawa S, Nakabayashi K, Fujii M, Scherer SW, Ayusawa D. Early
BrdU-responsive genes constitute a novel class of senescence-associated genes
in human cells. Experimental cell research. 2005 Apr;304(2):552–8. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/15748899.
[173] Endoh M, Kobayashi Y, Yamakami Y, Yonekura R, Fujii M, Ayusawa D.
Coordinate expression of the human pregnancy-specific glycoprotein gene
family during induced and replicative senescence. Biogerontology. 2009
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
183 John Michael Williams
BIBLIOGRAPHY
Apr;10(2):213–21. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18792801.
[174] Shanley DK, Kiely PA, Golla K, Allen S, Martin K, O’Riordan RT, et al.
Pregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the
platelet-fibrinogen interaction. PloS one. 2013 Jan;8(2):e57491. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3585349&tool=pmcentrez&rendertype=abstract.
[175] Boucheix C, Rubinstein E. Tetraspanins. Cellular and molecular life sciences :
CMLS. 2001 Aug;58(9):1189–205. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11577978.
[176] Sulkowski GN, Warren J, Ha CT, Dveksler GS. Characterization of receptors for
murine pregnancy specific glycoproteins 17 and 23. Placenta. 2011
Jun;32(8):1–8. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3142296&tool=pmcentrez&rendertype=abstract http:
//www.ncbi.nlm.nih.gov/pubmed/21669460.
[177] Schaefer L, Schaefer RM. Proteoglycans: from structural compounds to
signaling molecules. Cell and tissue research. 2010 Jan;339(1):237–46. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/19513755.
[178] Kuberan B, Lech M, Borjigin J, Rosenberg RD. Light-induced
3-O-sulfotransferase expression alters pineal heparan sulfate fine structure. A
surprising link to circadian rhythm. The Journal of biological chemistry. 2004
Feb;279(7):5053–4. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/14630922.
[179] Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC. Syndecan-1 regulates
alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is
blocked by synstatin, a novel peptide inhibitor. The Journal of experimental
medicine. 2009 Mar;206(3):691–705. Available from:
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
184 John Michael Williams
BIBLIOGRAPHY
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2699122&tool=pmcentrez&rendertype=abstract.
[180] Thompson J, Koumari R, Wagner K, Barnert S, Schleussner C, Schrewe H, et al.
The human pregnancy-specific glycoprotein genes are tightly linked on the
long arm of chromosome 19 and are coordinately expressed. Biochemical and
biophysical research communications. 1990 Mar;167(2):848–59. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1690992.
[181] Camolotto S, Racca a, Rena V, Nores R, Patrito LC, Genti-Raimondi S, et al.
Expression and transcriptional regulation of individual pregnancy-specific
glycoprotein genes in differentiating trophoblast cells. Placenta. 2010
Apr;31(4):312–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20116096.
[182] Dimitriadou F, Phocas I, Mantzavinos T, Sarandakou A, Rizos D, Zourlas PA.
Discordant secretion of pregnancy specific beta 1-glycoprotein and human
chorionic gonadotropin by human pre-embryos cultured in vitro. Fertility and
sterility. 1992 Mar;57(3):631–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1740210.
[183] Aronow BJ, Richardson BD, Handwerger S. Microarray analysis of trophoblast
differentiation: gene expression reprogramming in key gene function
categories. Physiological genomics. 2001 Jul;6(2):105–16. Available from:
http://physiolgenomics.physiology.org/content/6/2/105.short http:
//www.ncbi.nlm.nih.gov/pubmed/11459926.
[184] Streydio C, Swillens S, Georges M, Szpirer C, Vassart G. Structure, evolution
and chromosomal localization of the human pregnancy-specific beta
1-glycoprotein gene family. Genomics. 1990 Aug;7(4):661–2. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/2387594.
[185] Wu SM, Bazar LS, Cohn ML, Cahill RA, Chan WY. Expression of
pregnancy-specific beta 1-glycoprotein genes in hematopoietic cells. Molecular
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
185 John Michael Williams
BIBLIOGRAPHY
and cellular biochemistry. 1993 May;122(2):147–58. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8232246.
[186] Searle F, Leake BA, Bagshawe KD, Dent J.
Serum-SP1-pregnancy-specific-beta-glycoprotein in choriocarcinoma and other
neoplastic disease. Lancet. 1978 Mar;1(8064):579–81. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/76123.
[187] Fagnart OC, Cambiaso CL, Lejeune MD, Noel G, Maisin H, Masson PL.
Prognostic value of concentration of pregnancy-specific beta 1-glycoprotein
(SP1) in serum of patients with breast cancer. International journal of cancer
Journal international du cancer. 1985 Nov;36(5):541–4. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/3876999.
[188] Horne CH, Reid IN, Milne GD. Prognostic significance of inappropriate
production of pregnancy proteins by breast cancers. Lancet. 1976
Aug;2(7980):279–82. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/59853.
[189] Chamberlin ME, Lei KJ, Chou JY. Subtle differences in human
pregnancy-specific glycoprotein gene promoters allow for differential
expression. The Journal of biological chemistry. 1994 Jun;269(25):17152–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8006022.
[190] Salahshor S, Goncalves J, Chetty R, Gallinger S, Woodgett JR. Differential gene
expression profile reveals deregulation of pregnancy specific beta1
glycoprotein 9 early during colorectal carcinogenesis. BMC cancer. 2005
Jan;5:66. Available from: http://www.biomedcentral.com/1471-
2407/5/66/ http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=1184062&tool=pmcentrez&rendertype=abstract.
[191] Ball M, McLellan AS, Collins B, Coadwell J, Stewart F, Moore T. An abundant
placental transcript containing an IAP-LTR is allelic to mouse
pregnancy-specific glycoprotein 23 ( Psg23 ): cloning and genetic analysis.
Gene. 2004;325:103 – 113.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
186 John Michael Williams
BIBLIOGRAPHY
[192] Kawano K, Ebisawa M, Hase K, Fukuda S, Hijikata A, Kawano S, et al. Psg18 is
specifically expressed in follicle-associated epithelium. Cell structure and
function. 2007 Jan;32(2):115–26. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17984568.
[193] Phillips JM, Kuo IT, Richardson C, Weiss SR. A novel full-length isoform of
murine pregnancy-specific glycoprotein 16 (psg16) is expressed in the brain but
does not mediate murine coronavirus (MHV) entry. Journal of neurovirology.
2012 Apr;18(2):138–43. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22302612.
[194] Bocco JL, Panzetta-Dutari GM, Flury A, Patrito LC. Expression of pregnancy
specific beta 1-glycoprotein gene in human placenta and hydatiform mole.
Biochemistry international. 1989 May;18(5):999–1008. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/2528957.
[195] Frangsmyr L, Israelsson A, Teglund S, Matsunaga T, Hammarström S.
Evolution of the carcinoembryonic antigen family. structures of CGM9, CGM11
and pregnancy-specific glycoprotein promoters. Tumour biology : the journal
of the International Society for Oncodevelopmental Biology and Medicine.
2000;21(2):63–81. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10686536.
[196] Koritschoner NP, Bocco JL, Panzetta-Dutari GM, Dumur CI, Flury a, Patrito LC.
A novel human zinc finger protein that interacts with the core promoter
element of a TATA box-less gene. The Journal of biological chemistry. 1997
Apr;272(14):9573–80. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9083102.
[197] Blanchon L, Nores R, Gallot D, Marceau G, Borel V, Yang VW, et al. Activation
of the human pregnancy-specific glycoprotein PSG-5 promoter by KLF4 and
Sp1. Biochemical and biophysical research communications. 2006
May;343(3):745–753. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16563348 http:
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
187 John Michael Williams
BIBLIOGRAPHY
//www.sciencedirect.com/science/article/pii/S0006291X06005420.
[198] Racca AC, Camolotto S, Ridano ME, Bocco JL, Genti-Raimondi S,
Panzetta-Dutari GM. Krüppel-Like Factor 6 Expression Changes during
Trophoblast Syncytialization and Transactivates ßhCG and PSG Placental
Genes. PloS one. 2011 Jan;6(7):e22438. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3142166&tool=pmcentrez&rendertype=abstract.
[199] Nores R, Blanchon L, López-Díaz F, Bocco JL, Patrito LC, Sapin V, et al.
Transcriptional control of the human pregnancy-specific glycoprotein 5 gene is
dependent on two GT-boxes recognized by the ubiquitous specificity protein 1
(Sp1) transcription factor. Placenta. 2004 Jan;25(1):9–19. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15013634.
[200] López-Díaz F, Nores R, Panzetta-Dutari GM, Slavin D, Prieto C, Koritschoner
NP, et al. RXRalpha regulates the pregnancy-specific glycoprotein 5 gene
transcription through a functional retinoic acid responsive element. Placenta.
2007;28(8-9):898–906. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17475324.
[201] Oikawa D, Akai R, Iwawaki T. Positive contribution of the IRE1alpha-XBP1
pathway to placental expression of CEA family genes. FEBS letters. 2010
Mar;584(5):1066–70. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20146926.
[202] Panzetta-Dutari GM, Bocco JL, Reimund B, Flury A, Patrito LC. Nucleotide
sequence of a pregnancy-specific beta 1 glycoprotein gene family member.
Identification of a functional promoter region and several putative regulatory
sequences. Molecular biology reports. 1992 Sep;16(4):255–62. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1454058.
[203] Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, et al.
Functional activity of myogenic HLH proteins requires hetero-oligomerization
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
188 John Michael Williams
BIBLIOGRAPHY
with E12/E47-like proteins in vivo. Cell. 1991 Jul;66(2):305–15. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/1649701.
[204] Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies
a novel retinoic acid response pathway. Nature. 1990 May;345(6272):224–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2159111.
[205] Panzetta-Dutari GM, Koritschoner N. Transcription of genes encoding
pregnancy-specific glycoproteins is regulated by negative promoter-selective
elements. Biochemical. 2000;519:511–519. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221279/.
[206] Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced
by ATF6 and spliced by IRE1 in response to ER stress to produce a highly
active transcription factor. Cell. 2001 Dec;107(7):881–91. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11779464.
[207] Mattick JS, Amaral PP, Dinger ME, Mercer TR, Mehler MF. RNA regulation of
epigenetic processes. BioEssays : news and reviews in molecular, cellular and
developmental biology. 2009 Jan;31(1):51–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19154003.
[208] Cheung P, Lau P. Epigenetic regulation by histone methylation and histone
variants. Molecular endocrinology (Baltimore, Md). 2005 Mar;19(3):563–73.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15677708.
[209] Zlatanova J, Leuba SH, van Holde K. Chromatin fiber structure: morphology,
molecular determinants, structural transitions. Biophysical journal. 1998
May;74(5):2554–66. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1299597&tool=pmcentrez&rendertype=abstract.
[210] Bernstein E, Allis CD. RNA meets chromatin. Genes & development. 2005
Jul;19(14):1635–55. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16024654.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
189 John Michael Williams
BIBLIOGRAPHY
[211] Imhof A. Epigenetic regulators and histone modification. Briefings in
functional genomics & proteomics. 2006 Sep;5(3):222–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16951415.
[212] Kouzarides T. Chromatin modifications and their function. Cell. 2007
Feb;128(4):693–705. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17320507.
[213] Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene.
2001 Oct;278(1-2):25–31. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11707319.
[214] Kamakaka RT, Biggins S. Histone variants: deviants? Genes & development.
2005 Feb;19(3):295–310. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15687254.
[215] Zhang Z, Pugh BF. High-resolution genome-wide mapping of the primary
structure of chromatin. Cell. 2011 Jan;144(2):175–86. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3061432&tool=pmcentrez&rendertype=abstract.
[216] Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al.
Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010
Oct;143(1):46–58. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20887892.
[217] Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO
reports. 2001 Nov;2(11):986–91. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1084129&tool=pmcentrez&rendertype=abstract.
[218] Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The
transcriptional landscape of the mammalian genome. Science (New York, NY).
2005 Sep;309(5740):1559–63. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16141072.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
190 John Michael Williams
BIBLIOGRAPHY
[219] Ma H, Hao Y, Dong X, Gong Q, Chen J, Zhang J, et al. Molecular Mechanisms
and Function Prediction of Long Noncoding RNA. The Scientific World
Journal. 2012;2012(1):1–11. Available from:
http://www.hindawi.com/journals/tswj/2012/541786/.
[220] Amaral PP, Mattick JS. Noncoding RNA in development. Mammalian genome
: official journal of the International Mammalian Genome Society. 2008
Aug;19(7-8):454–92. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18839252.
[221] Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annual
review of biochemistry. 2012 Jan;81:145–66. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22663078.
[222] Prasanth KV, Spector DL. Eukaryotic regulatory RNAs: an answer to the
’genome complexity’ conundrum. Genes & development. 2007 Jan;21(1):11–42.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17210785.
[223] Moran Va, Perera RJ, Khalil AM. Emerging functional and mechanistic
paradigms of mammalian long non-coding RNAs. Nucleic acids research. 2012
Aug;40(14):6391–400. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3413108&tool=pmcentrez&rendertype=abstract.
[224] Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin
signature reveals over a thousand highly conserved large non-coding RNAs in
mammals. Nature. 2009 Mar;458(7235):223–7. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2754849&tool=pmcentrez&rendertype=abstract.
[225] Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D,
et al. A large intergenic noncoding RNA induced by p53 mediates global gene
repression in the p53 response. Cell. 2010 Aug;142(3):409–19. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2956184&tool=pmcentrez&rendertype=abstract.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
191 John Michael Williams
BIBLIOGRAPHY
[226] Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, et al. Large
intergenic non-coding RNA-RoR modulates reprogramming of human induced
pluripotent stem cells. Nature genetics. 2010 Dec;42(12):1113–7. Available
from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3040650&tool=pmcentrez&rendertype=abstract.
[227] Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, et al. Extensive and
coordinated transcription of noncoding RNAs within cell-cycle promoters.
Nature genetics. 2011 Jul;43(7):621–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21642992.
[228] Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, et al.
Many human large intergenic noncoding RNAs associate with
chromatin-modifying complexes and affect gene expression. Proceedings of the
National Academy of Sciences of the United States of America. 2009
Jul;106(28):11667–72. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2704857&tool=pmcentrez&rendertype=abstract.
[229] Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al.
Integrative annotation of human large intergenic noncoding RNAs reveals
global properties and specific subclasses. Genes & development. 2011
Sep;25(18):1915–27. Available from:
http://genesdev.cshlp.org/content/25/18/1915.short http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3185964&tool=
pmcentrez&rendertype=abstract.
[230] Redon S, Reichenbach P, Lingner J. The non-coding RNA TERRA is a natural
ligand and direct inhibitor of human telomerase. Nucleic acids research. 2010
Sep;38(17):5797–806. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2943627&tool=pmcentrez&rendertype=abstract.
[231] Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
192 John Michael Williams
BIBLIOGRAPHY
nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by
modulating SR splicing factor phosphorylation. Molecular cell. 2010
Sep;39(6):925–38. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20797886.
[232] Collins K. Physiological assembly and activity of human telomerase
complexes. Mechanisms of ageing and development;129(1-2):91–8. Available
from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2323683&tool=pmcentrez&rendertype=abstract.
[233] Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, et al.
Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional
silencing through chromatin-level regulation. Molecular cell. 2008
Oct;32(2):232–46. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18951091.
[234] Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R, et al.
The Air noncoding RNA epigenetically silences transcription by targeting G9a
to chromatin. Science (New York, NY). 2008 Dec;322(5908):1717–20. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/18988810.
[235] Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C, et al.
Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and
memories. Neuron. 2006 Nov;52(3):437–44. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17088210.
[236] Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N, et al.
Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor
trafficking. Neuron. 2006 Nov;52(3):445–59. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1784006&tool=pmcentrez&rendertype=abstract.
[237] Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D, et al.
Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors.
Neuron. 2006 Nov;52(3):475–84. Available from:
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
193 John Michael Williams
BIBLIOGRAPHY
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1764219&tool=pmcentrez&rendertype=abstract.
[238] Kawashima T, Okuno H, Nonaka M, Adachi-Morishima A, Kyo N, Okamura
M, et al. Synaptic activity-responsive element in the Arc/Arg3.1 promoter
essential for synapse-to-nucleus signaling in activated neurons. Proceedings of
the National Academy of Sciences of the United States of America. 2009
Jan;106(1):316–21. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2629236&tool=pmcentrez&rendertype=abstract.
[239] Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread
transcription at neuronal activity-regulated enhancers. Nature. 2010
May;465(7295):182–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/3020079 http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3020079&tool=
pmcentrez&rendertype=abstract.
[240] Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A
long noncoding RNA maintains active chromatin to coordinate homeotic gene
expression. Nature. 2011 Apr;472(7341):120–4. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21423168.
[241] Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the
control region of mitochondrial DNA in humans and chimpanzees. Molecular
biology and evolution. 1993 May;10(3):512–26. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8336541.
[242] Felsenstein J. Confidence Limits on Phylogenies: An Approach Using the
Bootstrap. Evolution. 1985 Jul;39(4):783. Available from:
http://www.jstor.org/stable/2408678?origin=crossref.
[243] Dye F. Obtaining Early Mammalian Embryos. Tested studies for laboratory
teaching. 1993;7:97–112. Available from:
http://www.ableweb.org/volumes/vol-7/8-dye.pdf.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
194 John Michael Williams
BIBLIOGRAPHY
[244] Conner D. Mouse embryo fibroblast (MEF) feeder cell preparation. Current
Protocols in Molecular Biology. 2001 May;Chapter 23:Unit 23.2. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18265203 http:
//onlinelibrary.wiley.com/doi/10.1002/0471142727.mb2302s51/full.
[245] Oda M, Shiota K, Tanaka S. Trophoblast stem cells. Methods in enzymology.
2006 Jan;419:387–400. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17141063.
[246] Himeno E, Tanaka S, Kunath T. Isolation and manipulation of mouse
trophoblast stem cells. Current protocols in stem cell biology. 2008 Oct;Chapter
1(October):Unit 1E.4. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18972374.
[247] Soares MJ, Konno T, Alam SMK. The prolactin family: effectors of
pregnancy-dependent adaptations. Trends in endocrinology and metabolism:
TEM. 2007 Apr;18(3):114–21. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17324580.
[248] Osoegawa K, Tateno M, Woon PY, Frengen E, Mammoser aG, Catanese JJ, et al.
Bacterial artificial chromosome libraries for mouse sequencing and functional
analysis. Genome research. 2000 Jan;10(1):116–28. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
310499&tool=pmcentrez&rendertype=abstract.
[249] Rubinson D, Dillon C, Kwiatkowski A. A lentivirus-based system to
functionally silence genes in primary mammalian cells, stem cells and
transgenic mice by RNA interference. Nature genetics. 2003 Mar;33(3):401–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12590264 http:
//www.nature.com/ng/journal/v33/n3/abs/ng1117.html.
[250] Ventura A, Meissner A. Cre-lox-regulated conditional RNA interference from
transgenes. Proceedings of the National Academy of Sciences of the United
States of America. 2004 Jul;101(28):10380–5. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
195 John Michael Williams
BIBLIOGRAPHY
478580&tool=pmcentrez&rendertype=abstract http:
//www.pnas.org/content/101/28/10380.short.
[251] Vandenbroucke II, Vandesompele J, Paepe aD, Messiaen L. Quantification of
splice variants using real-time PCR. Nucleic acids research. 2001
Jul;29(13):E68–8. Available from: http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=55792&tool=pmcentrez&rendertype=abstract.
[252] Goossens K, Van Soom A, Van Zeveren A, Favoreel H, Peelman LJ.
Quantification of fibronectin 1 (FN1) splice variants, including two novel ones,
and analysis of integrins as candidate FN1 receptors in bovine preimplantation
embryos. BMC developmental biology. 2009 Jan;9:1. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2648952&tool=pmcentrez&rendertype=abstract.
[253] Prete MD, Vernal R, Dolznig H. Isolation of polysome-bound mRNA from
solid tissues amenable for RT-PCR and profiling experiments. Rna.
2007;13(3):414–421. Available from:
http://rnajournal.cshlp.org/content/13/3/414.short.
[254] Stone AB. a simplified method for preparing sucrose gradients. biochem j.
1973;137:117–118.
[255] Sinha AU, Meller J. Cinteny: flexible analysis and visualization of synteny and
genome rearrangements in multiple organisms. BMC bioinformatics. 2007
Jan;8:82. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1821339&tool=pmcentrez&rendertype=abstract.
[256] Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F, et al.
Redefined nomenclature for members of the carcinoembryonic antigen family.
Experimental cell research. 1999 Nov;252(2):243–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11501563?dopt=Abstract http:
//www.ncbi.nlm.nih.gov/pubmed/11501563.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
196 John Michael Williams
BIBLIOGRAPHY
[257] Mangelsdorf DJ, Borgmeyer U, Heyman Ra, Zhou JY, Ong ES, Oro aE, et al.
Characterization of three RXR genes that mediate the action of 9-cis retinoic
acid. Genes & Development. 1992 Mar;6(3):329–344. Available from:
http://www.genesdev.org/cgi/doi/10.1101/gad.6.3.329.
[258] Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens.
Nature reviews Immunology. 2003 Apr;3(4):331–41. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12669023.
[259] Müllner E, Garcia-Sanz J. Polysome gradients. Manual of Immunology
Methods. 1997;p. 457–462. Available from:
http://www.researchgate.net/publication/231637449_Chapter_7.7_
Polysome_Gradients/file/9fcfd506ee5369746b.pdf.
[260] Dong X, Greven MC, Kundaje A, Djebali S, Brown JB, Cheng C, et al. Modeling
gene expression using chromatin features in various cellular contexts. Genome
biology. 2012 Sep;13(9):R53. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22950368.
[261] Thompson J, Zimmermann W. The carcinoembryonic antigen gene family:
structure, expression and evolution. Tumour biology : the journal of the
International Society for Oncodevelopmental Biology and Medicine. 1988
Jan;9(2-3):63–83. Available from:
http://content.karger.com/ProdukteDB/produkte.asp?Doi=217547 http:
//www.ncbi.nlm.nih.gov/pubmed/3041547.
[262] Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annual
review of immunology. 1998 Jan;16:137–61. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9597127.
[263] Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important
regulatory axis in the tumor microenvironment and progression. Trends in
immunology. 2010 Jun;31(6):220–7. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2891151&tool=pmcentrez&rendertype=abstract.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
197 John Michael Williams
BIBLIOGRAPHY
[264] Venkatesha S, Toporsian M, Lam C, Hanai Ji, Mammoto T, Kim YM, et al.
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature
medicine. 2006 Jun;12(6):642–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16751767.
[265] Ha CT, Waterhouse R. N-glycosylation is Required for Binding of Murine
Pregnancy-Specific Glycoproteins 17 and 19 to the Receptor CD9. American
Journal of . . . . 2008;p. 251–258. Available from:
http://onlinelibrary.wiley.com/doi/10.1111/j.1600-
0897.2007.00573.x/full.
[266] Hannon GJ. RNA interference. Nature. 2002 Jul;418(6894):244–51. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/15965464 http:
//www.ncbi.nlm.nih.gov/pubmed/12110901.
[267] Kunath T, Gish G, Lickert H, Jones N, Pawson T, Rossant J. Transgenic RNA
interference in ES cell-derived embryos recapitulates a genetic null phenotype.
Nature biotechnology. 2003 May;21(5):559–61. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12679785.
[268] Pan G, Li J, Zhou Y, Zheng H, Pei D. A negative feedback loop of transcription
factors that controls stem cell pluripotency and self-renewal. FASEB journal :
official publication of the Federation of American Societies for Experimental
Biology. 2006 Aug;20(10):1730–2. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16790525.
[269] Smale ST. Transcription initiation from TATA-less promoters within eukaryotic
protein-coding genes. Biochimica et biophysica acta. 1997 Mar;1351(1-2):73–88.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/9116046.
Expression and Regulation of Pregnancy-Specific
Glycoproteins in the mouse
198 John Michael Williams
